Document_and_Entity_Informatio
Document and Entity Information (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Mar. 03, 2014 | Jun. 28, 2013 | |
Document and Entity Information | ' | ' | ' |
Entity Registrant Name | 'Armored AutoGroup Inc. | ' | ' |
Entity Central Index Key | '0001537660 | ' | ' |
Document Type | '10-K | ' | ' |
Document Period End Date | 31-Dec-13 | ' | ' |
Amendment Flag | 'false | ' | ' |
Current Fiscal Year End Date | '--12-31 | ' | ' |
Entity Well-known Seasoned Issuer | 'No | ' | ' |
Entity Voluntary Filers | 'No | ' | ' |
Entity Current Reporting Status | 'Yes | ' | ' |
Entity Filer Category | 'Non-accelerated Filer | ' | ' |
Entity Public Float | ' | ' | $0 |
Entity Common Stock, Shares Outstanding | ' | 1,000 | ' |
Document Fiscal Year Focus | '2013 | ' | ' |
Document Fiscal Period Focus | 'FY | ' | ' |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Current assets: | ' | ' |
Cash | $21,253 | $4,206 |
Accounts receivable, net | 62,210 | 69,602 |
Inventories | 34,043 | 42,444 |
Other current assets | 9,790 | 12,891 |
Total current assets | 127,296 | 129,143 |
Property, plant and equipment, net | 28,936 | 31,473 |
Goodwill | 358,826 | 362,216 |
Intangible assets, net | 313,470 | 352,905 |
Deferred financing costs and other assets, net | 3,719 | 5,020 |
Total assets | 832,247 | 880,757 |
Current liabilities: | ' | ' |
Accounts payable | 8,128 | 13,158 |
Accrued expenses and other current liabilities | 23,455 | 28,571 |
Current portion of long-term debt, less discount | 71 | 279 |
Total current liabilities | 32,490 | 42,940 |
Long-term debt, less discount and current portion | 553,511 | 553,581 |
Other liability | 2,500 | 2,500 |
Deferred income taxes | 89,610 | 105,131 |
Total liabilities | 678,111 | 704,152 |
Commitments and contingencies (Note 11) | ' | ' |
Shareholder's Equity: | ' | ' |
Common stock ($0.01 par value, one thousand shares authorized, one thousand shares issued and outstanding at December 31, 2013 and 2012) | ' | ' |
Additional paid-in capital | 261,040 | 260,750 |
Accumulated deficit | -98,955 | -85,585 |
Accumulated other comprehensive (loss) income | -7,949 | 1,440 |
Total shareholder's equity | 154,136 | 176,605 |
Total liabilities and shareholder's equity | 832,247 | 880,757 |
Parent | ' | ' |
Current liabilities: | ' | ' |
Amount due to related party | 745 | 795 |
Clorox | ' | ' |
Current liabilities: | ' | ' |
Amount due to related party | $91 | $137 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, except Per Share data, unless otherwise specified | ||
CONSOLIDATED BALANCE SHEETS | ' | ' |
Common stock, par value (in dollars per share) | $0.01 | $0.01 |
Common stock, shares authorized | 1 | 1 |
Common stock, shares issued | 1 | 1 |
Common stock, shares outstanding | 1 | 1 |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | $64,461 | $71,007 | $80,075 | $74,413 | $69,029 | $68,348 | $82,695 | $86,396 | $289,956 | $306,468 | $281,317 |
Cost of products sold | ' | ' | ' | ' | ' | ' | ' | ' | 158,049 | 167,570 | 153,114 |
Cost of products sold-acquisition related | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4,439 |
Gross profit | 27,719 | 32,524 | 37,736 | 33,928 | 28,407 | 28,620 | 38,565 | 43,306 | 131,907 | 138,898 | 123,764 |
Operating expenses: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Selling and administrative expenses | ' | ' | ' | ' | ' | ' | ' | ' | 40,694 | 48,306 | 40,240 |
Advertising costs | ' | ' | ' | ' | ' | ' | ' | ' | 27,787 | 31,072 | 24,699 |
Research and development costs | ' | ' | ' | ' | ' | ' | ' | ' | 2,474 | 2,211 | 2,307 |
Amortization of acquired intangible assets | ' | ' | ' | ' | ' | ' | ' | ' | 36,788 | 36,701 | 36,701 |
Goodwill impairment | ' | ' | ' | ' | 24,100 | ' | ' | ' | ' | 24,117 | ' |
Acquisition related charges | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,020 |
Total operating expenses | ' | ' | ' | ' | ' | ' | ' | ' | 107,743 | 142,407 | 104,967 |
Operating profit (loss) | 3,030 | 6,102 | 4,093 | 10,939 | -22,425 | 27 | 3,683 | 15,206 | 24,164 | -3,509 | 18,797 |
Non-operating expenses | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Interest expense | ' | ' | ' | ' | ' | ' | ' | ' | 48,024 | 48,887 | 48,090 |
Other expense | ' | ' | ' | ' | ' | ' | ' | ' | 285 | 445 | 80 |
Loss before income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -24,145 | -52,841 | -29,373 |
Benefit for income taxes | ' | ' | ' | ' | ' | ' | ' | ' | 10,775 | 7,040 | 11,705 |
Net loss | -5,303 | -2,275 | -5,286 | -506 | -33,031 | -9,773 | -4,103 | 1,106 | -13,370 | -45,801 | -17,668 |
Other comprehensive (loss) income: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Foreign currency translation (loss) gain | ' | ' | ' | ' | ' | ' | ' | ' | -9,389 | 3,807 | -2,007 |
Comprehensive loss | ' | ' | ' | ' | ' | ' | ' | ' | ($22,759) | ($41,994) | ($19,675) |
CONSOLIDATED_STATEMENTS_OF_SHA
CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY (USD $) | Total | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive (Loss) Income | Accumulated Deficit |
In Thousands, unless otherwise specified | USD ($) | USD ($) | USD ($) | USD ($) | |
Balance at Dec. 31, 2010 | $237,742 | ' | $260,218 | ($360) | ($22,116) |
Balance (in shares) at Dec. 31, 2010 | ' | 1 | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity | ' | ' | ' | ' | ' |
Share based compensation | 266 | ' | 266 | ' | ' |
Translation adjustments | -2,007 | ' | ' | -2,007 | ' |
Net loss | -17,668 | ' | ' | ' | -17,668 |
Balance at Dec. 31, 2011 | 218,333 | ' | 260,484 | -2,367 | -39,784 |
Balance (in shares) at Dec. 31, 2011 | ' | 1 | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity | ' | ' | ' | ' | ' |
Share based compensation | 266 | ' | 266 | ' | ' |
Translation adjustments | 3,807 | ' | ' | 3,807 | ' |
Net loss | -45,801 | ' | ' | ' | -45,801 |
Balance at Dec. 31, 2012 | 176,605 | ' | 260,750 | 1,440 | -85,585 |
Balance (in shares) at Dec. 31, 2012 | ' | 1 | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity | ' | ' | ' | ' | ' |
Share based compensation | 290 | ' | 290 | ' | ' |
Translation adjustments | -9,389 | ' | ' | -9,389 | ' |
Net loss | -13,370 | ' | ' | ' | -13,370 |
Balance at Dec. 31, 2013 | $154,136 | ' | $261,040 | ($7,949) | ($98,955) |
Balance (in shares) at Dec. 31, 2013 | ' | 1 | ' | ' | ' |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Cash flows from operating activities: | ' | ' | ' |
Net loss | ($13,370) | ($45,801) | ($17,668) |
Adjustments: | ' | ' | ' |
Depreciation and amortization | 47,846 | 46,813 | 45,262 |
Goodwill impairment | ' | 24,117 | ' |
Share based compensation | 290 | 266 | 266 |
Deferred income taxes | -14,783 | -10,612 | -14,126 |
Other | 63 | 157 | 375 |
Cash effects of changes, net of acquisition effects in: | ' | ' | ' |
Accounts receivable | 8,955 | -15,302 | -18,934 |
Inventories | 9,276 | -5,194 | 972 |
Prepaid taxes | 1,215 | -4,436 | 306 |
Other current assets | 781 | -753 | -476 |
Book overdraft | ' | -1,987 | 1,987 |
Accounts payable and accrued liabilities | -10,622 | 10,509 | 2,299 |
Due to Clorox | -46 | 11,864 | -10,053 |
Other | -1,338 | 603 | ' |
Net cash provided by (used in) operating activities | 28,267 | 10,244 | -9,790 |
Cash flows from investing activities: | ' | ' | ' |
Capital expenditures | -4,305 | -7,698 | -13,011 |
Acquisition, net | -3,084 | ' | ' |
Net cash used in investing activities | -7,389 | -7,698 | -13,011 |
Cash flows from financing activities: | ' | ' | ' |
Borrowings under revolver | 23,000 | 64,001 | 29,500 |
Payments on revolver | -23,000 | -64,001 | -29,500 |
Principal payments on notes payable and other | -3,611 | -3,000 | -3,000 |
Payment on advance from Parent | -50 | ' | ' |
Advance from Parent | ' | ' | 795 |
Deferred financing costs | ' | -350 | -670 |
Net cash used in financing activities | -3,661 | -3,350 | -2,875 |
Effect of exchange rate changes on cash | -170 | 75 | -1,090 |
Net increase (decrease) in cash | 17,047 | -729 | -26,766 |
Cash at beginning of period | 4,206 | 4,935 | 31,701 |
Cash at end of period | 21,253 | 4,206 | 4,935 |
Supplemental cash flow disclosures: | ' | ' | ' |
Cash paid for interest | 43,878 | 45,314 | 40,866 |
Cash paid for income taxes | $4,099 | $8,207 | $2,116 |
The_Company_and_Summary_of_Sig
The Company and Summary of Significant Accounting Policies | 12 Months Ended | ||
Dec. 31, 2013 | |||
The Company and Summary of Significant Accounting Policies | ' | ||
The Company and Summary of Significant Accounting Policies | ' | ||
Note 1—The Company and Summary of Significant Accounting Policies | |||
The Company | |||
Armored AutoGroup Inc. is a consumer products company consisting primarily of Armor All and STP, two of the most recognizable brands in the automotive aftermarket appearance products and performance chemicals categories, respectively. Armored AutoGroup Inc. delivers its products to distributors, resellers and end users (collectively the customers) through its direct operations in the United States, Canada, Mexico, Australia, China and the United Kingdom and distributor relationships in approximately 50 countries. The Armor All and STP brands offer multiple automotive appearance and performance chemicals that can be found in most of the major developed countries around the world. | |||
The Company was formerly known as The AutoCare Products Business, excluding the Prestone and YPF licensed brands, a business of The Clorox Company ("Clorox") that operated through various Clorox wholly owned or controlled legal entities throughout the world. | |||
In September 2010, Viking Acquisition Inc., an entity owned by affiliates of Avista Capital Holdings, L.P. ("Avista"), entered into an agreement to acquire the AutoCare Products Business, Armor All, STP and certain other brands from Clorox pursuant to the terms of a Purchase and Sale Agreement dated September 21, 2010 (the "Acquisition"). The Acquisition closed on November 5, 2010 and included employees in the United States and other countries dedicated to the Company, related product patent and developed technology and certain other assets, including the manufacturing facilities located in Painesville, Ohio and Wales, U.K. Viking Acquisition Inc. was subsequently renamed as Armored AutoGroup Inc. ("AAG"). Armored AutoGroup Parent Inc. ("AAG Parent" or "Parent") indirectly owns all of AAG's issued and outstanding capital stock through its direct subsidiary and AAG's direct parent, Armored AutoGroup Intermediate Inc., ("Intermediate"). | |||
Basis of Presentation | |||
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP). The Company's fiscal year end is December 31. The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated. | |||
Use of Estimates | |||
The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and related disclosures. Specific areas, among others, requiring the application of management's estimates and judgment include assumptions pertaining to allowances for excess and obsolete inventory, provisions for cash discounts on amounts due from customers, share based compensation awards, fair values assigned to assets acquired and liabilities assumed in connection with acquisitions (see Note 7), accruals for consumer and trade promotion programs, future product volume and pricing estimates, future cash flows utilized in impairment testing of goodwill and other long lived assets, creditworthiness of customers and potential income tax. Actual results could differ materially from the estimates and assumptions made. | |||
Foreign Currency Translation | |||
Local currencies are the functional currencies for substantially all of the Company's foreign operations. When the transactional currency is different than the functional currency, transaction gains and losses are included as a component of other expense (income), net. Assets and liabilities of foreign operations are translated into U.S. dollars using the exchange rates in effect at the respective balance sheet reporting date. Income and expenses are translated at the average exchange rate during the period. Gains and losses on foreign currency translations are reported as a component of accumulated other comprehensive (loss) income. Deferred taxes are not provided on cumulative translation adjustments where the Company expects earnings of a foreign subsidiary to be indefinitely reinvested. | |||
Accounts Receivable, net | |||
We record accounts receivable at net realizable value. This value includes allowances for discounts and estimated uncollectible accounts to reflect losses anticipated on accounts receivable balances. The allowance for uncollectible accounts is based on historical write-offs, an analysis of past due accounts based on the contractual terms of the receivables, and the economic status of customers, if known. We believe that the allowance is sufficient to cover uncollectible amounts; however, there can be no assurance that unanticipated future business conditions of customers will not have a negative impact on our results of operations. Accounts receivable are written off against the allowance for estimated uncollectible accounts should we conclude their collection is improbable. | |||
Concentrations of Credit Risk | |||
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of accounts receivable. Concentrations of credit risk with respect to accounts receivable, which are typically unsecured, are limited to an extent due to the large number of entities comprising the Company's customer base and their dispersion across many geographical regions. The Company performs ongoing credit evaluations of the financial condition of its customers and requires credit enhancements, such as letters of credit and bank guarantees, in certain circumstances. | |||
The Company does, however, sell a significant portion of its products through third party distributors, resellers and significant retail customers (See Note 3) and, as a result, maintains at times significant receivables balances with these parties. If the financial condition of these distributors, resellers or significant retail customers should deteriorate substantially, the Company's results of operations, financial position and cash flows could be adversely affected. | |||
Cash at times may exceed FDIC insurable limits. | |||
Inventories | |||
Inventories are stated at the lower of cost or market under a first-in, first-out ("FIFO") basis. When necessary, the Company provides allowances to adjust the carrying value of its inventory to the lower of cost or market, including any costs to sell or dispose. Consideration is given to obsolescence, excessive inventory levels, product deterioration and other factors in evaluating net realizable value for the purposes of determining the lower of cost or market. | |||
Property, Plant and Equipment, net | |||
Property, plant and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expenses are calculated by the straight-line method using the estimated useful lives of the related assets. Routine repairs and maintenance are expensed when incurred. Leasehold improvements are depreciated over a period no longer than the lease term. Internal and external costs incurred in developing or obtaining computer software for internal use are capitalized in property, plant and equipment and are amortized on a straight-line basis, over the estimated useful life of the software. General and administrative costs related to developing or obtaining such software are expensed as incurred. | |||
The following table provides estimated useful lives generally assigned to property, plant and equipment by asset classification: | |||
Classification | Expected Useful Lives | ||
Land improvements | 10 - 30 years | ||
Buildings | 7 - 40 years | ||
Machinery and equipment | 2 - 15 years | ||
Computer software | 3 - 7 years | ||
Property, plant and equipment are reviewed for possible impairment whenever events or changes in circumstances occur that indicate that the carrying amount of an asset (or asset group) may not be recoverable. The Company's impairment review requires significant management judgment including estimating the future success of product lines, future sales volumes, revenue and expense growth rates, alternative uses for the assets and estimated proceeds from the disposal of the assets. The Company conducts reviews of idle and underutilized equipment when events or circumstances arise indicating that future cash flows are insufficient to recover the book value of asset groups, and reviews business plans for possible impairment indicators. Impairment occurs when the carrying amount of the asset (or asset group) exceeds its estimated future undiscounted cash flows. When impairment is indicated, an impairment charge is recorded for the difference between the asset's (or asset group's) book value and its estimated fair value. Depending on the asset, estimated fair value may be determined either by use of a discounted cash flow ("DCF") model or by reference to estimated selling values of assets in similar condition. The use of different assumptions would increase or decrease the estimated fair value of assets and would increase or decrease any impairment measurement. There have been no instances of impairment identified. | |||
Finite Lived Intangible Assets | |||
Amortization of intangible assets with finite lives (customer relationships and licensing arrangements) is recognized over estimated useful lives ranging from 5 to 10 years, which the Company believes reasonably represents the time period in which the economic benefits of the intangible assets are consumed or otherwise realized. The Company has experienced a negligible attrition rate in its customer base, and is not able to identify a reliable pattern of attrition and, as such, is utilizing the straight-line amortization method to amortize customer relationship intangible assets. Finite lived intangible assets are reviewed for possible impairment whenever events or changes in circumstances occur that indicate that the carrying amount of an asset may not be recoverable. There have been no instances of impairment identified. | |||
Indefinite Lived Intangible Assets | |||
The Company tests its trademarks and brand names with indefinite lives for impairment annually on the first day of the fourth quarter unless there are indications during an interim period that these assets are more likely than not to have become impaired. For trademarks and brand names with indefinite lives, impairment occurs when the carrying amount of an asset is greater than its estimated fair value. An impairment charge is recorded for the difference between the carrying amount and the fair value. The Company uses an income approach, the relief-from-royalty method, to estimate the fair value of its trademarks and trade names with indefinite lives. This method assumes that, in lieu of ownership, a third party would be willing to pay a royalty in order to obtain the rights to use the comparable asset. The determination of the fair values of trademarks and brand name assets with indefinite lives requires significant judgments in determining both the assets' estimated cash flows as well as the appropriate discount and royalty rates applied to those cash flows to determine fair value. Changes in such estimates or the application of alternative assumptions could produce different results. There have been no instances of impairment identified. | |||
Goodwill | |||
The Company tests its goodwill for impairment annually as of the first day of the fourth quarter unless there are indications during an interim period that these assets are more likely than not to have become impaired. The first step of the goodwill impairment test is to compare the fair value of each reporting unit to its carrying amount to determine if there is potential impairment. If the fair value of the reporting unit is less than its carrying value, the second step of the goodwill impairment test is performed to measure the amount of impairment loss. | |||
The second step of the goodwill impairment test compares the implied fair value of the reporting unit's goodwill with the carrying amount of that goodwill. If the carrying amount of the reporting unit's goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination. That is, the fair value of the reporting unit is allocated to all of the assets and liabilities of that unit (including any unrecognized intangible assets) as if the reporting unit had been acquired in a business combination at the date of the evaluation and the fair value was the purchase price paid to acquire the reporting unit. | |||
The Company estimates the fair value of reporting units using a weighting of fair values derived from an income approach and a market approach. Determining the fair value of a reporting unit under the first step of the goodwill impairment test and determining the fair value of individual assets and liabilities of a reporting unit (including unrecognized intangible assets) under the second step of the goodwill impairment test is inherently subjective in nature and often involves the use of significant estimates and assumptions based on known facts and circumstances at the time the Company performs the valuation. The use of different assumptions, inputs and judgments or changes in circumstances could materially affect the results of the valuation and could have a significant impact on whether or not an impairment charge is recognized and the magnitude of any such charge. | |||
Income approach—To determine fair value, the Company uses a DCF approach for each of the reporting units. Under this approach, the Company estimates the future cash flows of each reporting unit and discounts these cash flows at a rate of return that reflects their relative risk. The cash flows used in the DCF are consistent with the Company's long-range forecasts, and give consideration to historic and projected long-term business trends and strategies. The other key estimates and factors used in the DCF include, but are not limited to, discount rates, future sales volumes, revenue and expense growth rates, changes in working capital, capital expenditure forecasts, foreign exchange rates, currency devaluation, inflation, and a perpetuity growth rate. | |||
Market approach—The Company uses the guideline public company method to select reasonably similar/guideline publicly traded companies for each of the Company's reporting units. Using the guideline public company method, the Company calculates earnings before interest, taxes, depreciation and amortization ("EBITDA") multiples for each of the public companies using both historical and forecasted EBITDA figures. By applying these multiples to the appropriate historical and forecasted EBITDA figures for each reporting unit, fair value estimates are calculated. | |||
Revenue Recognition | |||
Sales are recognized when title to the product, ownership and risk of loss transfer to the customer, which can be on the date of shipment or the date of receipt by the customer and when all of the following have occurred: a firm sales arrangement exists, pricing is fixed and determinable, and collection is reasonably assured. Revenue includes shipping and handling costs, which generally are included in the list price to the customer. Taxes collected from customers and remitted to governmental authorities are not included in sales. A provision for payment discounts and product return allowances is recorded as a reduction of sales in the same period that the revenue is recognized. | |||
The Company routinely commits to on-going and one-time trade promotion programs with customers, consisting primarily of customer pricing allowances, merchandising funds and consumer coupons offered through various programs to customers and consumers. Accruals for expected payouts under these programs are included as accrued marketing and promotion in the accrued expenses and other liabilities line item in the Consolidated Balance Sheets and are recorded as a reduction of sales in the Statements of Comprehensive Loss. | |||
Amounts received by the Company from the licensing of certain trademarks are recorded as deferred revenue on the Consolidated Balance Sheets and are recognized as revenue on a straight-line basis over the term of the licensing agreement when the underlying royalties are earned. | |||
Cost of Products Sold | |||
Cost of products sold is primarily comprised of direct materials and supplies consumed in the manufacturing of product, as well as manufacturing labor, depreciation expense, direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product, contract manufacturing costs, and provisions for inventory losses (including losses relating to excess and obsolete inventory). Cost of products sold also includes the cost to distribute products to customers, inbound freight costs, internal transfer costs, warehousing costs and other shipping and handling activity as well as costs associated with developing and designing new packaging. | |||
Selling and Administrative Expenses | |||
Selling and administrative expense is primarily comprised of marketing expenses, selling expenses, administrative and other indirect overhead costs, depreciation and amortization expense on non-manufacturing assets and other miscellaneous operating items. Non-advertising related components of the Company's total marketing spending include costs associated with consumer promotions, product sampling and sales aids, all of which are included in selling and administrative expenses. | |||
Advertising Costs | |||
Advertising and sales promotion costs are expensed as incurred. Costs associated with the Company's television, print, radio, internet and in-store campaigns are expensed when the advertising or promotion is published or presented to consumers. Costs associated with the Company's racing sponsorships and promotional events are expensed at the time or during the period of the race or promotional event. | |||
Share Based Compensation | |||
The Company has granted both time based stock option awards and performance based stock option awards that vest subject to a liquidity event (e.g., an initial public offering or change in control, as defined) and based upon the attainment of specified minimum returns on capital to Parent shareholders. The Company measures share based compensation associated with the time based awards based on their fair values on the dates they were granted. The expense is recognized by amortizing the fair value on a straight-line basis over the vesting period. Although the Company has estimated the fair value of its performance based stock option awards, given that the performance condition (a liquidity event) is not probable of occurrence, the Company has not to-date recognized any share based compensation expense attendant to these awards (see Note 14). | |||
Employee Benefits | |||
In November 2010, the Company established a defined contribution plan for its U.S. employees, which qualifies as a tax deferred savings plan under Section 401(k) of the Internal Revenue Code ("IRC" or the "Code"). Eligible U.S. employees may contribute a percentage of their pre-tax compensation, subject to certain IRC limitations. The plan provides for employer matching contributions of 100% of participant income deferrals to a maximum of $1,000 and employer contributions up to 10% of a participant's annual base salary, subject to limits prescribed under U.S. federal regulations. | |||
Operating Leases | |||
The Company recognizes rental expense for operating leases, including those with rent abatement and escalation provisions, on a straight-line basis over the applicable lease term. | |||
Research and Development Costs | |||
Research and development costs are charged to expense as incurred. | |||
Deferred Financing Costs | |||
Deferred financing costs represent legal, other professional and bank underwriting fees incurred in connection with the issuance of debt. Such fees are amortized over the life of the related debt using the interest method and are included in interest expense. | |||
Income Taxes | |||
The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to the differences between the financial statement amounts and their respective tax bases. Management reviews the Company's deferred tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established when management believes that it is more likely than not that some portion or all of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company's tax provision in the period of change. In addition to valuation allowances, the Company provides for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement standards prescribed by accounting guidance on the accounting for uncertainty in income taxes. Amounts for uncertain tax positions are adjusted when new information becomes available or when positions are effectively settled. | |||
None of the Company's goodwill is expected to be deductible for tax purposes. | |||
The Company files a consolidated federal and certain state income tax returns with its Parent. Income taxes have been prepared on a separate return basis. The Company pays its tax liability on behalf of its Parent. | |||
Recent Accounting Pronouncements | |||
In February 2013 the FASB issued ASU No. 2013-04—Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date (ASU 2013-04). The ASU requires reporting and disclosure about obligations resulting from joint and several liability arrangements within its scope for which the total amount of the obligation is fixed at the reporting date. For the Company, ASU 2013-04 is effective January 1, 2014 for fiscal year 2014 and interim periods therein. The guidance in ASU 2013-04 is to be applied retrospectively for those obligations resulting from joint and several liability arrangements within its scope that exist at January 1, 2014. Adoption of ASU 2013-04 is not expected to have a material impact on the Company. | |||
In September 2013, Treasury and the Internal Revenue Service issued final regulations regarding the deduction and capitalization of expenditures related to tangible property. The final regulations under IRC Section 162, 167 and 263(a) apply to amounts paid to acquire, produce, or improve tangible property as well as dispositions of such property and are generally effective for tax years beginning on or after January 1, 2014. We have evaluated these regulations and determined they will not have a material impact on our consolidated results of operations, cash flows or financial position. | |||
The Company adopted the following pronouncements effective January 1, 2013: | |||
In July 2013 the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2013-11—Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward exists (ASU 2013-11). The ASU requires an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with an exception in certain circumstances where an unrecognized tax benefit, or portion thereof, is to be presented in the financial statements as a liability. ASU 2013-11 is effective for the Company January 1, 2014 for fiscal year 2014 and interim periods therein. The guidance in ASU 2013-11 is to be applied prospectively to all unrecognized tax benefits that exist at January 1, 2014. The Company adopted the provisions of ASU 2013-11 in 2013 (see Note 15). | |||
In February 2013, the FASB issued ASU 2013-02—Comprehensive Income (Topic 220): Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income (ASU 2013-02). Substantially all of the information that this update requires already is required to be disclosed elsewhere in financial statements under U.S. GAAP. However, the new requirement to present information about amounts reclassified out of accumulated other comprehensive income and their corresponding effect on net income will present, in one place, information about significant amounts reclassified and, in some cases, cross-references to related footnote disclosures. | |||
During July 2012, the FASB issued ASU 2012-02 Intangibles—Goodwill and Other (Topic 350) Testing Indefinite-Lived Intangible Assets for Impairment (ASU 2012-02) which was intended to reduce the cost and complexity of performing an impairment test for indefinite-lived intangible assets by simplifying how the Company tests those assets for impairment and to improve consistency in impairment testing guidance among long lived asset categories. Under ASU 2012-02, the Company has the option first to assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test in accordance with Subtopic 350-30, Intangibles—Goodwill and Other—General Intangibles Other than Goodwill. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. The Company also has the option to bypass the qualitative assessment for any indefinite-lived intangible asset in any period and proceed directly to performing the quantitative impairment test. The Company will be able to resume performing the qualitative assessment in any subsequent period. The Company did not use the qualitative assessment during 2013. | |||
In December 2011, the FASB issued ASU No. 2011-11, "Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities" ("ASU 2011-11") to amend the requirement for an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. An entity should provide the disclosures required by those amendments retrospectively for all comparative periods presented. Adoption of 2011-11 did not have an impact on the Company. | |||
RelatedParty_Transactions
Related-Party Transactions | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Related-Party Transactions | ' | ||||||||||
Related-Party Transactions | ' | ||||||||||
Note 2—Related-Party Transactions | |||||||||||
In conjunction with the Acquisition, the Company entered into a Transition Services Agreement ("TSA") with Clorox whereby Clorox would provide certain services, equipment and office space to the Company. Additionally under the TSA, the Company provided certain services to Clorox. Related party transactions and activities involving Clorox are not always consummated on terms equivalent to those that would prevail in an arm's-length transaction where conditions of competitive, free-market dealings may exist. On November 1, 2011, the Company completed the transition of its North American and export operations from Clorox provisioning to standalone operations. The Company completed the transition of certain international operations from Clorox in the second quarter of 2012 and terminated the remaining service components of the TSA. | |||||||||||
Net expenses under the TSA were (in thousands): | |||||||||||
Year ended | Year ended | Year ended | |||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Cost of products sold | $ | — | $ | — | $ | 6,616 | |||||
Selling and administrative expense | — | 732 | 3,436 | ||||||||
Research and development costs | — | — | 621 | ||||||||
| | | | | | | | | | | |
Total TSA expenses | $ | — | $ | 732 | $ | 10,673 | |||||
| | | | | | | | | | | |
| | | | | | | | | | | |
Further, on conclusion of the TSA we entered into a subsequent arrangement with Clorox for continuation of services in Australia and New Zealand, including warehousing, logistics, customer service and information systems facilities and support. Expenses for these services were (in thousands): | |||||||||||
Year ended | Year ended | Year ended | |||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Cost of products sold | $ | — | $ | 1,326 | $ | 1,154 | |||||
Selling and administrative expense | — | 712 | 333 | ||||||||
| | | | | | | | | | | |
Total TSA expenses | $ | — | $ | 2,038 | $ | 1,487 | |||||
| | | | | | | | | | | |
| | | | | | | | | | | |
Avista | |||||||||||
Avista and several of its employees together own approximately 99.3% of Parent, which is the sole stockholder of Intermediate, the Company's parent. As a result, Avista has the power to elect our board of directors and has the ability to exercise significant influence or control over the Company's operations. | |||||||||||
The Company has entered into a monitoring agreement with Avista and affiliates of Avista whereby Avista provides services for a fixed fee of $1.0 million annually to the Company. Selling and administrative expenses, including out of pocket expenses related to this monitoring agreement were (in thousands): | |||||||||||
Year ended | Year ended | Year ended | |||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Avista monitoring agreement fees | $ | 1,127 | $ | 1,055 | $ | 1,114 | |||||
In connection with the Acquisition and the issuance of its long-term debt, the Company paid $4.1 million to Avista and affiliates of Avista for consulting expenses and recorded these as deferred financing costs which are amortized over the term of the debt using the effective interest method. Related amortization expense was (in thousands): | |||||||||||
Year ended | Year ended | Year ended | |||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Amortization of Avista consulting expenses | $ | 604 | $ | 605 | $ | 605 | |||||
Directors and Officers | |||||||||||
In connection with the Acquisition and issuance of the Company's long-term debt, the Company incurred costs of $1.8 million for consulting expenses from individuals that later became directors and officers of the Company. Of this amount, $0.4 million was paid to certain directors and officers of the Company and $1.4 million was reinvested in the Company through the purchase of common stock. Of these consulting expenses, $1.3 million are included in acquisition related charges for the period from November 4, 2010 to December 31, 2010 with the remaining $0.5 million deferred and amortized over the term of the respective debt using the effective interest method. Related amortization expense was (in thousands): | |||||||||||
Year ended | Year ended | Year ended | |||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Amortization of directors' and officers' consulting expenses | $ | 68 | $ | 68 | $ | 68 | |||||
The Company engaged Charles McIlvaine, a former Director of the Company, to provide services associated with corporate development and other strategic initiatives on a consulting basis. Pursuant to this arrangement the Company recorded charges of $0.1 million and $0.2 million in the years ended December 31, 2012 and 2011, respectively, in selling and administrative expenses. | |||||||||||
Parent | |||||||||||
In May 2011, the Company received $795,000 on behalf of its Parent related to the sale of the Parent's stock to certain of the Company's employees. In 2013, the Company repurchased from a certain employee $50,000 of stock as a result of termination. As of December 31, 2013 and December 31, 2012 the Company had $745,000 and $795,000, respectively, non-interest bearing and due on demand to the Company's Parent related to sales of the Parent's stock to the Company's employees. | |||||||||||
Accounts_Receivable_net
Accounts Receivable, net | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Accounts Receivable, net | ' | ||||||||||||||||
Accounts Receivable, net | ' | ||||||||||||||||
Note 3—Accounts Receivable, net | |||||||||||||||||
The percentage of accounts receivable due from the Company's largest customers were: | |||||||||||||||||
December 31, | December 31, | ||||||||||||||||
2013 | 2012 | ||||||||||||||||
First | 24 | % | 22 | % | |||||||||||||
Second | 7 | % | 9 | % | |||||||||||||
The percentage of the Company's net sales to the Company's largest customer (Wal-Mart) was: | |||||||||||||||||
CONSOLIDATED | |||||||||||||||||
Year ended | Year ended | Year ended | |||||||||||||||
December 31, | December 31, | December 31, | |||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||
22% | 22% | 20% | |||||||||||||||
Sales to the Company's largest customer are principally made in North America. No other customers exceeded 10% of net sales in any period. | |||||||||||||||||
The Company's allowance for doubtful accounts is summarized as follows (in thousands): | |||||||||||||||||
Beginning | Provision | Amounts | Other | Ending | |||||||||||||
Balance | for | Written- | Deductions— | Balance | |||||||||||||
Doubtful | Off | Purchase | |||||||||||||||
Accounts | Accounting | ||||||||||||||||
Year ended December 31, 2013 | $ | 682 | $ | 174 | $ | (408 | ) | $ | — | $ | 448 | ||||||
Year ended December 31, 2012 | 390 | 370 | (78 | ) | — | 682 | |||||||||||
Year ended December 31, 2011 | 108 | 282 | — | — | 390 |
Inventories
Inventories | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Inventories | ' | ||||||||||||||||
Inventories | ' | ||||||||||||||||
Note 4—Inventories | |||||||||||||||||
Inventories consisted of the following (in thousands): | |||||||||||||||||
December 31, | December 31, | ||||||||||||||||
2013 | 2012 | ||||||||||||||||
Finished goods | $ | 28,400 | $ | 33,386 | |||||||||||||
Raw materials and packaging | 7,896 | 11,087 | |||||||||||||||
Allowances for obsolescence | (2,253 | ) | (2,029 | ) | |||||||||||||
| | | | | | | | ||||||||||
$ | 34,043 | $ | 42,444 | ||||||||||||||
| | | | | | | | ||||||||||
| | | | | | | | ||||||||||
The Company's allowance for obsolescence is summarized as follows (in thousands): | |||||||||||||||||
Year Ended December 31, | Beginning | Provision | Amounts | Other | Ending | ||||||||||||
Balance | for | Written- | Deductions— | Balance | |||||||||||||
obsolescence | Off | Purchase | |||||||||||||||
Accounting | |||||||||||||||||
2013 | $ | 2,029 | $ | 3,599 | $ | (3,375 | ) | $ | — | $ | 2,253 | ||||||
2012 | 2,051 | 1,195 | (1,217 | ) | — | $ | 2,029 | ||||||||||
2011 | 20 | 2,480 | (449 | ) | — | 2,051 |
Other_Current_Assets
Other Current Assets | 12 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Other Current Assets | ' | |||||||
Other Current Assets | ' | |||||||
Note 5—Other Current Assets | ||||||||
Other current assets consisted of the following (in thousands): | ||||||||
December 31, | December 31, | |||||||
2013 | 2012 | |||||||
Current deferred taxes | $ | 3,555 | $ | 4,315 | ||||
Deferred financing costs | 1,767 | 1,843 | ||||||
Prepaid income taxes | 2,453 | 3,963 | ||||||
Other | 2,015 | 2,770 | ||||||
| | | | | | | | |
$ | 9,790 | $ | 12,891 | |||||
| | | | | | | | |
| | | | | | | | |
Property_Plant_and_Equipment_n
Property, Plant and Equipment, net | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Property, Plant and Equipment, net. | ' | ||||||||||
Property, Plant and Equipment, net | ' | ||||||||||
Note 6—Property, Plant and Equipment, net | |||||||||||
Property, plant and equipment consisted of the following (in thousands): | |||||||||||
December 31, | December 31, | ||||||||||
2013 | 2012 | ||||||||||
Land and improvements | $ | 1,784 | $ | 1,405 | |||||||
Buildings | 3,769 | 3,679 | |||||||||
Machinery and equipment | 27,178 | 23,096 | |||||||||
Capitalized software | 12,182 | 12,040 | |||||||||
Construction in progress | 1,541 | 1,999 | |||||||||
| | | | | | | | ||||
46,454 | 42,219 | ||||||||||
Less: accumulated depreciation | (17,518 | ) | (10,746 | ) | |||||||
| | | | | | | | ||||
$ | 28,936 | $ | 31,473 | ||||||||
| | | | | | | | ||||
| | | | | | | | ||||
Depreciation expense related to property, plant and equipment and amortization of capitalized software was (in thousands): | |||||||||||
Year ended | |||||||||||
December 31, 2013 | December 31, 2012 | December 31, 2011 | |||||||||
Depreciation | $ | 4,953 | $ | 4,639 | $ | 4,505 | |||||
Amortization of capitalized software | 2,017 | 1,605 | 220 | ||||||||
| | | | | | | | | | | |
$ | 6,970 | $ | 6,244 | $ | 4,725 | ||||||
| | | | | | | | | | | |
| | | | | | | | | | | |
Goodwill_and_Intangible_Assets
Goodwill and Intangible Assets, net | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Goodwill and Intangible Assets, net | ' | ||||||||||||||||
Goodwill and Intangible Assets, net | ' | ||||||||||||||||
Note 7—Goodwill and Intangible Assets, net | |||||||||||||||||
During the fourth quarter of 2012, the Company revised its pricing structure for intercompany purchases and sales of goods ("Intercompany Pricing"). The change in Intercompany Pricing had the effect of increasing the cost of intercompany purchases in the Company's Europe, Middle East and Africa reporting unit, its Australia and New Zealand reporting unit and its Latin America and Asia reporting unit, while increasing the value of intercompany sales from the Company's North America reporting unit. As a result of this change in Intercompany Pricing, when the Company determined the fair value of the assets and liabilities of its reporting units in the first step of the goodwill impairment test as described in Note 1 the fair value of the Company's Europe, Middle East and Africa reporting unit and its Australia and New Zealand reporting unit were lower than the carrying values of those reporting units. This decrease in value resulted primarily from the change in the Intercompany Pricing structure. After completing the second step of the goodwill impairment test as described in Note 1, the Company recorded a $24.1 million non-cash goodwill impairment charge, which is included in impairment of goodwill in the consolidated statement of comprehensive loss. | |||||||||||||||||
The Company also evaluated the recoverability of its customer relationships and licensing arrangements intangible assets as well as its tangible, long lived assets. When there is prevalent indication of impairment of a finite and long-lived asset or asset group, the Company tests for recoverability by comparing the carrying value of an asset or asset group to their undiscounted cash flows. However, the Company concluded there was not a prevalence of evidence any impairment was present at the asset group level for any of its finite lived assets. | |||||||||||||||||
Changes in the carrying amount of goodwill and intangible assets were as follows (in thousands): | |||||||||||||||||
Trademarks and Other Intangible Assets | |||||||||||||||||
Goodwill | Trademarks | Customer | Licensing | Total | |||||||||||||
and Brands | Relationships | Arrangements | |||||||||||||||
Not Subject to | Subject to | Subject to | |||||||||||||||
Amortization | Amortization | Amortization | |||||||||||||||
Balance at December 31, 2011 | $ | 384,793 | $ | 99,176 | $ | 284,001 | $ | 4,998 | $ | 388,175 | |||||||
Amortization | — | — | (35,401 | ) | (1,300 | ) | (36,701 | ) | |||||||||
Impairment | (24,117 | ) | — | — | — | — | |||||||||||
Translation adjustments | 1,540 | 421 | 1,010 | — | 1,431 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Balance at December 31, 2012 | $ | 362,216 | $ | 99,597 | $ | 249,610 | $ | 3,698 | $ | 352,905 | |||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Amortization | — | — | (35,488 | ) | (1,300 | ) | (36,788 | ) | |||||||||
Acquisition, net | 580 | — | 1,823 | — | 1,823 | ||||||||||||
Translation adjustments | (3,970 | ) | (1,384 | ) | (3,086 | ) | — | (4,470 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Balance at December 31, 2013 | $ | 358,826 | $ | 98,213 | $ | 212,859 | $ | 2,398 | $ | 313,470 | |||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Customer relationships and licensing arrangements subject to amortization are reported on the Consolidated Balance Sheet net of accumulated amortization of $114.7 million, and $79.3 million, at December 31, 2013 and 2012, respectively. The weighted average remaining amortization period for customer relationships and licensing arrangements subject to amortization is 6 years and 2 years, respectively. In the third quarter of 2013, the Company made an acquisition in Europe, increasing goodwill and customer relationships by $0.6 million and $1.8 million (which will be amortized over 7 years), respectively. Licensing royalties were $2.3 million, $3.0 million and $3.3 million in the years ended December 31, 2013, 2012 and 2011, respectively. Although licensing agreements may not be renewed for strategic or other reasons, the Company generally maintains and extends its existing license arrangements. | |||||||||||||||||
Expected future amortization expense for these intangible assets as of December 31, 2013 is as follows: | |||||||||||||||||
Fiscal Years | |||||||||||||||||
2014 | $ | 36,961 | |||||||||||||||
2015 | 36,759 | ||||||||||||||||
2016 | 35,661 | ||||||||||||||||
2017 | 34,173 | ||||||||||||||||
2018 | 26,090 | ||||||||||||||||
Thereafter | 49,117 | ||||||||||||||||
| | | | | |||||||||||||
$ | 218,761 | ||||||||||||||||
| | | | | |||||||||||||
| | | | | |||||||||||||
Accrued_Expenses_and_Other_Cur
Accrued Expenses and Other Current Liabilities | 12 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Accrued Expenses and Other Current Liabilities | ' | |||||||
Accrued Expenses and Other Current Liabilities | ' | |||||||
Note 8—Accrued Expenses and Other Current Liabilities | ||||||||
The following summarizes the Company's accrued expenses and other current liabilities (in thousands): | ||||||||
December 31, | December 31, | |||||||
2013 | 2012 | |||||||
Trade, sales promotion and advertising | $ | 8,777 | $ | 9,022 | ||||
Accrued interest | 8,029 | 8,191 | ||||||
Accrued taxes | 50 | 3,421 | ||||||
Compensation and benefits | 2,156 | 2,928 | ||||||
Other | 4,443 | 5,009 | ||||||
| | | | | | | | |
$ | 23,455 | $ | 28,571 | |||||
| | | | | | | | |
| | | | | | | | |
Debt
Debt | 12 Months Ended | |||||||||||||
Dec. 31, 2013 | ||||||||||||||
Debt | ' | |||||||||||||
Debt | ' | |||||||||||||
Note 9—Debt | ||||||||||||||
The following summarizes the Company's debt (in thousands): | ||||||||||||||
December 31, 2013 | ||||||||||||||
Credit Facility | ||||||||||||||
Total | ||||||||||||||
Long-Term | ||||||||||||||
Revolver | Term Loan | Senior Notes | Debt | |||||||||||
Balance | $ | — | $ | 291,000 | $ | 275,000 | $ | 566,000 | ||||||
Less: discount | — | (5,018 | ) | (7,400 | ) | (12,418 | ) | |||||||
| | | | | | | | | | | | | | |
$ | — | 285,982 | 267,600 | 553,582 | ||||||||||
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Less: current portion, net of discount | (1,324 | ) | 1,253 | (71 | ) | |||||||||
| | | | | | | | | | | | | | |
Long-term portion, net of discount | $ | 284,658 | $ | 268,853 | $ | 553,511 | ||||||||
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
December 31, 2012 | ||||||||||||||
Credit Facility | ||||||||||||||
Total | ||||||||||||||
Long-Term | ||||||||||||||
Revolver | Term Loan | Senior Notes | Debt | |||||||||||
Balance | $ | — | $ | 294,000 | $ | 275,000 | $ | 569,000 | ||||||
Less: discount | — | (6,610 | ) | (8,530 | ) | (15,140 | ) | |||||||
| | | | | | | | | | | | | | |
$ | — | 287,390 | 266,470 | 553,860 | ||||||||||
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Less: current portion, net of discount | (1,414 | ) | 1,135 | (279 | ) | |||||||||
| | | | | | | | | | | | | | |
Long-term portion, net of discount | $ | 285,976 | $ | 267,605 | $ | 553,581 | ||||||||
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Credit Facility | ||||||||||||||
In connection with the Acquisition on November 5, 2010, the Company entered into a credit agreement, among Intermediate, the Company, several lenders, JPMorgan Chase Bank, N.A., as administrative agent, and the other agents parties thereto (the "Credit Facility"). Borrowings under the Credit Facility bear interest at a rate of the sum of (i) the greater of the London Interbank Offered Rate ("LIBOR") or 1.75% and (ii) 4.25%. The Credit Facility provided revolving credit and a Term Loan as follows: | ||||||||||||||
Revolver—A secured $50.0 million revolving credit loan (the "Revolver"), which continues into November 2015. Further to interest as described above on the Revolver, an annual commitment fee of 0.75% is charged quarterly based on the average daily unused portion of the Revolver. No amounts were outstanding against the Revolver at December 31, 2013 and 2012. | ||||||||||||||
Term Loan—A $300.0 million term loan (the "Term Loan") with quarterly principal payments of $0.8 million and the remaining principal maturing in November 2016. | ||||||||||||||
In September 2012, the Company entered into an amendment of the Credit Facility revising the maximum consolidated leverage ratio and the minimum consolidated interest coverage ratio as applicable to the Company's $50.0 million Revolver. Costs associated with the amendment of $0.4 million have been deferred and are recorded as other current assets and other non-current assets on the Company's Consolidated Balance Sheets, and will be amortized to interest expense together with other of the Company's deferred financing costs using the effective interest method. | ||||||||||||||
The Credit Facility is collateralized by substantially all of the assets of the Company. The Credit Facility is subject to certain covenants which restrict the payment of dividends, the Company's ability to incur indebtedness or liens, or make certain investments and requires the Company to maintain certain financial ratios. As of December 31, 2012, the Company was in compliance with all covenants related to the Credit Facility. The Company's payment obligations under the Credit Facility are guaranteed, jointly and severally, by all of the Company's wholly owned domestic subsidiaries. See Note 18 for financial information for the Company and its subsidiaries. | ||||||||||||||
Senior Notes | ||||||||||||||
In connection with the Acquisition on November 5, 2010, the Company issued 9.25% senior unsecured notes ("Senior Notes") in an aggregate principal amount of $275.0 million, which will mature in November 2018. The coupon interest on these notes is payable semiannually on May 1 and November 1. | ||||||||||||||
Under terms of a registration rights agreement the Company entered into with respect to the Senior Notes, the Company agreed to use commercially reasonable efforts to complete an exchange offer related to the Senior Notes by April 28, 2012. Until the exchange offer was completed on August 23, 2012, additional interest of $0.3 million accrued on the Senior Notes that was paid November 2012. | ||||||||||||||
The indenture that governs the Senior Notes is subject to certain covenants which restrict the payment of dividends, the Company's ability to incur indebtedness or liens, or make certain investments. The Company's payment obligations under the Senior Notes are guaranteed, jointly and severally, by all of the Company's wholly owned domestic subsidiaries. See Note 18 for financial information for the Company and its subsidiaries. | ||||||||||||||
Interest Expense | ||||||||||||||
Interest expense associated with the Credit Facility and the Senior Notes including commitment fees for unused borrowings, and amortization of original issue discount and deferred financing costs was (in thousands): | ||||||||||||||
Year Ended | ||||||||||||||
December 31, | December 31, | December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||||
Credit Facility | ||||||||||||||
Revolver | $ | 864 | $ | 1,485 | $ | 1,076 | ||||||||
Term Loan | 19,954 | 20,110 | 20,096 | |||||||||||
Senior Notes | 27,089 | 26,980 | 26,907 | |||||||||||
Other | 117 | 312 | 11 | |||||||||||
| | | | | | | | | | | ||||
$ | 48,024 | $ | 48,887 | $ | 48,090 | |||||||||
| | | | | | | | | | | ||||
| | | | | | | | | | | ||||
Debt Maturities | ||||||||||||||
Debt maturities are as follows as of December 31, 2013 (in thousands): | ||||||||||||||
Fiscal Years | ||||||||||||||
2014 | $ | 3,000 | ||||||||||||
2015 | 3,000 | |||||||||||||
2016 | 285,000 | |||||||||||||
2017 | — | |||||||||||||
2018 | 275,000 | |||||||||||||
| | | | | ||||||||||
$ | 566,000 | |||||||||||||
| | | | | ||||||||||
| | | | | ||||||||||
Deferred Financing Costs, net | ||||||||||||||
Costs associated with the establishment of the Credit Facility and Senior Notes have been deferred and are recorded as other current assets and other non-current assets on the Company's Consolidated Balance Sheets as follows (in thousands): | ||||||||||||||
December 31, | December 31, | |||||||||||||
2013 | 2012 | |||||||||||||
Balance | $ | 9,979 | $ | 9,979 | ||||||||||
Less: accumulated amortization | (4,814 | ) | (3,228 | ) | ||||||||||
| | | | | | | | |||||||
5,165 | 6,751 | |||||||||||||
Less: current portion, net of amortization | (1,767 | ) | (1,843 | ) | ||||||||||
| | | | | | | | |||||||
Long-term portion, net of amortization | $ | 3,398 | $ | 4,908 | ||||||||||
| | | | | | | | |||||||
| | | | | | | | |||||||
Fair_Value_Measurement_of_Asse
Fair Value Measurement of Assets and Liabilities | 12 Months Ended | |||||||||||||
Dec. 31, 2013 | ||||||||||||||
Fair Value Measurement of Assets and Liabilities | ' | |||||||||||||
Fair Value Measurement of Assets and Liabilities | ' | |||||||||||||
Note 10—Fair Value Measurement of Assets and Liabilities | ||||||||||||||
The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value which is intended to increase consistency and comparability and related disclosures. An asset or liability's classification is based on the lowest level of input that is significant to the fair value measurement and is disclosed in one of the following three categories: | ||||||||||||||
Level 1—Quoted market prices in active markets for identical assets or liabilities. | ||||||||||||||
Level 2—Observable market-based inputs or unobservable inputs that are corroborated by market data. | ||||||||||||||
Level 3—Unobservable inputs reflecting the reporting entity's own assumptions. | ||||||||||||||
The Company's financial instruments consist of cash, trade accounts receivable, trade accounts payable and long-term debt. Due to their short-term maturity, the carrying amounts of cash, trade accounts receivable and trade accounts payable approximate their fair market values. The carrying and fair values of the Company's long-term debt were as follows (in thousands): | ||||||||||||||
December 31, 2013 | December 31, 2012 | |||||||||||||
Carrying | Fair | Carrying | Fair | |||||||||||
Value | Value | Value | Value | |||||||||||
Term loan | $ | 285,982 | $ | 291,000 | $ | 287,390 | $ | 281,138 | ||||||
Senior notes | 267,600 | 267,438 | 266,470 | 233,063 | ||||||||||
The fair value of the Term Loan and Senior Notes was determined using broker quotes (Level 2). The broker quotes are determined on an analysis of discounted cash flows together with applicable forward LIBOR rates. | ||||||||||||||
Commitments_and_Contingencies
Commitments and Contingencies | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Commitments and Contingencies | ' | ||||||||||||||||
Commitments and Contingencies | ' | ||||||||||||||||
Note 11—Commitments and Contingencies | |||||||||||||||||
The Company leases various manufacturing, warehousing and office facilities under non-cancelable operating lease agreements which expire at various dates through 2019. The Company also has a number of third party service providers covering aspects of the administration of the business, including procurement, contract manufacturing, logistics, transportation, warehousing, software maintenance, systems support and hosting. In its marketing and brand support, the Company employs sponsorships, television, print, digital and online advertising. In sourcing of these services the Company generally enters into enforceable and legally binding agreements specifying all significant terms, including quantity, price and the approximate timing of the provision of the good or service to the Company. Under its existing non-cancelable contracts, as of December 31, 2013 the Company is required to pay minimum annual payments as follows (in thousands): | |||||||||||||||||
Year Ended December 31, | Operating | Procurement, | Software | Sponsorship | Advisory | ||||||||||||
Leases | Contract | Maintenance, | and Media | Services and | |||||||||||||
Manufacturing, | Systems | Agreements | Monitoring | ||||||||||||||
Warehousing | Support and | ||||||||||||||||
and Logistics | Hosting | ||||||||||||||||
Obligations | |||||||||||||||||
2014 | $ | 1,573 | $ | 19,374 | $ | 1,065 | $ | 8,801 | $ | 1,000 | |||||||
2015 | 1,315 | 3,386 | 534 | 820 | 1,000 | ||||||||||||
2016 | 1,165 | 3,125 | 143 | 845 | 1,000 | ||||||||||||
2017 | 604 | 1,976 | — | — | 1,000 | ||||||||||||
2018 | 515 | — | — | — | 1,000 | ||||||||||||
Thereafter | 332 | — | — | — | 1,000 | ||||||||||||
| | | | | | | | | | | | | | | | | |
$ | 5,504 | $ | 27,861 | $ | 1,742 | $ | 10,466 | $ | 6,000 | ||||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Operating lease arrangements—Certain of the Company's operating lease agreements contain rent abatement and rent escalation clauses. The Company expenses rent on a straight-line basis over the life its leases, which commences on the date the Company has the right to control leased property. Certain of the Company's facility operating lease agreements also provide for additional conditional payments in connection with the lease of the property (e.g., share of operating expenses, insurance, and real estate taxes). These additional payments are not included in the summary of above. | |||||||||||||||||
Rental expense for all operating leases was (in thousands): | |||||||||||||||||
Years ended | |||||||||||||||||
December 31, 2013 | December 31, 2012 | December 31, 2011 | |||||||||||||||
$ | 1,744 | $ | 2,773 | $ | 1,966 | ||||||||||||
Procurement, contract manufacturing, warehousing and logistics obligations—The Company secures procurement capabilities, its warehousing facilities and attendant services, and logistics and transportation expertise under several contracts extending into 2017. These outsourcing arrangements typically provide for a base fee and variable costs determined with reference to volume or the provision of additional services, and terms providing for termination for convenience on 120 days' notice and the payment of stipulated fees and additional costs. Only fixed or base fees on an ongoing basis for the term of the contracted services are included in the above summary. Further, the Company has ongoing relationships with various suppliers who procure, manufacture and/or package the Company's products ("Contract Manufacturers"). Certain of the Company's Contract Manufacturers maintain title and control of raw materials and components, materials utilized in finished products, and of the finished products themselves until shipment to the Company's customers or third party distribution centers in accordance with agreed upon shipment terms. The Company purchases and maintains title and control of raw materials and components packaged by other of its Contract Manufacturers and is only obligated further for the services themselves. The Company typically does not have definitive minimum purchase obligations included in the contract terms with its Contract Manufacturers or other raw material or component suppliers. In the ordinary course of business, supply and service needs are communicated by the Company to its Contract Manufacturers based on orders and short-term projections, ranging typically three months. The Company is committed to purchase the products produced by the Contract Manufacturers based on the projections provided. | |||||||||||||||||
Software maintenance, systems support and hosting—The Company outsources much of its information technology infrastructure. These arrangements typically provide for a base or fixed fee and additional costs associated with added systems users and supplementary services, and terms providing for early contract termination with notice and the payment of stipulated fees. Only fixed or base fees on an ongoing basis for the term of the contracted services are included in the above summary. | |||||||||||||||||
Sponsorship and media agreements—The Company's marketing campaigns rely heavily on racing and rally sponsorships, promotional events, television, print and online advertising. Sponsorship commitments extend into 2016 and the Company's media plan extends through 2014. | |||||||||||||||||
Advisory Services and Monitoring Agreement—Under the Company's Advisory Services and Monitoring Agreement, Avista is providing the Company ongoing advisory services with respect to strategic business plans, corporate development and financial monitoring. | |||||||||||||||||
Litigation_and_Other_Legal_Mat
Litigation and Other Legal Matters | 12 Months Ended |
Dec. 31, 2013 | |
Litigation and Other Legal Matters | ' |
Litigation and Other Legal Matters | ' |
Note 12—Litigation and Other Legal Matters | |
The Company is subject to various lawsuits and claims relating to issues such as contract disputes, product liability, patents and trademarks, advertising, employee and other matters. Although the results of claims and litigation cannot be predicted with certainty, it is the opinion of management that the ultimate disposition of these matters will not have a material adverse effect, individually or in the aggregate, on the Company's financial position or results of operations. | |
In connection with the Acquisition, Clorox retained liability associated with a potential contract claim and the Company has agreed to indemnify and reimburse Clorox for 50% of the first $5.0 million in costs related to the contract claim. As of December 31, 2013 and 2012, the Company has accrued a $2.5 million long-term liability related to this contingency. | |
Common_Stock
Common Stock | 12 Months Ended |
Dec. 31, 2013 | |
Common Stock | ' |
Common Stock | ' |
Note 13—Common Stock | |
The Company has one thousand shares of $0.01 par value common stock authorized, issued and outstanding at December 31, 2013 and 2012. Through Intermediate, Parent indirectly owns all of the Company's common stock. 99.3% of Parent's issued and outstanding common stock is owned by Avista, with the remaining aggregate 0.7% owned by certain members of management and the Board of Directors ("Management Stockholders") and purchased in connection with the Acquisition. | |
Repurchase right | |
Under the terms of the Stockholders' Agreement dated November 5, 2010 among Parent, Avista, and the Management Stockholders, Parent has the option but not an obligation to repurchase all of the shares of Parent common stock held by former Company employees whether acquired directly on Acquisition or issued pursuant to the exercise of stock options to former Company employees who terminate employment under certain circumstances. The purchase price of the Parent's call option as prescribed in the Stockholders' Agreement is to be determined through a valuation of Parent common stock on a minority, non-marketable interest basis or, under certain circumstances, based on cost, as defined therein. As there is no active market for Parent's common stock, the Company estimates the fair value of its common stock as determined by the Board of Directors in good faith. If a participant in the 2010 AAG Stock Option Plan (see Note 14) were to terminate employment with the Company, the Parent's exercise of its repurchase right under the Stockholders' Agreement on shares received by the former Company employee through the exercise of stock options may require equity awards to be expensed in the Company's statement of comprehensive loss in the period in which the termination occurs. | |
Share_Based_Compensation_Plans
Share Based Compensation Plans | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Share Based Compensation Plans | ' | ||||||||||
Share Based Compensation Plans | ' | ||||||||||
Note 14—Share Based Compensation Plans | |||||||||||
The following table presents details of total share based compensation expense that is included in the Company's statements of comprehensive loss (in thousands): | |||||||||||
Year ended | |||||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Cost of products sold | $ | 15 | $ | 13 | $ | 13 | |||||
Selling and administrative expenses | 260 | 243 | 243 | ||||||||
Research and development costs | 15 | 10 | 10 | ||||||||
| | | | | | | | | | | |
Total share based compensation costs | $ | 290 | $ | 266 | $ | 266 | |||||
| | | | | | | | | | | |
| | | | | | | | | | | |
In November 2010, the Parent's board of directors approved the 2010 Equity Incentive Plan (the "2010 AAG Option Plan"), which authorized equity awards to be granted for up to 26,500,000 shares of Parent's common stock. Under the 2010 AAG Option Plan, certain management and key employees of the Company have been or may be granted a combination of time based and performance based options to purchase the Parent's common stock. Share based compensation expense related to employee grants under the 2010 AAG Option Plan has been reflected in these financial statements. As of December 31, 2013, equity awards for approximately 5,992,000 shares of Parent's common stock remain available for grant under the 2010 AAG Option Plan. | |||||||||||
The Company utilizes an option pricing method employing a Black Scholes model to estimate the fair value of stock options granted. The following weighted average assumptions were used for time based and performance based option grants in the periods: | |||||||||||
Year ended | Year ended | Year ended | |||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Expected life | 6.5 years | 6.5 years | 6.5 years | ||||||||
Expected volatility | 34.00% | 35.00% | 50.00% | ||||||||
Risk-free interest rate | 1.23% - 2.03% | 0.91% - 1.36% | 1.45% - 3.05% | ||||||||
Dividend yield | 0% | 0% | 0% | ||||||||
Time based and performance based options expire ten years from the date of grant. The expected life of the stock options on the option grants during the period is determined based on the average of the weighted vesting term and the contractual term of the options. The Company estimates stock option forfeitures based on historical data from Clorox and will adjust the rate to expected forfeitures when Company-specific experience indicates a different trend. Expected volatility for the period is determined consistently based on a five-company peer group, all of which have publicly traded stock. The risk-free interest rate is based on the implied yield on a U.S. Treasury yield curve with a term similar to the expected remaining term of the option on the date of the grant. Dividend yield for the period is determined based on projected annual dividend payments. | |||||||||||
The following table summarizes stock option activity for time based options under the 2010 AAG Option Plan for the periods presented (in thousands, except per share amounts): | |||||||||||
Number of | Weighted- | ||||||||||
Time based | Average | ||||||||||
Shares | Exercise | ||||||||||
Price | |||||||||||
Non-vested at December 31, 2011 | 5,867 | 1.01 | |||||||||
Granted | 493 | 1 | |||||||||
Forfeited | (354 | ) | 1 | ||||||||
Vested | (1,298 | ) | 1.01 | ||||||||
| | | | | | | | ||||
Non-vested at December 31, 2012 | 4,708 | 1.02 | |||||||||
Granted | 935 | 1 | |||||||||
Forfeited | (614 | ) | 1 | ||||||||
Vested | (1,153 | ) | 1.01 | ||||||||
| | | | | | | | ||||
Non-vested at December 31, 2013 | 3,876 | 1.02 | |||||||||
Vested and exercisable at December 31, 2013 | 2,827 | 1 | |||||||||
| | | | | | | | ||||
Outstanding at December 31, 2013 | 6,703 | 1.01 | |||||||||
| | | | | | | | ||||
| | | | | | | | ||||
Under the 2010 AAG Option Plan, time based options vest ratably over the applicable service period, five years, on each anniversary of the date of grant and, regardless, immediately upon a change in control event, subject to certain conditions. The Company recognizes share based compensation expense on a straight-line basis over the vesting period. There have been no vested, time based stock options exercised to date under the 2010 AAG Option Plan and no cash received. The weighted average fair value of time based options granted in 2013, 2012 and 2011 was $0.15, $0.15 and $0.21, respectively. The aggregate fair value of options vested in 2013, 2012 and 2011 was $0.2 million, $0.3 million and $0.2 million, respectively. At December 31, 2013, the total amount of unrecognized compensation cost for time based options granted is $0.6 million. At December 31, 2013, vested and exercisable options and total time based options outstanding have weighted average remaining contractual terms of 7.1 and 7.8 years, respectively, and carry no intrinsic value. | |||||||||||
The following table summarizes stock option activity for performance based options under the 2010 AAG Option Plan for the periods presented (in thousands, except per share and year amounts): | |||||||||||
Number of | Weighted- | ||||||||||
Performance | Average | ||||||||||
based | Exercise | ||||||||||
Shares | Price | ||||||||||
Non-vested at December 31, 2011 | 12,848 | 1.01 | |||||||||
Granted | 985 | 1 | |||||||||
Forfeited | (971 | ) | 1 | ||||||||
| | | | | | | | ||||
Non-vested at December 31, 2012 | 12,862 | 1.01 | |||||||||
Granted | 1,869 | 1 | |||||||||
Forfeited | (926 | ) | 1 | ||||||||
| | | | | | | | ||||
Non-vested and outstanding at December 31, 2013 | 13,805 | 1.01 | |||||||||
| | | | | | | | ||||
| | | | | | | | ||||
Under the 2010 AAG Option Plan, performance based options vest subject to a liquidity event (e.g., an initial public offering or change in control, as defined) and based upon the attainment of specified minimum returns on capital to Parent shareholders. Compensation expense on performance based option grants is not recognized until it is probable that the liquidity event will occur. For all periods the Company did not recognize share based compensation expense related to its performance based grants given that the performance condition (a liquidity event) has not occurred in any of those periods. The weighted average fair value of performance based options granted to date has been $0.06. At December 31, 2013, the total amount of unrecognized compensation costs and the weighted average remaining contractual term for performance based options was $0.8 million and 7.5 years, respectively. | |||||||||||
Income_Taxes
Income Taxes | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Income Taxes | ' | ||||||||||
Income Taxes | ' | ||||||||||
Note 15—Income Taxes | |||||||||||
The benefit provision for income taxes on loss before income taxes, by tax jurisdiction, consisted of the following (in thousands): | |||||||||||
Year Ended | |||||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Current: | |||||||||||
Federal | $ | 3,006 | $ | 1,425 | $ | 1,323 | |||||
State | 537 | 364 | 994 | ||||||||
Foreign | 892 | 1,783 | 104 | ||||||||
| | | | | | | | | | | |
Total current | 4,435 | 3,572 | 2,421 | ||||||||
Deferred: | |||||||||||
Federal | (11,874 | ) | (11,060 | ) | (12,069 | ) | |||||
State | (2,818 | ) | 1,206 | (1,343 | ) | ||||||
Foreign | (518 | ) | (758 | ) | (714 | ) | |||||
| | | | | | | | | | | |
Total deferred | (15,210 | ) | (10,612 | ) | (14,126 | ) | |||||
| | | | | | | | | | | |
Total | $ | (10,775 | ) | $ | (7,040 | ) | $ | (11,705 | ) | ||
| | | | | | | | | | | |
| | | | | | | | | | | |
The components of loss before income taxes, by tax jurisdiction, were as follows (in thousands): | |||||||||||
Year Ended | |||||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
United States | $ | (19,478 | ) | $ | (24,880 | ) | $ | (20,823 | ) | ||
Foreign | (4,667 | ) | (27,961 | ) | (8,550 | ) | |||||
| | | | | | | | | | | |
$ | (24,145 | ) | $ | (52,841 | ) | $ | (29,373 | ) | |||
| | | | | | | | | | | |
| | | | | | | | | | | |
A reconciliation of the statutory federal income tax rate to the Company's effective tax rate on loss before income taxes follows: | |||||||||||
Year Ended | |||||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Statutory federal tax rate | 35 | % | 35 | % | 35 | % | |||||
Non-deductible impairment of goodwill | — | (12.3 | ) | — | |||||||
State taxes (net of federal tax benefits) | 6.8 | (1.9 | ) | 0.8 | |||||||
Foreign rate differential | (1.3 | ) | (3.0 | ) | 2.9 | ||||||
Domestic production activities deduction | 0.8 | 0.6 | — | ||||||||
Acquisition related | — | 0.4 | (0.6 | ) | |||||||
Change in Valuation Allowance | (2.3 | ) | — | — | |||||||
UK interest deduction | 1.8 | — | — | ||||||||
Other differences | 3.8 | (5.5 | ) | 1.7 | |||||||
| | | | | | | | | | | |
Effective tax rate | 44.6 | % | 13.3 | % | 39.8 | % | |||||
| | | | | | | | | | | |
| | | | | | | | | | | |
The Company's effective benefit rate for 2013 differs from the statutory rate primarily due to state taxes. Other items impacting the Company's effective benefit rate relate primarily to differences in the foreign rates when compared to the statutory rate and adjustments resulting from the filing of the income tax returns and change in valuation allowance in certain foreign jurisdictions. | |||||||||||
Deferred tax assets and liabilities are recognized for the future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax bases using enacted tax rates in effect for the year in which the differences are expected to be reversed. Significant deferred tax assets and liabilities consist of the following (in thousands): | |||||||||||
December 31, | December 31, | ||||||||||
2013 | 2012 | ||||||||||
Deferred tax assets: | |||||||||||
Accrual and reserves | $ | 1,841 | $ | 1,718 | |||||||
Inventory costs | 2,064 | 2,743 | |||||||||
Acquisition related | 2,225 | 2,438 | |||||||||
Net operating losses | 1,806 | 1,190 | |||||||||
Other | — | 42 | |||||||||
| | | | | | | | ||||
Total deferred tax assets | 7,936 | 8,131 | |||||||||
| | | | | | | | ||||
Deferred tax liabilities: | |||||||||||
Fixed and intangible assets | (93,388 | ) | (108,947 | ) | |||||||
| | | | | | | | ||||
Total deferred tax liabilities | (93,388 | ) | (108,947 | ) | |||||||
| | | | | | | | ||||
Valuation Allowance | (603 | ) | — | ||||||||
| | | | | | | | ||||
Net deferred tax liabilities | $ | (86,055 | ) | $ | (100,816 | ) | |||||
| | | | | | | | ||||
| | | | | | | | ||||
The net deferred tax assets and liabilities are included in the balance sheets as follows (in thousands): | |||||||||||
December 31, | December 31, | ||||||||||
2013 | 2012 | ||||||||||
Current deferred tax assets | $ | 3,555 | $ | 4,315 | |||||||
Non-current deferred tax liabilities | (89,610 | ) | (105,131 | ) | |||||||
| | | | | | | | ||||
Net deferred tax liabilities | $ | (86,055 | ) | $ | (100,816 | ) | |||||
| | | | | | | | ||||
| | | | | | | | ||||
The Company periodically reviews its deferred tax assets for recoverability. A valuation allowance is established when the Company believes that it is more likely than not that some portion or all of its deferred tax assets will not be realized. As of December 31, 2013, the Company had aggregate foreign net operating losses of approximately $10.0 million, which is comprised of losses of $8.2 million, $1.1 million, $0.5 million and $0.2 million in the United Kingdom, China, Puerto Rico, and other foreign jurisdictions, respectively. Losses in the United Kingdom are subject to an indefinite carryforward period; however, due to limitations on the ability to utilize such losses to offset income from only certain members of the United Kingdom group, a full valuation allowance has been provided on such losses. Losses in China and Puerto Rico are subject to five and ten year carryforward periods, respectively, and also carry a full valuation allowance. | |||||||||||
In connection with Acquisition, Clorox has agreed to indemnify the Company for any taxes and interest associated with the periods prior to November 4, 2010. | |||||||||||
The Company recognizes interest and penalties related to uncertain tax positions as a component of income tax expense. As of December 31, 2013 and December 31, 2012, the total balance of accrued interest and penalties related to uncertain tax positions was $0.1 million and $0.2 million, respectively. | |||||||||||
The following is a reconciliation of the beginning and ending amounts of the Company's gross unrecognized tax benefits (in thousands): | |||||||||||
Year Ended | |||||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Unrecognized tax benefits—beginning of period | $ | 379 | $ | 417 | $ | 586 | |||||
Gross increases—tax positions in prior periods | 625 | — | — | ||||||||
Gross increase—current period tax positions | — | 75 | — | ||||||||
Statute of limitations lapse | (51 | ) | — | — | |||||||
Settlements | (88 | ) | (113 | ) | (169 | ) | |||||
| | | | | | | | | | | |
Unrecognized tax benefits—end of period | $ | 865 | $ | 379 | $ | 417 | |||||
| | | | | | | | | | | |
| | | | | | | | | | | |
As of December 31, 2013 and December 31, 2012, the total amount of unrecognized tax benefits was $0.9 million, and $0.4 million, respectively, which would affect the effective tax rate, if recognized. Of the 2013 and 2012 balances above, $0.2 million and $0.3 million, respectively, relates to periods which were included within Clorox tax returns. An offsetting receivable has been recorded in other assets for the Clorox indemnity as of December 31, 2013 and 2012. As of December 31, 2013, the Company had an uncertain tax position of $0.6 million which was offset against a corresponding net operating loss in accordance with ASU 2013-11. | |||||||||||
The Company is subject to exam by the U.S. federal, state, and foreign tax authorities on its filings since 2010. During 2013, the U.S. federal tax return filed by the Company for 2010 was examined by the IRS, and resulted in no change. | |||||||||||
In the twelve months succeeding December 31, 2013, the Company expects total unrecognized tax benefits to change by $0.1 million due to the lapse of statute of limitations on a portion of the unrecognized tax benefit indemnified by Clorox. Audit outcomes and the timing of audit settlements are subject to significant uncertainty. | |||||||||||
The Company provides for U.S. income taxes on the earnings of foreign subsidiaries unless the earnings are considered indefinitely invested outside of the U.S. No provision has been made for U.S. income taxes or foreign withholding taxes on $0.7 million of cumulative unremitted earnings of certain foreign subsidiaries as of December 31, 2013 due to existing tax law and the Company's intention to indefinitely reinvest these earnings outside the U.S. The Company determined that the calculation of the amount of unrecognized deferred tax liability related to these cumulative unremitted earnings was not practicable. If these earnings were distributed to the Company's U.S. entity, the Company would be subject to additional U.S. income taxes and foreign withholding taxes would be reduced by available foreign tax credits. | |||||||||||
Retirement_Income_and_Health_B
Retirement Income and Health Benefit Plans | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Retirement Income and Health Benefit Plans | ' | ||||||||||
Retirement Income and Health Benefit Plans | ' | ||||||||||
Note 16—Retirement Income and Health Benefit Plans | |||||||||||
Defined Contribution Plans | |||||||||||
The Company established a defined contribution plan in the United States for the Company's employees that contain two components, a 401(k) component and a profit-sharing component, which qualifies as a tax deferred savings plan under Section 401(k) of the IRC ("The Plan"). Eligible U.S. employees may contribute a percentage of their pre-tax compensation, subject to certain IRC limitations. The Plan provides for employer matching contributions to be made up to $1,000 per year and profit sharing contributions at the discretion of the Board of Directors. The Company's aggregate cost of the defined contribution plans was (in thousands): | |||||||||||
Year Ended | |||||||||||
December 31, 2013 | December 31, | December 31, | |||||||||
2012 | 2011 | ||||||||||
$804 | $ | 1,622 | $ | 1,137 |
Segment_Data
Segment Data | 12 Months Ended | |||||||||||||
Dec. 31, 2013 | ||||||||||||||
Segment Data | ' | |||||||||||||
Segment Data | ' | |||||||||||||
Note 17—Segment Data | ||||||||||||||
The Company manages its business through two geographic segments: North America and International. | ||||||||||||||
• | ||||||||||||||
North America—consists of auto-care products marketed and sold in the United States and Canada. Products within this segment include auto-care products primarily under the Armor All and STP brands. | ||||||||||||||
• | ||||||||||||||
International—consists of products sold outside North America, including Australia, Europe and other international locations. Products within this segment include auto-care products primarily under the Armor All and STP brands. | ||||||||||||||
The Company does not allocate its cost of products sold—acquisition related, acquisition related charges, amortization of intangible assets or interest expense between its North America and International segments but includes them in the tables below under Corporate in order to reconcile the North America and International segments' performance to the Company's Statements of Comprehensive Loss. All intersegment sales are eliminated and are not included in the Company's reportable segments' net sales. | ||||||||||||||
The following summarizes the financial performance of the Company's operating segments (in thousands): | ||||||||||||||
Year ended December 31, 2013 | ||||||||||||||
North America | International | Corporate | Consolidated | |||||||||||
Net sales | $ | 215,165 | $ | 74,791 | $ | — | $ | 289,956 | ||||||
Earnings (loss) before income taxes | 52,118 | 8,549 | (84,812 | ) | (24,145 | ) | ||||||||
Capital expenditures | 3,848 | 457 | — | 4,305 | ||||||||||
Depreciation and amortization | 6,133 | 841 | 36,788 | 43,762 | ||||||||||
Share based compensation | 266 | 24 | — | 290 | ||||||||||
Year ended December 31, 2012 | ||||||||||||||
North America | International | Corporate | Consolidated | |||||||||||
Net sales | $ | 232,467 | $ | 74,001 | $ | — | $ | 306,468 | ||||||
Earnings (loss) before income taxes(1) | 48,909 | (16,162 | ) | (85,588 | ) | (52,841 | ) | |||||||
Capital expenditures | 6,481 | 1,217 | — | 7,698 | ||||||||||
Depreciation and amortization | 5,622 | 431 | 36,701 | 42,754 | ||||||||||
Share based compensation | 256 | 10 | — | 266 | ||||||||||
-1 | ||||||||||||||
During the fourth quarter of 2012, the Company recorded a $24.1 million non-cash impairment charge on goodwill allocated to its Europe, Middle East and Africa reporting unit and its Australia and New Zealand reporting unit, both reporting units being included within the Company's international segment. See Notes 1 and 7. | ||||||||||||||
Year ended December 31, 2011 | ||||||||||||||
North America | International | Corporate | Consolidated | |||||||||||
Net sales | $ | 212,114 | $ | 69,203 | $ | — | $ | 281,317 | ||||||
Earnings (loss) before income taxes | 33,327 | 27,553 | (90,253 | ) | (29,373 | ) | ||||||||
Capital expenditures | 11,986 | 1,025 | — | 13,011 | ||||||||||
Depreciation and amortization | 7,454 | 1,107 | 36,701 | 45,262 | ||||||||||
Share based compensation | 256 | 10 | — | 266 | ||||||||||
The following is a summary of sales by product categories for the Company's North America segment (in thousands): | ||||||||||||||
Year Ended | ||||||||||||||
December 31, | December 31, | December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||||
North America: | ||||||||||||||
Appearance products | $ | 160,180 | $ | 171,592 | $ | 152,035 | ||||||||
Performance chemicals products | 54,985 | 60,875 | 60,079 | |||||||||||
| | | | | | | | | | | ||||
Total net sales | $ | 215,165 | $ | 232,467 | $ | 212,114 | ||||||||
| | | | | | | | | | | ||||
| | | | | | | | | | | ||||
The Company has not historically tracked net sales by product categories for its International segment. | ||||||||||||||
The Company has three products that have accounted for 10% or more of total net sales: | ||||||||||||||
Year Ended | ||||||||||||||
December 31, | December 31, | December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||||
Armor-All wipes | 18 | % | 17 | % | 18 | % | ||||||||
Armor-All protectant | 21 | % | 22 | % | 26 | % | ||||||||
STP fuel and oil additives | 16 | % | 18 | % | 19 | % | ||||||||
The Company has operations in the United States and abroad, including Canada, Europe, Australia and other international locations. Net sales based on geography are summarized as follows (in thousands): | ||||||||||||||
Year Ended | ||||||||||||||
December 31, | December 31, | December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||||
U.S. | $ | 194,745 | $ | 210,086 | $ | 191,436 | ||||||||
Canada | 20,420 | 22,381 | 20,678 | |||||||||||
Europe | 25,229 | 24,518 | 22,270 | |||||||||||
Australia and rest of world | 49,562 | 49,483 | 46,933 | |||||||||||
| | | | | | | | | | | ||||
Total net sales | $ | 289,956 | $ | 306,468 | $ | 281,317 | ||||||||
| | | | | | | | | | | ||||
| | | | | | | | | | | ||||
Long lived, tangible assets based on geography are summarized as follows (in thousands): | ||||||||||||||
December 31, | December 31, | |||||||||||||
2013 | 2012 | |||||||||||||
U.S. | $ | 26,095 | $ | 28,079 | ||||||||||
Rest of world | 2,841 | 3,394 | ||||||||||||
| | | | | | | | |||||||
Total long lived tangible assets | $ | 28,936 | $ | 31,473 | ||||||||||
| | | | | | | | |||||||
| | | | | | | | |||||||
The Company does not allocate intangible assets or debt and its associated deferred financing costs to its North America and International segments but includes them as Corporate balance sheet items. The following summarizes total assets of the Company's operating segments (in thousands): | ||||||||||||||
December 31, | December 31, | |||||||||||||
2013 | 2012 | |||||||||||||
North America | $ | 123,964 | $ | 128,461 | ||||||||||
International | 30,823 | 30,424 | ||||||||||||
Corporate | 677,460 | 721,872 | ||||||||||||
| | | | | | | | |||||||
Total assets | $ | 832,247 | $ | 880,757 | ||||||||||
| | | | | | | | |||||||
| | | | | | | | |||||||
Financial_Information_for_the_
Financial Information for the Company and Its Subsidiaries | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Financial Information for the Company and Its Subsidiaries | ' | ||||||||||||||||
Financial Information for the Company and Its Subsidiaries | ' | ||||||||||||||||
Note 18—Financial Information for the Company and Its Subsidiaries | |||||||||||||||||
The Company's payment obligations under the Senior Notes are guaranteed, jointly and severally, by all of the Company's wholly owned domestic subsidiaries that guarantee the obligations of the Company under the Credit Facility. These guarantees are full and unconditional, subject, in the case of the subsidiary guarantors, to customary release provisions. The Company conducts substantially all of its business through its subsidiaries. In servicing payments to be made on the Senior Notes and other indebtedness, and to satisfy other liquidity requirements, the Company will rely, in large part, on cash flows from these subsidiaries, mainly in the form of dividends, royalties and advances or payments on account of intercompany loan arrangements. The ability of these subsidiaries to make dividend payments to the Company will be affected by, among other factors, the obligations of these entities to their creditors, requirements of corporate and other law, and restrictions contained in agreements entered into by or relating to these entities. | |||||||||||||||||
The following supplemental consolidating financial information sets forth, on a combining basis, balance sheets, statements of comprehensive income (loss) and statements of cash flows for the Company, the guarantor subsidiaries, the non-guarantor subsidiaries and elimination entries necessary to consolidate the Company and its subsidiaries. This information is presented in lieu of separate financial statements and other related disclosures pursuant to Regulation S-X Rule 3-10 of the Securities Exchange Act of 1934, as amended, "Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered." | |||||||||||||||||
The operating and investing activities of the separate legal entities are fully interdependent and integrated. Accordingly, the results of the separate legal entities are not representative of what the operating results would be on a standalone basis. | |||||||||||||||||
Condensed Consolidating Balance Sheet | |||||||||||||||||
Year Ended December 31, 2013 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
ASSETS | |||||||||||||||||
Current assets: | |||||||||||||||||
Cash | $ | 14,843 | $ | — | $ | 6,410 | $ | — | $ | 21,253 | |||||||
Accounts receivable | 78 | 44,885 | 17,247 | — | 62,210 | ||||||||||||
Inventory | — | 24,553 | 9,490 | — | 34,043 | ||||||||||||
Other current assets | 53,853 | (45,072 | ) | 1,009 | — | 9,790 | |||||||||||
| | | | | | | | | | | | | | | | | |
Total current assets | 68,774 | 24,366 | 34,156 | — | 127,296 | ||||||||||||
Property, plant and equipment | 8,061 | 18,037 | 2,838 | — | 28,936 | ||||||||||||
Goodwill | — | 310,576 | 48,250 | — | 358,826 | ||||||||||||
Intangible assets | — | 276,461 | 38,198 | (1,189 | ) | 313,470 | |||||||||||
Investment in subsidiaries | 647,107 | 115,394 | — | (762,501 | ) | — | |||||||||||
Other assets | 3,632 | 87 | — | — | 3,719 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total assets | $ | 727,574 | $ | 744,921 | $ | 123,442 | $ | (763,690 | ) | $ | 832,247 | ||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
LIABILITIES AND | |||||||||||||||||
SHAREHOLDER'S EQUITY | |||||||||||||||||
Current liabilities: | |||||||||||||||||
Accounts payable | $ | 169 | $ | 5,103 | $ | 2,856 | $ | — | $ | 8,128 | |||||||
Accrued expenses and other current liabilities | 10,063 | 8,263 | 5,129 | — | 23,455 | ||||||||||||
Due to Clorox | 69 | 23 | (1 | ) | — | 91 | |||||||||||
Due to Parent | 745 | — | — | — | 745 | ||||||||||||
Notes payable, current portion | 71 | — | — | — | 71 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total current liabilities | 11,117 | 13,389 | 7,984 | 32,490 | |||||||||||||
Notes payable, less current portion and discount | 553,511 | — | — | — | 553,511 | ||||||||||||
Other liabilities | 2,500 | — | — | — | 2,500 | ||||||||||||
Deferred income taxes | 5,121 | 84,425 | 64 | — | 89,610 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total liabilities | 572,249 | 97,814 | 8,048 | — | 678,111 | ||||||||||||
Shareholder's equity | 155,325 | 647,107 | 115,394 | (763,690 | ) | 154,136 | |||||||||||
| | | | | | | | | | | | | | | | | |
Total liabilities and shareholder's equity | $ | 727,574 | $ | 744,921 | $ | 123,442 | $ | (763,690 | ) | $ | 832,247 | ||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidating Balance Sheet | |||||||||||||||||
Year Ended December 31, 2012 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
ASSETS | |||||||||||||||||
Current assets: | |||||||||||||||||
Cash | $ | 1,477 | $ | — | $ | 2,729 | $ | — | $ | 4,206 | |||||||
Accounts receivable | 105 | 49,635 | 19,862 | — | 69,602 | ||||||||||||
Inventory | — | 31,718 | 10,726 | — | 42,444 | ||||||||||||
Other current assets | 50,116 | (38,357 | ) | 1,132 | — | 12,891 | |||||||||||
| | | | | | | | | | | | | | | | | |
Total current assets | 51,698 | 42,996 | 34,449 | — | 129,143 | ||||||||||||
Property, plant and equipment | 8,682 | 19,397 | 3,394 | — | 31,473 | ||||||||||||
Goodwill | — | 310,577 | 51,639 | — | 362,216 | ||||||||||||
Intangible assets | — | 307,401 | 45,887 | (383 | ) | 352,905 | |||||||||||
Investment in subsidiaries | 687,226 | 122,893 | — | (810,119 | ) | — | |||||||||||
Other assets | 4,943 | 77 | — | — | 5,020 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total assets | $ | 752,549 | $ | 803,341 | $ | 135,369 | $ | (810,502 | ) | $ | 880,757 | ||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
LIABILITIES AND | |||||||||||||||||
SHAREHOLDER'S EQUITY | |||||||||||||||||
Current liabilities: | |||||||||||||||||
Accounts payable | $ | 888 | $ | 8,868 | $ | 3,402 | $ | — | $ | 13,158 | |||||||
Accrued expenses and other current liabilities | 12,397 | 7,215 | 8,959 | — | 28,571 | ||||||||||||
Due to Clorox | — | 22 | 115 | — | 137 | ||||||||||||
Due to Parent | 795 | — | — | — | 795 | ||||||||||||
Notes payable, current portion | 279 | — | — | — | 279 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total current liabilities | 14,359 | 16,105 | 12,476 | 42,940 | |||||||||||||
Notes payable, less current portion and discount | 553,581 | — | — | — | 553,581 | ||||||||||||
Other liabilities | 2,500 | — | — | — | 2,500 | ||||||||||||
Deferred income taxes | 5,121 | 100,010 | — | — | 105,131 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total liabilities | 575,561 | 116,115 | 12,476 | — | 704,152 | ||||||||||||
Shareholder's equity | 176,988 | 687,226 | 122,893 | (810,502 | ) | 176,605 | |||||||||||
| | | | | | | | | | | | | | | | | |
Total liabilities and shareholder's equity | $ | 752,549 | $ | 803,341 | $ | 135,369 | $ | (810,502 | ) | $ | 880,757 | ||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Comprehensive (Loss) Income | |||||||||||||||||
Year Ended December 31, 2013 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
Net sales | $ | — | $ | 235,897 | $ | 75,557 | $ | (21,498 | ) | $ | 289,956 | ||||||
Cost of products sold | — | 124,194 | 55,353 | (21,498 | ) | 158,049 | |||||||||||
| | | | | | | | | | | | | | | | | |
Gross profit | — | 111,703 | 20,204 | — | 131,907 | ||||||||||||
Operating expenses: | |||||||||||||||||
Selling and administrative expenses | 19,316 | 10,903 | 10,475 | — | 40,694 | ||||||||||||
Advertising costs | — | 21,549 | 6,238 | — | 27,787 | ||||||||||||
Research and development costs | — | 2,463 | 11 | — | 2,474 | ||||||||||||
Amortization of acquired intangible assets | — | 30,181 | 6,607 | — | 36,788 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total operating expenses | 19,316 | 65,096 | 23,331 | — | 107,743 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Operating (loss) profit | (19,316 | ) | 46,607 | (3,127 | ) | — | 24,164 | ||||||||||
Non-operating expenses (income): | |||||||||||||||||
Interest expense | 48,015 | 1 | 8 | — | 48,024 | ||||||||||||
Other (income) expense | (72 | ) | 82 | 275 | — | 285 | |||||||||||
| | | | | | | | | | | | | | | | | |
(Loss) earnings before income taxes | (67,259 | ) | 46,524 | (3,410 | ) | — | (24,145 | ) | |||||||||
(Benefit) provision for income taxes | (19,194 | ) | 8,045 | 374 | — | (10,775 | ) | ||||||||||
Equity earnings (loss) of subsidiaries, net of taxes | 34,695 | (3,784 | ) | — | (30,911 | ) | — | ||||||||||
| | | | | | | | | | | | | | | | | |
Net (loss) earnings | $ | (13,370 | ) | $ | 34,695 | $ | (3,784 | ) | $ | (30,911 | ) | $ | (13,370 | ) | |||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Other comprehensive (loss) income: | |||||||||||||||||
Foreign currency translation gain (loss) | (9,389 | ) | (9,389 | ) | (9,389 | ) | 18,778 | (9,389 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Comprehensive (loss) income | $ | (22,759 | ) | $ | 25,306 | $ | (13,173 | ) | $ | (12,133 | ) | $ | (22,759 | ) | |||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Comprehensive (Loss) Income | |||||||||||||||||
Year Ended December 31, 2012 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
Net sales | $ | 154 | $ | 255,078 | $ | 79,693 | $ | (28,457 | ) | $ | 306,468 | ||||||
Cost of products sold | — | 137,302 | 58,725 | (28,457 | ) | 167,570 | |||||||||||
| | | | | | | | | | | | | | | | | |
Gross profit | 154 | 117,776 | 20,968 | — | 138,898 | ||||||||||||
Operating expenses: | |||||||||||||||||
Selling and administrative expenses | 23,788 | 13,434 | 11,084 | — | 48,306 | ||||||||||||
Advertising costs | — | 24,296 | 6,776 | — | 31,072 | ||||||||||||
Research and development costs | — | 2,211 | — | — | 2,211 | ||||||||||||
Amortization of acquired intangible assets | — | 30,181 | 6,520 | — | 36,701 | ||||||||||||
Goodwill impairment | — | — | 24,117 | — | 24,117 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total operating expenses | 23,788 | 70,122 | 48,497 | — | 142,407 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Operating (loss) profit | (23,634 | ) | 47,654 | (27,529 | ) | — | (3,509 | ) | |||||||||
Non-operating expenses (income): | |||||||||||||||||
Interest expense | 48,887 | — | — | — | 48,887 | ||||||||||||
Other (income) expense | 61 | (48 | ) | 432 | — | 445 | |||||||||||
| | | | | | | | | | | | | | | | | |
(Loss) earnings before income taxes | (72,582 | ) | 47,702 | (27,961 | ) | — | (52,841 | ) | |||||||||
(Benefit) provision for income taxes | (2,751 | ) | (5,312 | ) | 1,023 | — | (7,040 | ) | |||||||||
Equity earnings (loss) of subsidiaries, net of taxes | 24,030 | (28,984 | ) | — | 4,954 | — | |||||||||||
| | | | | | | | | | | | | | | | | |
Net (loss) earnings | $ | (45,801 | ) | $ | 24,030 | $ | (28,984 | ) | $ | 4,954 | $ | (45,801 | ) | ||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Other comprehensive (loss) income: | |||||||||||||||||
Foreign currency translation gain (loss) | 3,807 | 3,807 | 3,807 | (7,614 | ) | 3,807 | |||||||||||
| | | | | | | | | | | | | | | | | |
Comprehensive (loss) income | $ | (41,994 | ) | $ | 27,837 | $ | (25,117 | ) | $ | (2,660 | ) | $ | (41,994 | ) | |||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Comprehensive (Loss) Income | |||||||||||||||||
Year Ended December 31, 2011 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
Net sales | $ | — | $ | 233,176 | $ | 77,870 | $ | (29,729 | ) | $ | 281,317 | ||||||
Cost of products sold | — | 123,721 | 59,122 | (29,729 | ) | 153,114 | |||||||||||
Cost of products sold—acquisition related | — | 4,439 | — | — | 4,439 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Gross profit | — | 105,016 | 18,748 | — | 123,764 | ||||||||||||
Operating expenses: | |||||||||||||||||
Selling and administrative expenses | 17,475 | 11,766 | 10,999 | — | 40,240 | ||||||||||||
Advertising costs | — | 17,941 | 6,758 | — | 24,699 | ||||||||||||
Research and development costs | — | 2,307 | — | — | 2,307 | ||||||||||||
Amortization of acquired intangible assets | — | 30,181 | 6,520 | — | 36,701 | ||||||||||||
Acquisition related charges | 1,020 | — | — | — | 1,020 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total operating expenses | 18,495 | 62,195 | 24,277 | — | 104,967 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Operating (loss) profit | (18,495 | ) | 42,821 | (5,529 | ) | — | 18,797 | ||||||||||
Non-operating expenses (income): | |||||||||||||||||
Interest expense | 48,090 | — | — | — | 48,090 | ||||||||||||
Other (income) expense | (64 | ) | (95 | ) | 239 | — | 80 | ||||||||||
| | | | | | | | | | | | | | | | | |
(Loss) earnings before income taxes | (66,521 | ) | 42,916 | (5,768 | ) | — | (29,373 | ) | |||||||||
(Benefit) provision for income taxes | (35,194 | ) | 24,099 | (610 | ) | — | (11,705 | ) | |||||||||
Equity earnings (loss) of subsidiaries, net of taxes | 13,659 | (5,158 | ) | — | (8,501 | ) | — | ||||||||||
| | | | | | | | | | | | | | | | | |
Net (loss) earnings | $ | (17,668 | ) | $ | 13,659 | $ | (5,158 | ) | $ | (8,501 | ) | $ | (17,668 | ) | |||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Other comprehensive (loss) income: | |||||||||||||||||
Foreign currency translation loss | (2,007 | ) | (2,007 | ) | (2,007 | ) | 4,014 | (2,007 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Comprehensive (loss) income | $ | (19,675 | ) | $ | 11,652 | $ | (7,165 | ) | $ | (4,487 | ) | $ | (19,675 | ) | |||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Cash Flows | |||||||||||||||||
Year Ended December 31, 2013 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||
Net earnings (loss) | $ | (13,370 | ) | $ | 34,695 | $ | (3,784 | ) | $ | (30,911 | ) | $ | (13,370 | ) | |||
Adjustments: | |||||||||||||||||
Depreciation and amortization | 6,066 | 34,194 | 7,586 | — | 47,846 | ||||||||||||
Share based compensation | 290 | — | — | — | 290 | ||||||||||||
Deferred income taxes | 765 | (15,589 | ) | 41 | — | (14,783 | ) | ||||||||||
Equity (loss) earnings of subsidiaries, net of taxes | (34,695 | ) | 3,784 | — | 30,911 | — | |||||||||||
Other | — | 75 | (12 | ) | — | 63 | |||||||||||
Cash effect of changes, net of acquisition effects, in: | |||||||||||||||||
Receivables | 27 | 4,750 | 4,178 | — | 8,955 | ||||||||||||
Inventory | — | 7,165 | 2,111 | — | 9,276 | ||||||||||||
Due from Clorox | 69 | — | (115 | ) | — | (46 | ) | ||||||||||
Other current assets | (5,782 | ) | 6,709 | (146 | ) | — | 781 | ||||||||||
Prepaid taxes | 1,215 | — | — | — | 1,215 | ||||||||||||
Accounts payable and accrued liabilities | (3,052 | ) | (2,717 | ) | (4,853 | ) | — | (10,622 | ) | ||||||||
Intercompany | 66,019 | (70,338 | ) | 2,981 | — | (1,338 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Net cash provided by operating activities | 17,552 | 2,728 | 7,987 | — | 28,267 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Cash flows from investing activities: | |||||||||||||||||
Capital expenditures | (1,136 | ) | (2,728 | ) | (441 | ) | — | (4,305 | ) | ||||||||
Acquisition, net | — | — | (3,084 | ) | — | (3,084 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Net cash used in investing activities | (1,136 | ) | (2,728 | ) | (3,525 | ) | — | (7,389 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Cash flows from financing activities: | |||||||||||||||||
Borrowings under revolver | 23,000 | — | — | — | 23,000 | ||||||||||||
Payments on revolver | (23,000 | ) | — | — | — | (23,000 | ) | ||||||||||
Principal payments on notes payable and other | (3,000 | ) | — | (611 | ) | — | (3,611 | ) | |||||||||
Advance from Parent | (50 | ) | — | — | — | (50 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Net cash used in financing activities | (3,050 | ) | — | (611 | ) | — | (3,661 | ) | |||||||||
| | | | | | | | | | | | | | | | | |
Effect of exchange rate on cash | — | — | (170 | ) | — | (170 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Net increase in cash | 13,366 | — | 3,681 | — | 17,047 | ||||||||||||
Cash at beginning of period | 1,477 | — | 2,729 | — | 4,206 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Cash at end of period | $ | 14,843 | $ | — | $ | 6,410 | $ | — | $ | 21,253 | |||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Cash Flows | |||||||||||||||||
Year Ended December 31, 2012 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||
Net earnings (loss) | $ | (45,801 | ) | $ | 24,030 | $ | (28,984 | ) | $ | 4,954 | $ | (45,801 | ) | ||||
Adjustments: | |||||||||||||||||
Depreciation and amortization | 5,651 | 33,958 | 7,204 | — | 46,813 | ||||||||||||
Goodwill impairment | — | — | 24,117 | — | 24,117 | ||||||||||||
Share based compensation | 266 | — | — | — | 266 | ||||||||||||
Deferred income taxes | — | (11,360 | ) | 748 | — | (10,612 | ) | ||||||||||
Equity (loss) earnings of subsidiaries, net of taxes | (24,030 | ) | 28,984 | — | (4,954 | ) | — | ||||||||||
Other | — | 157 | — | — | 157 | ||||||||||||
Cash effect of changes, net of acquisition effects, in: | |||||||||||||||||
Receivables | 661 | (7,214 | ) | (8,749 | ) | — | (15,302 | ) | |||||||||
Inventory | — | (2,354 | ) | (2,840 | ) | — | (5,194 | ) | |||||||||
Due from Clorox | (244 | ) | 11,455 | 653 | — | 11,864 | |||||||||||
Other current assets | (40,890 | ) | 38,822 | 1,315 | — | (753 | ) | ||||||||||
Accounts payable and accrued liabilities | (2,885 | ) | 6,567 | 6,827 | — | 10,509 | |||||||||||
Book overdraft | (1,987 | ) | — | — | — | (1,987 | ) | ||||||||||
Income taxes payable | 31,173 | (35,531 | ) | (78 | ) | (4,436 | ) | ||||||||||
Intercompany | 83,755 | (81,930 | ) | (820 | ) | (402 | ) | 603 | |||||||||
| | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | 5,669 | 5,584 | (607 | ) | (402 | ) | 10,244 | ||||||||||
| | | | | | | | | | | | | | | | | |
Cash flows from investing activities: | |||||||||||||||||
Capital expenditures | (1,453 | ) | (4,976 | ) | (1,269 | ) | — | (7,698 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Net cash used in investing activities | (1,453 | ) | (4,976 | ) | (1,269 | ) | — | (7,698 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Cash flows from financing activities: | |||||||||||||||||
Borrowings under revolver | 64,001 | — | — | — | 64,001 | ||||||||||||
Payments on revolver | (64,001 | ) | — | — | — | (64,001 | ) | ||||||||||
Principal payments on notes payable | (3,000 | ) | — | — | — | (3,000 | ) | ||||||||||
Debt financing costs | (350 | ) | — | — | — | (350 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Net cash used in financing activities | (3,350 | ) | — | — | — | (3,350 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Effect of exchange rate on cash | 611 | (608 | ) | (330 | ) | 402 | 75 | ||||||||||
| | | | | | | | | | | | | | | | | |
Net (decrease) increase in cash | 1,477 | — | (2,206 | ) | — | (729 | ) | ||||||||||
Cash at beginning of period | — | — | 4,935 | — | 4,935 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Cash at end of period | $ | 1,477 | $ | — | $ | 2,729 | $ | — | $ | 4,206 | |||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Cash Flows | |||||||||||||||||
Year Ended December 31, 2011 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||
Net earnings (loss) | $ | (17,668 | ) | $ | 13,659 | $ | (5,158 | ) | $ | (8,501 | ) | $ | (17,668 | ) | |||
Adjustments: | |||||||||||||||||
Depreciation and amortization | 4,316 | 33,319 | 7,627 | — | 45,262 | ||||||||||||
Share based compensation | 266 | — | — | — | 266 | ||||||||||||
Deferred income taxes | (1,716 | ) | (12,410 | ) | — | — | (14,126 | ) | |||||||||
Equity (loss) earnings of subsidiaries, net of taxes | (13,659 | ) | 5,158 | — | 8,501 | — | |||||||||||
Other | — | 80 | 295 | 375 | |||||||||||||
Cash effect of changes, net of acquisition effects, in: | |||||||||||||||||
Receivables, net | (615 | ) | (15,881 | ) | (2,438 | ) | — | (18,934 | ) | ||||||||
Inventory | — | (932 | ) | 1,904 | — | 972 | |||||||||||
Due from Clorox | (820 | ) | (7,807 | ) | (1,426 | ) | — | (10,053 | ) | ||||||||
Other current assets | 1,040 | (541 | ) | (975 | ) | — | (476 | ) | |||||||||
Book overdraft | 1,987 | — | — | — | 1,987 | ||||||||||||
Accounts payable and accrued liabilities | 8,855 | (6,044 | ) | (512 | ) | — | 2,299 | ||||||||||
Intercompany receivable / payable | 34,712 | (40,710 | ) | 5,612 | 386 | — | |||||||||||
Income taxes payable | (35,142 | ) | 35,448 | — | — | 306 | |||||||||||
| | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | (18,444 | ) | 3,339 | 4,929 | 386 | (9,790 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Cash flows from investing activities: | |||||||||||||||||
Capital expenditures | (8,647 | ) | (3,339 | ) | (1,025 | ) | — | (13,011 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Net cash used in investing activities | (8,647 | ) | (3,339 | ) | (1,025 | ) | — | (13,011 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Cash flows from financing activities: | |||||||||||||||||
Borrowings under revolver | 29,500 | — | — | — | 29,500 | ||||||||||||
Payments on revolver | (29,500 | ) | — | — | — | (29,500 | ) | ||||||||||
Principal payments on notes payable | (3,000 | ) | — | — | — | (3,000 | ) | ||||||||||
Advance from Parent | 795 | — | — | — | 795 | ||||||||||||
Debt financing costs | (670 | ) | — | — | — | (670 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Net cash used in financing activities | (2,875 | ) | — | — | — | (2,875 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Effect of exchange rate on cash | — | — | (704 | ) | (386 | ) | (1,090 | ) | |||||||||
| | | | | | | | | | | | | | | | | |
Net (decrease) increase in cash | (29,966 | ) | — | 3,200 | — | (26,766 | ) | ||||||||||
Cash at beginning of period | 29,966 | — | 1,735 | — | 31,701 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Cash at end of period | $ | — | $ | — | $ | 4,935 | $ | — | $ | 4,935 | |||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Quarterly_Financial_Informatio
Quarterly Financial Information (Unaudited) | 12 Months Ended | |||||||||||||
Dec. 31, 2013 | ||||||||||||||
Quarterly Financial Information (Unaudited) | ' | |||||||||||||
Quarterly Financial Information (Unaudited) | ' | |||||||||||||
Note 19—Quarterly Financial Information (Unaudited) | ||||||||||||||
The following table presents selected unaudited financial information for the eight quarters in the two year period ended December 31, 2013. The Company's business is moderately seasonal. Sales are typically higher in the first half of the calendar year as the Company's customers purchase stock for the spring and summer seasons when weather is warmer in the northern hemisphere than in the fall and winter months. This pattern is largely reflective of our customers' seasonal purchasing patterns, as well as the timing of our promotional activities. Weather can also influence consumer behavior, especially for appearance products. Our appearance products sell best during warm, dry weather, and sell less strongly if weather is cold and wet. For these reasons, among others, the Company's results for any quarter are not necessarily indicative of future quarterly results and, accordingly, period-to-period comparisons should not be relied upon as an indication of future performance (in thousands). | ||||||||||||||
March 31, | June 30, | September 30, | December 31, | |||||||||||
2013 | 2013 | 2013 | 2013 | |||||||||||
Net sales | $ | 74,413 | $ | 80,075 | $ | 71,007 | $ | 64,461 | ||||||
Gross profit | 33,928 | 37,736 | 32,524 | 27,719 | ||||||||||
Income from operations | 10,939 | 4,093 | 6,102 | 3,030 | ||||||||||
Net loss | (506 | ) | (5,286 | ) | (2,275 | ) | (5,303 | ) | ||||||
March 31, | June 30, | September 30, | December 31, | |||||||||||
2012 | 2012 | 2012 | 2012 | |||||||||||
Net sales | $ | 86,396 | $ | 82,695 | $ | 68,348 | $ | 69,029 | ||||||
Gross profit | 43,306 | 38,565 | 28,620 | 28,407 | ||||||||||
Income (loss) from operations(1) | 15,206 | 3,683 | 27 | (22,425 | ) | |||||||||
Net earnings (loss) | 1,106 | (4,103 | ) | (9,773 | ) | (33,031 | ) | |||||||
-1 | ||||||||||||||
During the fourth quarter of 2012, the Company recorded a $24.1 million non-cash impairment charge on goodwill allocated to its Europe, Middle East and Africa reporting unit and its Australia and New Zealand reporting unit. See Notes 1 and 7. | ||||||||||||||
Subsequent_Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2013 | |
Subsequent Events | ' |
Subsequent Events | ' |
Note 20—Subsequent Events | |
On March 17, 2014, the Company paid $10.0 million to acquire a non-controlling equity interest in IDQ Acquisition Corp. ("IDQ") and also paid $1.2 million in transaction fees and closing costs. The transaction fees and closing costs included $0.3 million paid to a board member for services rendered in connection with the transaction. On the same date, Parent acquired a controlling equity interest in IDQ. In connection with the investment the Company entered into a Shared Services and Supply Agreement (the "Shared Services Agreement") with IDQ and Parent pursuant to which certain products and services will be provided on an arm's-length basis by one party to another, as agreed by the Company and IDQ, with the purpose of utilizing the assets and operations of each company to increase sales and lower the combined costs for the mutual benefit of both IDQ and us. In anticipation of the IDQ investment, on March 11, 2014, the Company entered into an amendment of the Credit Facility revising a defined term, Consolidated EBITDA. Consolidated EBITDA is used in the calculation certain financial condition covenants under the Credit Facility. The revision to the definition of Consolidated EBITDA excludes from Consolidated EBITDA fees and expenses incurred for the Company's investment in IDQ Acquisition Corp., the Company's implementation of a management services agreement with IDQ Acquisition Corp. and the Company's pursuit of cost savings, expense reductions and other operating improvements and synergies related to IDQ. | |
The_Company_and_Summary_of_Sig1
The Company and Summary of Significant Accounting Policies (Policies) | 12 Months Ended | ||
Dec. 31, 2013 | |||
The Company and Summary of Significant Accounting Policies | ' | ||
Basis of Presentation | ' | ||
Basis of Presentation | |||
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP). The Company's fiscal year end is December 31. The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated. | |||
Use of Estimates | ' | ||
Use of Estimates | |||
The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and related disclosures. Specific areas, among others, requiring the application of management's estimates and judgment include assumptions pertaining to allowances for excess and obsolete inventory, provisions for cash discounts on amounts due from customers, share based compensation awards, fair values assigned to assets acquired and liabilities assumed in connection with acquisitions (see Note 7), accruals for consumer and trade promotion programs, future product volume and pricing estimates, future cash flows utilized in impairment testing of goodwill and other long lived assets, creditworthiness of customers and potential income tax. Actual results could differ materially from the estimates and assumptions made. | |||
Foreign Currency Translation | ' | ||
Foreign Currency Translation | |||
Local currencies are the functional currencies for substantially all of the Company's foreign operations. When the transactional currency is different than the functional currency, transaction gains and losses are included as a component of other expense (income), net. Assets and liabilities of foreign operations are translated into U.S. dollars using the exchange rates in effect at the respective balance sheet reporting date. Income and expenses are translated at the average exchange rate during the period. Gains and losses on foreign currency translations are reported as a component of accumulated other comprehensive (loss) income. Deferred taxes are not provided on cumulative translation adjustments where the Company expects earnings of a foreign subsidiary to be indefinitely reinvested. | |||
Accounts Receivable, net | ' | ||
Accounts Receivable, net | |||
We record accounts receivable at net realizable value. This value includes allowances for discounts and estimated uncollectible accounts to reflect losses anticipated on accounts receivable balances. The allowance for uncollectible accounts is based on historical write-offs, an analysis of past due accounts based on the contractual terms of the receivables, and the economic status of customers, if known. We believe that the allowance is sufficient to cover uncollectible amounts; however, there can be no assurance that unanticipated future business conditions of customers will not have a negative impact on our results of operations. Accounts receivable are written off against the allowance for estimated uncollectible accounts should we conclude their collection is improbable. | |||
Concentrations of Credit Risk | ' | ||
Concentrations of Credit Risk | |||
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of accounts receivable. Concentrations of credit risk with respect to accounts receivable, which are typically unsecured, are limited to an extent due to the large number of entities comprising the Company's customer base and their dispersion across many geographical regions. The Company performs ongoing credit evaluations of the financial condition of its customers and requires credit enhancements, such as letters of credit and bank guarantees, in certain circumstances. | |||
The Company does, however, sell a significant portion of its products through third party distributors, resellers and significant retail customers (See Note 3) and, as a result, maintains at times significant receivables balances with these parties. If the financial condition of these distributors, resellers or significant retail customers should deteriorate substantially, the Company's results of operations, financial position and cash flows could be adversely affected. | |||
Cash at times may exceed FDIC insurable limits. | |||
Inventories | ' | ||
Inventories | |||
Inventories are stated at the lower of cost or market under a first-in, first-out ("FIFO") basis. When necessary, the Company provides allowances to adjust the carrying value of its inventory to the lower of cost or market, including any costs to sell or dispose. Consideration is given to obsolescence, excessive inventory levels, product deterioration and other factors in evaluating net realizable value for the purposes of determining the lower of cost or market. | |||
Property, Plant and Equipment, net | ' | ||
Property, Plant and Equipment, net | |||
Property, plant and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expenses are calculated by the straight-line method using the estimated useful lives of the related assets. Routine repairs and maintenance are expensed when incurred. Leasehold improvements are depreciated over a period no longer than the lease term. Internal and external costs incurred in developing or obtaining computer software for internal use are capitalized in property, plant and equipment and are amortized on a straight-line basis, over the estimated useful life of the software. General and administrative costs related to developing or obtaining such software are expensed as incurred. | |||
The following table provides estimated useful lives generally assigned to property, plant and equipment by asset classification: | |||
Classification | Expected Useful Lives | ||
Land improvements | 10 - 30 years | ||
Buildings | 7 - 40 years | ||
Machinery and equipment | 2 - 15 years | ||
Computer software | 3 - 7 years | ||
Property, plant and equipment are reviewed for possible impairment whenever events or changes in circumstances occur that indicate that the carrying amount of an asset (or asset group) may not be recoverable. The Company's impairment review requires significant management judgment including estimating the future success of product lines, future sales volumes, revenue and expense growth rates, alternative uses for the assets and estimated proceeds from the disposal of the assets. The Company conducts reviews of idle and underutilized equipment when events or circumstances arise indicating that future cash flows are insufficient to recover the book value of asset groups, and reviews business plans for possible impairment indicators. Impairment occurs when the carrying amount of the asset (or asset group) exceeds its estimated future undiscounted cash flows. When impairment is indicated, an impairment charge is recorded for the difference between the asset's (or asset group's) book value and its estimated fair value. Depending on the asset, estimated fair value may be determined either by use of a discounted cash flow ("DCF") model or by reference to estimated selling values of assets in similar condition. The use of different assumptions would increase or decrease the estimated fair value of assets and would increase or decrease any impairment measurement. There have been no instances of impairment identified. | |||
Finite Lived Intangible Assets | ' | ||
Finite Lived Intangible Assets | |||
Amortization of intangible assets with finite lives (customer relationships and licensing arrangements) is recognized over estimated useful lives ranging from 5 to 10 years, which the Company believes reasonably represents the time period in which the economic benefits of the intangible assets are consumed or otherwise realized. The Company has experienced a negligible attrition rate in its customer base, and is not able to identify a reliable pattern of attrition and, as such, is utilizing the straight-line amortization method to amortize customer relationship intangible assets. Finite lived intangible assets are reviewed for possible impairment whenever events or changes in circumstances occur that indicate that the carrying amount of an asset may not be recoverable. There have been no instances of impairment identified. | |||
Indefinite Lived Intangible Assets | ' | ||
Indefinite Lived Intangible Assets | |||
The Company tests its trademarks and brand names with indefinite lives for impairment annually on the first day of the fourth quarter unless there are indications during an interim period that these assets are more likely than not to have become impaired. For trademarks and brand names with indefinite lives, impairment occurs when the carrying amount of an asset is greater than its estimated fair value. An impairment charge is recorded for the difference between the carrying amount and the fair value. The Company uses an income approach, the relief-from-royalty method, to estimate the fair value of its trademarks and trade names with indefinite lives. This method assumes that, in lieu of ownership, a third party would be willing to pay a royalty in order to obtain the rights to use the comparable asset. The determination of the fair values of trademarks and brand name assets with indefinite lives requires significant judgments in determining both the assets' estimated cash flows as well as the appropriate discount and royalty rates applied to those cash flows to determine fair value. Changes in such estimates or the application of alternative assumptions could produce different results. There have been no instances of impairment identified. | |||
Goodwill | ' | ||
Goodwill | |||
The Company tests its goodwill for impairment annually as of the first day of the fourth quarter unless there are indications during an interim period that these assets are more likely than not to have become impaired. The first step of the goodwill impairment test is to compare the fair value of each reporting unit to its carrying amount to determine if there is potential impairment. If the fair value of the reporting unit is less than its carrying value, the second step of the goodwill impairment test is performed to measure the amount of impairment loss. | |||
The second step of the goodwill impairment test compares the implied fair value of the reporting unit's goodwill with the carrying amount of that goodwill. If the carrying amount of the reporting unit's goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination. That is, the fair value of the reporting unit is allocated to all of the assets and liabilities of that unit (including any unrecognized intangible assets) as if the reporting unit had been acquired in a business combination at the date of the evaluation and the fair value was the purchase price paid to acquire the reporting unit. | |||
The Company estimates the fair value of reporting units using a weighting of fair values derived from an income approach and a market approach. Determining the fair value of a reporting unit under the first step of the goodwill impairment test and determining the fair value of individual assets and liabilities of a reporting unit (including unrecognized intangible assets) under the second step of the goodwill impairment test is inherently subjective in nature and often involves the use of significant estimates and assumptions based on known facts and circumstances at the time the Company performs the valuation. The use of different assumptions, inputs and judgments or changes in circumstances could materially affect the results of the valuation and could have a significant impact on whether or not an impairment charge is recognized and the magnitude of any such charge. | |||
Income approach—To determine fair value, the Company uses a DCF approach for each of the reporting units. Under this approach, the Company estimates the future cash flows of each reporting unit and discounts these cash flows at a rate of return that reflects their relative risk. The cash flows used in the DCF are consistent with the Company's long-range forecasts, and give consideration to historic and projected long-term business trends and strategies. The other key estimates and factors used in the DCF include, but are not limited to, discount rates, future sales volumes, revenue and expense growth rates, changes in working capital, capital expenditure forecasts, foreign exchange rates, currency devaluation, inflation, and a perpetuity growth rate. | |||
Market approach—The Company uses the guideline public company method to select reasonably similar/guideline publicly traded companies for each of the Company's reporting units. Using the guideline public company method, the Company calculates earnings before interest, taxes, depreciation and amortization ("EBITDA") multiples for each of the public companies using both historical and forecasted EBITDA figures. By applying these multiples to the appropriate historical and forecasted EBITDA figures for each reporting unit, fair value estimates are calculated. | |||
Revenue Recognition | ' | ||
Revenue Recognition | |||
Sales are recognized when title to the product, ownership and risk of loss transfer to the customer, which can be on the date of shipment or the date of receipt by the customer and when all of the following have occurred: a firm sales arrangement exists, pricing is fixed and determinable, and collection is reasonably assured. Revenue includes shipping and handling costs, which generally are included in the list price to the customer. Taxes collected from customers and remitted to governmental authorities are not included in sales. A provision for payment discounts and product return allowances is recorded as a reduction of sales in the same period that the revenue is recognized. | |||
The Company routinely commits to on-going and one-time trade promotion programs with customers, consisting primarily of customer pricing allowances, merchandising funds and consumer coupons offered through various programs to customers and consumers. Accruals for expected payouts under these programs are included as accrued marketing and promotion in the accrued expenses and other liabilities line item in the Consolidated Balance Sheets and are recorded as a reduction of sales in the Statements of Comprehensive Loss. | |||
Amounts received by the Company from the licensing of certain trademarks are recorded as deferred revenue on the Consolidated Balance Sheets and are recognized as revenue on a straight-line basis over the term of the licensing agreement when the underlying royalties are earned. | |||
Cost of Products Sold | ' | ||
Cost of Products Sold | |||
Cost of products sold is primarily comprised of direct materials and supplies consumed in the manufacturing of product, as well as manufacturing labor, depreciation expense, direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product, contract manufacturing costs, and provisions for inventory losses (including losses relating to excess and obsolete inventory). Cost of products sold also includes the cost to distribute products to customers, inbound freight costs, internal transfer costs, warehousing costs and other shipping and handling activity as well as costs associated with developing and designing new packaging. | |||
Selling and Administrative Expenses | ' | ||
Selling and Administrative Expenses | |||
Selling and administrative expense is primarily comprised of marketing expenses, selling expenses, administrative and other indirect overhead costs, depreciation and amortization expense on non-manufacturing assets and other miscellaneous operating items. Non-advertising related components of the Company's total marketing spending include costs associated with consumer promotions, product sampling and sales aids, all of which are included in selling and administrative expenses. | |||
Advertising Costs | ' | ||
Advertising Costs | |||
Advertising and sales promotion costs are expensed as incurred. Costs associated with the Company's television, print, radio, internet and in-store campaigns are expensed when the advertising or promotion is published or presented to consumers. Costs associated with the Company's racing sponsorships and promotional events are expensed at the time or during the period of the race or promotional event. | |||
Share Based Compensation | ' | ||
Share Based Compensation | |||
The Company has granted both time based stock option awards and performance based stock option awards that vest subject to a liquidity event (e.g., an initial public offering or change in control, as defined) and based upon the attainment of specified minimum returns on capital to Parent shareholders. The Company measures share based compensation associated with the time based awards based on their fair values on the dates they were granted. The expense is recognized by amortizing the fair value on a straight-line basis over the vesting period. Although the Company has estimated the fair value of its performance based stock option awards, given that the performance condition (a liquidity event) is not probable of occurrence, the Company has not to-date recognized any share based compensation expense attendant to these awards (see Note 14). | |||
Employee Benefits | ' | ||
Employee Benefits | |||
In November 2010, the Company established a defined contribution plan for its U.S. employees, which qualifies as a tax deferred savings plan under Section 401(k) of the Internal Revenue Code ("IRC" or the "Code"). Eligible U.S. employees may contribute a percentage of their pre-tax compensation, subject to certain IRC limitations. The plan provides for employer matching contributions of 100% of participant income deferrals to a maximum of $1,000 and employer contributions up to 10% of a participant's annual base salary, subject to limits prescribed under U.S. federal regulations. | |||
Operating Leases | ' | ||
Operating Leases | |||
The Company recognizes rental expense for operating leases, including those with rent abatement and escalation provisions, on a straight-line basis over the applicable lease term. | |||
Research and Development Costs | ' | ||
Research and Development Costs | |||
Research and development costs are charged to expense as incurred. | |||
Deferred Financing Costs | ' | ||
Deferred Financing Costs | |||
Deferred financing costs represent legal, other professional and bank underwriting fees incurred in connection with the issuance of debt. Such fees are amortized over the life of the related debt using the interest method and are included in interest expense. | |||
Income Taxes | ' | ||
Income Taxes | |||
The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to the differences between the financial statement amounts and their respective tax bases. Management reviews the Company's deferred tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established when management believes that it is more likely than not that some portion or all of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company's tax provision in the period of change. In addition to valuation allowances, the Company provides for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement standards prescribed by accounting guidance on the accounting for uncertainty in income taxes. Amounts for uncertain tax positions are adjusted when new information becomes available or when positions are effectively settled. | |||
None of the Company's goodwill is expected to be deductible for tax purposes. | |||
The Company files a consolidated federal and certain state income tax returns with its Parent. Income taxes have been prepared on a separate return basis. The Company pays its tax liability on behalf of its Parent. | |||
Recent Accounting Pronouncements | ' | ||
Recent Accounting Pronouncements | |||
In February 2013 the FASB issued ASU No. 2013-04—Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date (ASU 2013-04). The ASU requires reporting and disclosure about obligations resulting from joint and several liability arrangements within its scope for which the total amount of the obligation is fixed at the reporting date. For the Company, ASU 2013-04 is effective January 1, 2014 for fiscal year 2014 and interim periods therein. The guidance in ASU 2013-04 is to be applied retrospectively for those obligations resulting from joint and several liability arrangements within its scope that exist at January 1, 2014. Adoption of ASU 2013-04 is not expected to have a material impact on the Company. | |||
In September 2013, Treasury and the Internal Revenue Service issued final regulations regarding the deduction and capitalization of expenditures related to tangible property. The final regulations under IRC Section 162, 167 and 263(a) apply to amounts paid to acquire, produce, or improve tangible property as well as dispositions of such property and are generally effective for tax years beginning on or after January 1, 2014. We have evaluated these regulations and determined they will not have a material impact on our consolidated results of operations, cash flows or financial position. | |||
The Company adopted the following pronouncements effective January 1, 2013: | |||
In July 2013 the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2013-11—Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward exists (ASU 2013-11). The ASU requires an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with an exception in certain circumstances where an unrecognized tax benefit, or portion thereof, is to be presented in the financial statements as a liability. ASU 2013-11 is effective for the Company January 1, 2014 for fiscal year 2014 and interim periods therein. The guidance in ASU 2013-11 is to be applied prospectively to all unrecognized tax benefits that exist at January 1, 2014. The Company adopted the provisions of ASU 2013-11 in 2013 (see Note 15). | |||
In February 2013, the FASB issued ASU 2013-02—Comprehensive Income (Topic 220): Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income (ASU 2013-02). Substantially all of the information that this update requires already is required to be disclosed elsewhere in financial statements under U.S. GAAP. However, the new requirement to present information about amounts reclassified out of accumulated other comprehensive income and their corresponding effect on net income will present, in one place, information about significant amounts reclassified and, in some cases, cross-references to related footnote disclosures. | |||
During July 2012, the FASB issued ASU 2012-02 Intangibles—Goodwill and Other (Topic 350) Testing Indefinite-Lived Intangible Assets for Impairment (ASU 2012-02) which was intended to reduce the cost and complexity of performing an impairment test for indefinite-lived intangible assets by simplifying how the Company tests those assets for impairment and to improve consistency in impairment testing guidance among long lived asset categories. Under ASU 2012-02, the Company has the option first to assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test in accordance with Subtopic 350-30, Intangibles—Goodwill and Other—General Intangibles Other than Goodwill. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. The Company also has the option to bypass the qualitative assessment for any indefinite-lived intangible asset in any period and proceed directly to performing the quantitative impairment test. The Company will be able to resume performing the qualitative assessment in any subsequent period. The Company did not use the qualitative assessment during 2013. | |||
In December 2011, the FASB issued ASU No. 2011-11, "Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities" ("ASU 2011-11") to amend the requirement for an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. An entity should provide the disclosures required by those amendments retrospectively for all comparative periods presented. Adoption of 2011-11 did not have an impact on the Company. | |||
The_Company_and_Summary_of_Sig2
The Company and Summary of Significant Accounting Policies (Tables) | 12 Months Ended | ||
Dec. 31, 2013 | |||
The Company and Summary of Significant Accounting Policies | ' | ||
Schedule of property, plant and equipment | ' | ||
Classification | Expected Useful Lives | ||
Land improvements | 10 - 30 years | ||
Buildings | 7 - 40 years | ||
Machinery and equipment | 2 - 15 years | ||
Computer software | 3 - 7 years |
RelatedParty_Transactions_Tabl
Related-Party Transactions (Tables) | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Avista and affiliates of Avista | Amortization of deferred finance costs | ' | ||||||||||
Related-party transactions | ' | ||||||||||
Schedule of related party transactions | ' | ||||||||||
Related amortization expense was (in thousands): | |||||||||||
Year ended | Year ended | Year ended | |||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Amortization of Avista consulting expenses | $ | 604 | $ | 605 | $ | 605 | |||||
Avista and affiliates of Avista | Selling and administrative expenses | ' | ||||||||||
Related-party transactions | ' | ||||||||||
Schedule of related party transactions | ' | ||||||||||
Selling and administrative expenses, including out of pocket expenses related to this monitoring agreement were (in thousands): | |||||||||||
Year ended | Year ended | Year ended | |||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Avista monitoring agreement fees | $ | 1,127 | $ | 1,055 | $ | 1,114 | |||||
Directors and Officers | Amortization of deferred finance costs | ' | ||||||||||
Related-party transactions | ' | ||||||||||
Schedule of related party transactions | ' | ||||||||||
Related amortization expense was (in thousands): | |||||||||||
Year ended | Year ended | Year ended | |||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Amortization of directors' and officers' consulting expenses | $ | 68 | $ | 68 | $ | 68 | |||||
Clorox | Net Expenses | ' | ||||||||||
Related-party transactions | ' | ||||||||||
Schedule of related party transactions | ' | ||||||||||
Net expenses under the TSA were (in thousands): | |||||||||||
Year ended | Year ended | Year ended | |||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Cost of products sold | $ | — | $ | — | $ | 6,616 | |||||
Selling and administrative expense | — | 732 | 3,436 | ||||||||
Research and development costs | — | — | 621 | ||||||||
| | | | | | | | | | | |
Total TSA expenses | $ | — | $ | 732 | $ | 10,673 | |||||
| | | | | | | | | | | |
| | | | | | | | | | | |
Clorox | Net Expenses | Subsequent arrangement | ' | ||||||||||
Related-party transactions | ' | ||||||||||
Schedule of related party transactions | ' | ||||||||||
Expenses for these services were (in thousands): | |||||||||||
Year ended | Year ended | Year ended | |||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Cost of products sold | $ | — | $ | 1,326 | $ | 1,154 | |||||
Selling and administrative expense | — | 712 | 333 | ||||||||
| | | | | | | | | | | |
Total TSA expenses | $ | — | $ | 2,038 | $ | 1,487 | |||||
| | | | | | | | | | | |
| | | | | | | | | | | |
Accounts_Receivable_net_Tables
Accounts Receivable, net (Tables) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Credit Concentration Risk | ' | ||||||||||||||||
Schedule of an allowance for doubtful accounts | ' | ||||||||||||||||
The Company's allowance for doubtful accounts is summarized as follows (in thousands): | |||||||||||||||||
Beginning | Provision | Amounts | Other | Ending | |||||||||||||
Balance | for | Written- | Deductions— | Balance | |||||||||||||
Doubtful | Off | Purchase | |||||||||||||||
Accounts | Accounting | ||||||||||||||||
Year ended December 31, 2013 | $ | 682 | $ | 174 | $ | (408 | ) | $ | — | $ | 448 | ||||||
Year ended December 31, 2012 | 390 | 370 | (78 | ) | — | 682 | |||||||||||
Year ended December 31, 2011 | 108 | 282 | — | — | 390 | ||||||||||||
Accounts receivable | Credit concentration risk | ' | ||||||||||||||||
Credit Concentration Risk | ' | ||||||||||||||||
Schedule of the Company's product lines that have accounted for 10% or more of total combined net sales | ' | ||||||||||||||||
December 31, | December 31, | ||||||||||||||||
2013 | 2012 | ||||||||||||||||
First | 24 | % | 22 | % | |||||||||||||
Second | 7 | % | 9 | % | |||||||||||||
Net sales | Credit concentration risk | ' | ||||||||||||||||
Credit Concentration Risk | ' | ||||||||||||||||
Schedule of the Company's product lines that have accounted for 10% or more of total combined net sales | ' | ||||||||||||||||
CONSOLIDATED | |||||||||||||||||
Year ended | Year ended | Year ended | |||||||||||||||
December 31, | December 31, | December 31, | |||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||
22% | 22% | 20% |
Inventories_Tables
Inventories (Tables) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Inventories | ' | ||||||||||||||||
Schedule of inventories | ' | ||||||||||||||||
Inventories consisted of the following (in thousands): | |||||||||||||||||
December 31, | December 31, | ||||||||||||||||
2013 | 2012 | ||||||||||||||||
Finished goods | $ | 28,400 | $ | 33,386 | |||||||||||||
Raw materials and packaging | 7,896 | 11,087 | |||||||||||||||
Allowances for obsolescence | (2,253 | ) | (2,029 | ) | |||||||||||||
| | | | | | | | ||||||||||
$ | 34,043 | $ | 42,444 | ||||||||||||||
| | | | | | | | ||||||||||
| | | | | | | | ||||||||||
Summary of allowance for obsolescence | ' | ||||||||||||||||
The Company's allowance for obsolescence is summarized as follows (in thousands): | |||||||||||||||||
Year Ended December 31, | Beginning | Provision | Amounts | Other | Ending | ||||||||||||
Balance | for | Written- | Deductions— | Balance | |||||||||||||
obsolescence | Off | Purchase | |||||||||||||||
Accounting | |||||||||||||||||
2013 | $ | 2,029 | $ | 3,599 | $ | (3,375 | ) | $ | — | $ | 2,253 | ||||||
2012 | 2,051 | 1,195 | (1,217 | ) | — | $ | 2,029 | ||||||||||
2011 | 20 | 2,480 | (449 | ) | — | 2,051 |
Other_Current_Assets_Tables
Other Current Assets (Tables) | 12 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Other Current Assets | ' | |||||||
Schedule of other current assets | ' | |||||||
Other current assets consisted of the following (in thousands): | ||||||||
December 31, | December 31, | |||||||
2013 | 2012 | |||||||
Current deferred taxes | $ | 3,555 | $ | 4,315 | ||||
Deferred financing costs | 1,767 | 1,843 | ||||||
Prepaid income taxes | 2,453 | 3,963 | ||||||
Other | 2,015 | 2,770 | ||||||
| | | | | | | | |
$ | 9,790 | $ | 12,891 | |||||
| | | | | | | | |
| | | | | | | | |
Property_Plant_and_Equipment_n1
Property, Plant and Equipment, net (Tables) | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Property, Plant and Equipment, net. | ' | ||||||||||
Schedule of property, plant and equipment | ' | ||||||||||
Property, plant and equipment consisted of the following (in thousands): | |||||||||||
December 31, | December 31, | ||||||||||
2013 | 2012 | ||||||||||
Land and improvements | $ | 1,784 | $ | 1,405 | |||||||
Buildings | 3,769 | 3,679 | |||||||||
Machinery and equipment | 27,178 | 23,096 | |||||||||
Capitalized software | 12,182 | 12,040 | |||||||||
Construction in progress | 1,541 | 1,999 | |||||||||
| | | | | | | | ||||
46,454 | 42,219 | ||||||||||
Less: accumulated depreciation | (17,518 | ) | (10,746 | ) | |||||||
| | | | | | | | ||||
$ | 28,936 | $ | 31,473 | ||||||||
| | | | | | | | ||||
| | | | | | | | ||||
Schedule of depreciation expense related to property, plant and equipment and amortization of capitalized software | ' | ||||||||||
Depreciation expense related to property, plant and equipment and amortization of capitalized software was (in thousands): | |||||||||||
Year ended | |||||||||||
December 31, 2013 | December 31, 2012 | December 31, 2011 | |||||||||
Depreciation | $ | 4,953 | $ | 4,639 | $ | 4,505 | |||||
Amortization of capitalized software | 2,017 | 1,605 | 220 | ||||||||
| | | | | | | | | | | |
$ | 6,970 | $ | 6,244 | $ | 4,725 | ||||||
| | | | | | | | | | | |
| | | | | | | | | | | |
Goodwill_and_Intangible_Assets1
Goodwill and Intangible Assets, net (Tables) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Goodwill and Intangible Assets, net | ' | ||||||||||||||||
Schedule of changes in the carrying amount of goodwill and intangible assets | ' | ||||||||||||||||
Changes in the carrying amount of goodwill and intangible assets were as follows (in thousands): | |||||||||||||||||
Trademarks and Other Intangible Assets | |||||||||||||||||
Goodwill | Trademarks | Customer | Licensing | Total | |||||||||||||
and Brands | Relationships | Arrangements | |||||||||||||||
Not Subject to | Subject to | Subject to | |||||||||||||||
Amortization | Amortization | Amortization | |||||||||||||||
Balance at December 31, 2011 | $ | 384,793 | $ | 99,176 | $ | 284,001 | $ | 4,998 | $ | 388,175 | |||||||
Amortization | — | — | (35,401 | ) | (1,300 | ) | (36,701 | ) | |||||||||
Impairment | (24,117 | ) | — | — | — | — | |||||||||||
Translation adjustments | 1,540 | 421 | 1,010 | — | 1,431 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Balance at December 31, 2012 | $ | 362,216 | $ | 99,597 | $ | 249,610 | $ | 3,698 | $ | 352,905 | |||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Amortization | — | — | (35,488 | ) | (1,300 | ) | (36,788 | ) | |||||||||
Acquisition, net | 580 | — | 1,823 | — | 1,823 | ||||||||||||
Translation adjustments | (3,970 | ) | (1,384 | ) | (3,086 | ) | — | (4,470 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Balance at December 31, 2013 | $ | 358,826 | $ | 98,213 | $ | 212,859 | $ | 2,398 | $ | 313,470 | |||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Schedule of expected future amortization expense for intangible assets | ' | ||||||||||||||||
Expected future amortization expense for these intangible assets as of December 31, 2013 is as follows: | |||||||||||||||||
Fiscal Years | |||||||||||||||||
2014 | $ | 36,961 | |||||||||||||||
2015 | 36,759 | ||||||||||||||||
2016 | 35,661 | ||||||||||||||||
2017 | 34,173 | ||||||||||||||||
2018 | 26,090 | ||||||||||||||||
Thereafter | 49,117 | ||||||||||||||||
| | | | | |||||||||||||
$ | 218,761 | ||||||||||||||||
| | | | | |||||||||||||
| | | | | |||||||||||||
Accrued_Expenses_and_Other_Cur1
Accrued Expenses and Other Current Liabilities (Tables) | 12 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Accrued Expenses and Other Current Liabilities | ' | |||||||
Summary of the Company's accrued expenses and other current liabilities | ' | |||||||
The following summarizes the Company's accrued expenses and other current liabilities (in thousands): | ||||||||
December 31, | December 31, | |||||||
2013 | 2012 | |||||||
Trade, sales promotion and advertising | $ | 8,777 | $ | 9,022 | ||||
Accrued interest | 8,029 | 8,191 | ||||||
Accrued taxes | 50 | 3,421 | ||||||
Compensation and benefits | 2,156 | 2,928 | ||||||
Other | 4,443 | 5,009 | ||||||
| | | | | | | | |
$ | 23,455 | $ | 28,571 | |||||
| | | | | | | | |
| | | | | | | | |
Debt_Tables
Debt (Tables) | 12 Months Ended | |||||||||||||
Dec. 31, 2013 | ||||||||||||||
Debt | ' | |||||||||||||
Summary of debt | ' | |||||||||||||
The following summarizes the Company's debt (in thousands): | ||||||||||||||
December 31, 2013 | ||||||||||||||
Credit Facility | ||||||||||||||
Total | ||||||||||||||
Long-Term | ||||||||||||||
Revolver | Term Loan | Senior Notes | Debt | |||||||||||
Balance | $ | — | $ | 291,000 | $ | 275,000 | $ | 566,000 | ||||||
Less: discount | — | (5,018 | ) | (7,400 | ) | (12,418 | ) | |||||||
| | | | | | | | | | | | | | |
$ | — | 285,982 | 267,600 | 553,582 | ||||||||||
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Less: current portion, net of discount | (1,324 | ) | 1,253 | (71 | ) | |||||||||
| | | | | | | | | | | | | | |
Long-term portion, net of discount | $ | 284,658 | $ | 268,853 | $ | 553,511 | ||||||||
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
December 31, 2012 | ||||||||||||||
Credit Facility | ||||||||||||||
Total | ||||||||||||||
Long-Term | ||||||||||||||
Revolver | Term Loan | Senior Notes | Debt | |||||||||||
Balance | $ | — | $ | 294,000 | $ | 275,000 | $ | 569,000 | ||||||
Less: discount | — | (6,610 | ) | (8,530 | ) | (15,140 | ) | |||||||
| | | | | | | | | | | | | | |
$ | — | 287,390 | 266,470 | 553,860 | ||||||||||
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Less: current portion, net of discount | (1,414 | ) | 1,135 | (279 | ) | |||||||||
| | | | | | | | | | | | | | |
Long-term portion, net of discount | $ | 285,976 | $ | 267,605 | $ | 553,581 | ||||||||
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Schedule of interest expense | ' | |||||||||||||
Interest expense associated with the Credit Facility and the Senior Notes including commitment fees for unused borrowings, and amortization of original issue discount and deferred financing costs was (in thousands): | ||||||||||||||
Year Ended | ||||||||||||||
December 31, | December 31, | December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||||
Credit Facility | ||||||||||||||
Revolver | $ | 864 | $ | 1,485 | $ | 1,076 | ||||||||
Term Loan | 19,954 | 20,110 | 20,096 | |||||||||||
Senior Notes | 27,089 | 26,980 | 26,907 | |||||||||||
Other | 117 | 312 | 11 | |||||||||||
| | | | | | | | | | | ||||
$ | 48,024 | $ | 48,887 | $ | 48,090 | |||||||||
| | | | | | | | | | | ||||
| | | | | | | | | | | ||||
Schedule of debt maturities | ' | |||||||||||||
Debt maturities are as follows as of December 31, 2013 (in thousands): | ||||||||||||||
Fiscal Years | ||||||||||||||
2014 | $ | 3,000 | ||||||||||||
2015 | 3,000 | |||||||||||||
2016 | 285,000 | |||||||||||||
2017 | — | |||||||||||||
2018 | 275,000 | |||||||||||||
| | | | | ||||||||||
$ | 566,000 | |||||||||||||
| | | | | ||||||||||
| | | | | ||||||||||
Schedule of deferred financing costs | ' | |||||||||||||
Costs associated with the establishment of the Credit Facility and Senior Notes have been deferred and are recorded as other current assets and other non-current assets on the Company's Consolidated Balance Sheets as follows (in thousands): | ||||||||||||||
December 31, | December 31, | |||||||||||||
2013 | 2012 | |||||||||||||
Balance | $ | 9,979 | $ | 9,979 | ||||||||||
Less: accumulated amortization | (4,814 | ) | (3,228 | ) | ||||||||||
| | | | | | | | |||||||
5,165 | 6,751 | |||||||||||||
Less: current portion, net of amortization | (1,767 | ) | (1,843 | ) | ||||||||||
| | | | | | | | |||||||
Long-term portion, net of amortization | $ | 3,398 | $ | 4,908 | ||||||||||
| | | | | | | | |||||||
| | | | | | | | |||||||
Fair_Value_Measurement_of_Asse1
Fair Value Measurement of Assets and Liabilities (Tables) | 12 Months Ended | |||||||||||||
Dec. 31, 2013 | ||||||||||||||
Fair Value Measurement of Assets and Liabilities | ' | |||||||||||||
Schedule of carrying and fair values of the Company's long-term debt | ' | |||||||||||||
The carrying and fair values of the Company's long-term debt were as follows (in thousands): | ||||||||||||||
December 31, 2013 | December 31, 2012 | |||||||||||||
Carrying | Fair | Carrying | Fair | |||||||||||
Value | Value | Value | Value | |||||||||||
Term loan | $ | 285,982 | $ | 291,000 | $ | 287,390 | $ | 281,138 | ||||||
Senior notes | 267,600 | 267,438 | 266,470 | 233,063 |
Commitments_and_Contingencies_
Commitments and Contingencies (Tables) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Commitments and Contingencies | ' | ||||||||||||||||
Schedule of minimum annual payment | ' | ||||||||||||||||
Under its existing non-cancelable contracts, as of December 31, 2013 the Company is required to pay minimum annual payments as follows (in thousands): | |||||||||||||||||
Year Ended December 31, | Operating | Procurement, | Software | Sponsorship | Advisory | ||||||||||||
Leases | Contract | Maintenance, | and Media | Services and | |||||||||||||
Manufacturing, | Systems | Agreements | Monitoring | ||||||||||||||
Warehousing | Support and | ||||||||||||||||
and Logistics | Hosting | ||||||||||||||||
Obligations | |||||||||||||||||
2014 | $ | 1,573 | $ | 19,374 | $ | 1,065 | $ | 8,801 | $ | 1,000 | |||||||
2015 | 1,315 | 3,386 | 534 | 820 | 1,000 | ||||||||||||
2016 | 1,165 | 3,125 | 143 | 845 | 1,000 | ||||||||||||
2017 | 604 | 1,976 | — | — | 1,000 | ||||||||||||
2018 | 515 | — | — | — | 1,000 | ||||||||||||
Thereafter | 332 | — | — | — | 1,000 | ||||||||||||
| | | | | | | | | | | | | | | | | |
$ | 5,504 | $ | 27,861 | $ | 1,742 | $ | 10,466 | $ | 6,000 | ||||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Schedule of rental expense for all operating leases | ' | ||||||||||||||||
Rental expense for all operating leases was (in thousands): | |||||||||||||||||
Years ended | |||||||||||||||||
December 31, 2013 | December 31, 2012 | December 31, 2011 | |||||||||||||||
$ | 1,744 | $ | 2,773 | $ | 1,966 |
Share_Based_Compensation_Plans1
Share Based Compensation Plans (Tables) | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Share Based Compensation Plans | ' | ||||||||||
Schedule of total share based compensation expense included in the Company's statements of comprehensive loss | ' | ||||||||||
The following table presents details of total share based compensation expense that is included in the Company's statements of comprehensive loss (in thousands): | |||||||||||
Year ended | |||||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Cost of products sold | $ | 15 | $ | 13 | $ | 13 | |||||
Selling and administrative expenses | 260 | 243 | 243 | ||||||||
Research and development costs | 15 | 10 | 10 | ||||||||
| | | | | | | | | | | |
Total share based compensation costs | $ | 290 | $ | 266 | $ | 266 | |||||
| | | | | | | | | | | |
| | | | | | | | | | | |
2010 AAG Option Plan | Time-based and performance based options | ' | ||||||||||
Share Based Compensation Plans | ' | ||||||||||
Schedule of weighted-average assumptions used for time-based and performance based option grants | ' | ||||||||||
Year ended | Year ended | Year ended | |||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Expected life | 6.5 years | 6.5 years | 6.5 years | ||||||||
Expected volatility | 34.00% | 35.00% | 50.00% | ||||||||
Risk-free interest rate | 1.23% - 2.03% | 0.91% - 1.36% | 1.45% - 3.05% | ||||||||
Dividend yield | 0% | 0% | 0% | ||||||||
2010 AAG Option Plan | Time-based options | ' | ||||||||||
Share Based Compensation Plans | ' | ||||||||||
Summary of stock option activity | ' | ||||||||||
The following table summarizes stock option activity for time based options under the 2010 AAG Option Plan for the periods presented (in thousands, except per share amounts): | |||||||||||
Number of | Weighted- | ||||||||||
Time based | Average | ||||||||||
Shares | Exercise | ||||||||||
Price | |||||||||||
Non-vested at December 31, 2011 | 5,867 | 1.01 | |||||||||
Granted | 493 | 1 | |||||||||
Forfeited | (354 | ) | 1 | ||||||||
Vested | (1,298 | ) | 1.01 | ||||||||
| | | | | | | | ||||
Non-vested at December 31, 2012 | 4,708 | 1.02 | |||||||||
Granted | 935 | 1 | |||||||||
Forfeited | (614 | ) | 1 | ||||||||
Vested | (1,153 | ) | 1.01 | ||||||||
| | | | | | | | ||||
Non-vested at December 31, 2013 | 3,876 | 1.02 | |||||||||
Vested and exercisable at December 31, 2013 | 2,827 | 1 | |||||||||
| | | | | | | | ||||
Outstanding at December 31, 2013 | 6,703 | 1.01 | |||||||||
| | | | | | | | ||||
| | | | | | | | ||||
2010 AAG Option Plan | Performance based options | ' | ||||||||||
Share Based Compensation Plans | ' | ||||||||||
Summary of stock option activity | ' | ||||||||||
The following table summarizes stock option activity for performance based options under the 2010 AAG Option Plan for the periods presented (in thousands, except per share and year amounts): | |||||||||||
Number of | Weighted- | ||||||||||
Performance | Average | ||||||||||
based | Exercise | ||||||||||
Shares | Price | ||||||||||
Non-vested at December 31, 2011 | 12,848 | 1.01 | |||||||||
Granted | 985 | 1 | |||||||||
Forfeited | (971 | ) | 1 | ||||||||
| | | | | | | | ||||
Non-vested at December 31, 2012 | 12,862 | 1.01 | |||||||||
Granted | 1,869 | 1 | |||||||||
Forfeited | (926 | ) | 1 | ||||||||
| | | | | | | | ||||
Non-vested and outstanding at December 31, 2013 | 13,805 | 1.01 | |||||||||
| | | | | | | | ||||
| | | | | | | | ||||
Income_Taxes_Tables
Income Taxes (Tables) | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Income Taxes | ' | ||||||||||
Schedule of components of benefit provision for income taxes on loss before income taxes, by tax jurisdiction | ' | ||||||||||
The benefit provision for income taxes on loss before income taxes, by tax jurisdiction, consisted of the following (in thousands): | |||||||||||
Year Ended | |||||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Current: | |||||||||||
Federal | $ | 3,006 | $ | 1,425 | $ | 1,323 | |||||
State | 537 | 364 | 994 | ||||||||
Foreign | 892 | 1,783 | 104 | ||||||||
| | | | | | | | | | | |
Total current | 4,435 | 3,572 | 2,421 | ||||||||
Deferred: | |||||||||||
Federal | (11,874 | ) | (11,060 | ) | (12,069 | ) | |||||
State | (2,818 | ) | 1,206 | (1,343 | ) | ||||||
Foreign | (518 | ) | (758 | ) | (714 | ) | |||||
| | | | | | | | | | | |
Total deferred | (15,210 | ) | (10,612 | ) | (14,126 | ) | |||||
| | | | | | | | | | | |
Total | $ | (10,775 | ) | $ | (7,040 | ) | $ | (11,705 | ) | ||
| | | | | | | | | | | |
| | | | | | | | | | | |
Schedule of components of loss before income taxes, by tax jurisdiction | ' | ||||||||||
The components of loss before income taxes, by tax jurisdiction, were as follows (in thousands): | |||||||||||
Year Ended | |||||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
United States | $ | (19,478 | ) | $ | (24,880 | ) | $ | (20,823 | ) | ||
Foreign | (4,667 | ) | (27,961 | ) | (8,550 | ) | |||||
| | | | | | | | | | | |
$ | (24,145 | ) | $ | (52,841 | ) | $ | (29,373 | ) | |||
| | | | | | | | | | | |
| | | | | | | | | | | |
Schedule of reconciliation of statutory federal income tax rate to the Company's effective tax rate on loss before income taxes | ' | ||||||||||
Year Ended | |||||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Statutory federal tax rate | 35 | % | 35 | % | 35 | % | |||||
Non-deductible impairment of goodwill | — | (12.3 | ) | — | |||||||
State taxes (net of federal tax benefits) | 6.8 | (1.9 | ) | 0.8 | |||||||
Foreign rate differential | (1.3 | ) | (3.0 | ) | 2.9 | ||||||
Domestic production activities deduction | 0.8 | 0.6 | — | ||||||||
Acquisition related | — | 0.4 | (0.6 | ) | |||||||
Change in Valuation Allowance | (2.3 | ) | — | — | |||||||
UK interest deduction | 1.8 | — | — | ||||||||
Other differences | 3.8 | (5.5 | ) | 1.7 | |||||||
| | | | | | | | | | | |
Effective tax rate | 44.6 | % | 13.3 | % | 39.8 | % | |||||
| | | | | | | | | | | |
| | | | | | | | | | | |
Schedule of components of significant deferred tax assets and liabilities | ' | ||||||||||
Significant deferred tax assets and liabilities consist of the following (in thousands): | |||||||||||
December 31, | December 31, | ||||||||||
2013 | 2012 | ||||||||||
Deferred tax assets: | |||||||||||
Accrual and reserves | $ | 1,841 | $ | 1,718 | |||||||
Inventory costs | 2,064 | 2,743 | |||||||||
Acquisition related | 2,225 | 2,438 | |||||||||
Net operating losses | 1,806 | 1,190 | |||||||||
Other | — | 42 | |||||||||
| | | | | | | | ||||
Total deferred tax assets | 7,936 | 8,131 | |||||||||
| | | | | | | | ||||
Deferred tax liabilities: | |||||||||||
Fixed and intangible assets | (93,388 | ) | (108,947 | ) | |||||||
| | | | | | | | ||||
Total deferred tax liabilities | (93,388 | ) | (108,947 | ) | |||||||
| | | | | | | | ||||
Valuation Allowance | (603 | ) | — | ||||||||
| | | | | | | | ||||
Net deferred tax liabilities | $ | (86,055 | ) | $ | (100,816 | ) | |||||
| | | | | | | | ||||
| | | | | | | | ||||
Schedule of net deferred tax assets and liabilities included in the balance sheets | ' | ||||||||||
The net deferred tax assets and liabilities are included in the balance sheets as follows (in thousands): | |||||||||||
December 31, | December 31, | ||||||||||
2013 | 2012 | ||||||||||
Current deferred tax assets | $ | 3,555 | $ | 4,315 | |||||||
Non-current deferred tax liabilities | (89,610 | ) | (105,131 | ) | |||||||
| | | | | | | | ||||
Net deferred tax liabilities | $ | (86,055 | ) | $ | (100,816 | ) | |||||
| | | | | | | | ||||
| | | | | | | | ||||
Schedule of reconciliation of the beginning and ending amounts of the Company's gross unrecognized tax benefits | ' | ||||||||||
The following is a reconciliation of the beginning and ending amounts of the Company's gross unrecognized tax benefits (in thousands): | |||||||||||
Year Ended | |||||||||||
December 31, | December 31, | December 31, | |||||||||
2013 | 2012 | 2011 | |||||||||
Unrecognized tax benefits—beginning of period | $ | 379 | $ | 417 | $ | 586 | |||||
Gross increases—tax positions in prior periods | 625 | — | — | ||||||||
Gross increase—current period tax positions | — | 75 | — | ||||||||
Statute of limitations lapse | (51 | ) | — | — | |||||||
Settlements | (88 | ) | (113 | ) | (169 | ) | |||||
| | | | | | | | | | | |
Unrecognized tax benefits—end of period | $ | 865 | $ | 379 | $ | 417 | |||||
| | | | | | | | | | | |
| | | | | | | | | | | |
Retirement_Income_and_Health_B1
Retirement Income and Health Benefit Plans (Tables) | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Retirement Income and Health Benefit Plans | ' | ||||||||||
Schedule of the Company's aggregate cost of defined benefit contribution plan | ' | ||||||||||
The Company's aggregate cost of the defined contribution plans was (in thousands): | |||||||||||
Year Ended | |||||||||||
December 31, 2013 | December 31, | December 31, | |||||||||
2012 | 2011 | ||||||||||
$804 | $ | 1,622 | $ | 1,137 |
Segment_Data_Tables
Segment Data (Tables) | 12 Months Ended | |||||||||||||
Dec. 31, 2013 | ||||||||||||||
Segment Data | ' | |||||||||||||
Summary of the financial performance of the Company's operating segments | ' | |||||||||||||
The following summarizes the financial performance of the Company's operating segments (in thousands): | ||||||||||||||
Year ended December 31, 2013 | ||||||||||||||
North America | International | Corporate | Consolidated | |||||||||||
Net sales | $ | 215,165 | $ | 74,791 | $ | — | $ | 289,956 | ||||||
Earnings (loss) before income taxes | 52,118 | 8,549 | (84,812 | ) | (24,145 | ) | ||||||||
Capital expenditures | 3,848 | 457 | — | 4,305 | ||||||||||
Depreciation and amortization | 6,133 | 841 | 36,788 | 43,762 | ||||||||||
Share based compensation | 266 | 24 | — | 290 | ||||||||||
Year ended December 31, 2012 | ||||||||||||||
North America | International | Corporate | Consolidated | |||||||||||
Net sales | $ | 232,467 | $ | 74,001 | $ | — | $ | 306,468 | ||||||
Earnings (loss) before income taxes(1) | 48,909 | (16,162 | ) | (85,588 | ) | (52,841 | ) | |||||||
Capital expenditures | 6,481 | 1,217 | — | 7,698 | ||||||||||
Depreciation and amortization | 5,622 | 431 | 36,701 | 42,754 | ||||||||||
Share based compensation | 256 | 10 | — | 266 | ||||||||||
-1 | ||||||||||||||
During the fourth quarter of 2012, the Company recorded a $24.1 million non-cash impairment charge on goodwill allocated to its Europe, Middle East and Africa reporting unit and its Australia and New Zealand reporting unit, both reporting units being included within the Company's international segment. See Notes 1 and 7. | ||||||||||||||
Year ended December 31, 2011 | ||||||||||||||
North America | International | Corporate | Consolidated | |||||||||||
Net sales | $ | 212,114 | $ | 69,203 | $ | — | $ | 281,317 | ||||||
Earnings (loss) before income taxes | 33,327 | 27,553 | (90,253 | ) | (29,373 | ) | ||||||||
Capital expenditures | 11,986 | 1,025 | — | 13,011 | ||||||||||
Depreciation and amortization | 7,454 | 1,107 | 36,701 | 45,262 | ||||||||||
Share based compensation | 256 | 10 | — | 266 | ||||||||||
Segment data | ' | |||||||||||||
Schedule of net sales based on geography | ' | |||||||||||||
Net sales based on geography are summarized as follows (in thousands): | ||||||||||||||
Year Ended | ||||||||||||||
December 31, | December 31, | December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||||
U.S. | $ | 194,745 | $ | 210,086 | $ | 191,436 | ||||||||
Canada | 20,420 | 22,381 | 20,678 | |||||||||||
Europe | 25,229 | 24,518 | 22,270 | |||||||||||
Australia and rest of world | 49,562 | 49,483 | 46,933 | |||||||||||
| | | | | | | | | | | ||||
Total net sales | $ | 289,956 | $ | 306,468 | $ | 281,317 | ||||||||
| | | | | | | | | | | ||||
| | | | | | | | | | | ||||
Summary of long-lived, tangible assets based on geography | ' | |||||||||||||
Long lived, tangible assets based on geography are summarized as follows (in thousands): | ||||||||||||||
December 31, | December 31, | |||||||||||||
2013 | 2012 | |||||||||||||
U.S. | $ | 26,095 | $ | 28,079 | ||||||||||
Rest of world | 2,841 | 3,394 | ||||||||||||
| | | | | | | | |||||||
Total long lived tangible assets | $ | 28,936 | $ | 31,473 | ||||||||||
| | | | | | | | |||||||
| | | | | | | | |||||||
Schedule of total assets of the Company's operating segments | ' | |||||||||||||
The following summarizes total assets of the Company's operating segments (in thousands): | ||||||||||||||
December 31, | December 31, | |||||||||||||
2013 | 2012 | |||||||||||||
North America | $ | 123,964 | $ | 128,461 | ||||||||||
International | 30,823 | 30,424 | ||||||||||||
Corporate | 677,460 | 721,872 | ||||||||||||
| | | | | | | | |||||||
Total assets | $ | 832,247 | $ | 880,757 | ||||||||||
| | | | | | | | |||||||
| | | | | | | | |||||||
Net sales | Product Concentration | ' | |||||||||||||
Segment data | ' | |||||||||||||
Schedule of the Company's product lines that have accounted for 10% or more of total combined net sales | ' | |||||||||||||
Year Ended | ||||||||||||||
December 31, | December 31, | December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||||
Armor-All wipes | 18 | % | 17 | % | 18 | % | ||||||||
Armor-All protectant | 21 | % | 22 | % | 26 | % | ||||||||
STP fuel and oil additives | 16 | % | 18 | % | 19 | % | ||||||||
North America | ' | |||||||||||||
Segment data | ' | |||||||||||||
Summary of sales by geography | ' | |||||||||||||
The following is a summary of sales by product categories for the Company's North America segment (in thousands): | ||||||||||||||
Year Ended | ||||||||||||||
December 31, | December 31, | December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||||
North America: | ||||||||||||||
Appearance products | $ | 160,180 | $ | 171,592 | $ | 152,035 | ||||||||
Performance chemicals products | 54,985 | 60,875 | 60,079 | |||||||||||
| | | | | | | | | | | ||||
Total net sales | $ | 215,165 | $ | 232,467 | $ | 212,114 | ||||||||
| | | | | | | | | | | ||||
| | | | | | | | | | | ||||
Financial_Information_for_the_1
Financial Information for the Company and Its Subsidiaries (Tables) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Financial Information for the Company and Its Subsidiaries | ' | ||||||||||||||||
Schedule of Condensed Consolidating Balance Sheet | ' | ||||||||||||||||
Condensed Consolidating Balance Sheet | |||||||||||||||||
Year Ended December 31, 2013 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
ASSETS | |||||||||||||||||
Current assets: | |||||||||||||||||
Cash | $ | 14,843 | $ | — | $ | 6,410 | $ | — | $ | 21,253 | |||||||
Accounts receivable | 78 | 44,885 | 17,247 | — | 62,210 | ||||||||||||
Inventory | — | 24,553 | 9,490 | — | 34,043 | ||||||||||||
Other current assets | 53,853 | (45,072 | ) | 1,009 | — | 9,790 | |||||||||||
| | | | | | | | | | | | | | | | | |
Total current assets | 68,774 | 24,366 | 34,156 | — | 127,296 | ||||||||||||
Property, plant and equipment | 8,061 | 18,037 | 2,838 | — | 28,936 | ||||||||||||
Goodwill | — | 310,576 | 48,250 | — | 358,826 | ||||||||||||
Intangible assets | — | 276,461 | 38,198 | (1,189 | ) | 313,470 | |||||||||||
Investment in subsidiaries | 647,107 | 115,394 | — | (762,501 | ) | — | |||||||||||
Other assets | 3,632 | 87 | — | — | 3,719 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total assets | $ | 727,574 | $ | 744,921 | $ | 123,442 | $ | (763,690 | ) | $ | 832,247 | ||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
LIABILITIES AND | |||||||||||||||||
SHAREHOLDER'S EQUITY | |||||||||||||||||
Current liabilities: | |||||||||||||||||
Accounts payable | $ | 169 | $ | 5,103 | $ | 2,856 | $ | — | $ | 8,128 | |||||||
Accrued expenses and other current liabilities | 10,063 | 8,263 | 5,129 | — | 23,455 | ||||||||||||
Due to Clorox | 69 | 23 | (1 | ) | — | 91 | |||||||||||
Due to Parent | 745 | — | — | — | 745 | ||||||||||||
Notes payable, current portion | 71 | — | — | — | 71 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total current liabilities | 11,117 | 13,389 | 7,984 | 32,490 | |||||||||||||
Notes payable, less current portion and discount | 553,511 | — | — | — | 553,511 | ||||||||||||
Other liabilities | 2,500 | — | — | — | 2,500 | ||||||||||||
Deferred income taxes | 5,121 | 84,425 | 64 | — | 89,610 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total liabilities | 572,249 | 97,814 | 8,048 | — | 678,111 | ||||||||||||
Shareholder's equity | 155,325 | 647,107 | 115,394 | (763,690 | ) | 154,136 | |||||||||||
| | | | | | | | | | | | | | | | | |
Total liabilities and shareholder's equity | $ | 727,574 | $ | 744,921 | $ | 123,442 | $ | (763,690 | ) | $ | 832,247 | ||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidating Balance Sheet | |||||||||||||||||
Year Ended December 31, 2012 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
ASSETS | |||||||||||||||||
Current assets: | |||||||||||||||||
Cash | $ | 1,477 | $ | — | $ | 2,729 | $ | — | $ | 4,206 | |||||||
Accounts receivable | 105 | 49,635 | 19,862 | — | 69,602 | ||||||||||||
Inventory | — | 31,718 | 10,726 | — | 42,444 | ||||||||||||
Other current assets | 50,116 | (38,357 | ) | 1,132 | — | 12,891 | |||||||||||
| | | | | | | | | | | | | | | | | |
Total current assets | 51,698 | 42,996 | 34,449 | — | 129,143 | ||||||||||||
Property, plant and equipment | 8,682 | 19,397 | 3,394 | — | 31,473 | ||||||||||||
Goodwill | — | 310,577 | 51,639 | — | 362,216 | ||||||||||||
Intangible assets | — | 307,401 | 45,887 | (383 | ) | 352,905 | |||||||||||
Investment in subsidiaries | 687,226 | 122,893 | — | (810,119 | ) | — | |||||||||||
Other assets | 4,943 | 77 | — | — | 5,020 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total assets | $ | 752,549 | $ | 803,341 | $ | 135,369 | $ | (810,502 | ) | $ | 880,757 | ||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
LIABILITIES AND | |||||||||||||||||
SHAREHOLDER'S EQUITY | |||||||||||||||||
Current liabilities: | |||||||||||||||||
Accounts payable | $ | 888 | $ | 8,868 | $ | 3,402 | $ | — | $ | 13,158 | |||||||
Accrued expenses and other current liabilities | 12,397 | 7,215 | 8,959 | — | 28,571 | ||||||||||||
Due to Clorox | — | 22 | 115 | — | 137 | ||||||||||||
Due to Parent | 795 | — | — | — | 795 | ||||||||||||
Notes payable, current portion | 279 | — | — | — | 279 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total current liabilities | 14,359 | 16,105 | 12,476 | 42,940 | |||||||||||||
Notes payable, less current portion and discount | 553,581 | — | — | — | 553,581 | ||||||||||||
Other liabilities | 2,500 | — | — | — | 2,500 | ||||||||||||
Deferred income taxes | 5,121 | 100,010 | — | — | 105,131 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total liabilities | 575,561 | 116,115 | 12,476 | — | 704,152 | ||||||||||||
Shareholder's equity | 176,988 | 687,226 | 122,893 | (810,502 | ) | 176,605 | |||||||||||
| | | | | | | | | | | | | | | | | |
Total liabilities and shareholder's equity | $ | 752,549 | $ | 803,341 | $ | 135,369 | $ | (810,502 | ) | $ | 880,757 | ||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Schedule of Condensed Consolidating Statement of Comprehensive (Loss) Income | ' | ||||||||||||||||
Condensed Consolidating Statement of Comprehensive (Loss) Income | |||||||||||||||||
Year Ended December 31, 2013 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
Net sales | $ | — | $ | 235,897 | $ | 75,557 | $ | (21,498 | ) | $ | 289,956 | ||||||
Cost of products sold | — | 124,194 | 55,353 | (21,498 | ) | 158,049 | |||||||||||
| | | | | | | | | | | | | | | | | |
Gross profit | — | 111,703 | 20,204 | — | 131,907 | ||||||||||||
Operating expenses: | |||||||||||||||||
Selling and administrative expenses | 19,316 | 10,903 | 10,475 | — | 40,694 | ||||||||||||
Advertising costs | — | 21,549 | 6,238 | — | 27,787 | ||||||||||||
Research and development costs | — | 2,463 | 11 | — | 2,474 | ||||||||||||
Amortization of acquired intangible assets | — | 30,181 | 6,607 | — | 36,788 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total operating expenses | 19,316 | 65,096 | 23,331 | — | 107,743 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Operating (loss) profit | (19,316 | ) | 46,607 | (3,127 | ) | — | 24,164 | ||||||||||
Non-operating expenses (income): | |||||||||||||||||
Interest expense | 48,015 | 1 | 8 | — | 48,024 | ||||||||||||
Other (income) expense | (72 | ) | 82 | 275 | — | 285 | |||||||||||
| | | | | | | | | | | | | | | | | |
(Loss) earnings before income taxes | (67,259 | ) | 46,524 | (3,410 | ) | — | (24,145 | ) | |||||||||
(Benefit) provision for income taxes | (19,194 | ) | 8,045 | 374 | — | (10,775 | ) | ||||||||||
Equity earnings (loss) of subsidiaries, net of taxes | 34,695 | (3,784 | ) | — | (30,911 | ) | — | ||||||||||
| | | | | | | | | | | | | | | | | |
Net (loss) earnings | $ | (13,370 | ) | $ | 34,695 | $ | (3,784 | ) | $ | (30,911 | ) | $ | (13,370 | ) | |||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Other comprehensive (loss) income: | |||||||||||||||||
Foreign currency translation gain (loss) | (9,389 | ) | (9,389 | ) | (9,389 | ) | 18,778 | (9,389 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Comprehensive (loss) income | $ | (22,759 | ) | $ | 25,306 | $ | (13,173 | ) | $ | (12,133 | ) | $ | (22,759 | ) | |||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Comprehensive (Loss) Income | |||||||||||||||||
Year Ended December 31, 2012 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
Net sales | $ | 154 | $ | 255,078 | $ | 79,693 | $ | (28,457 | ) | $ | 306,468 | ||||||
Cost of products sold | — | 137,302 | 58,725 | (28,457 | ) | 167,570 | |||||||||||
| | | | | | | | | | | | | | | | | |
Gross profit | 154 | 117,776 | 20,968 | — | 138,898 | ||||||||||||
Operating expenses: | |||||||||||||||||
Selling and administrative expenses | 23,788 | 13,434 | 11,084 | — | 48,306 | ||||||||||||
Advertising costs | — | 24,296 | 6,776 | — | 31,072 | ||||||||||||
Research and development costs | — | 2,211 | — | — | 2,211 | ||||||||||||
Amortization of acquired intangible assets | — | 30,181 | 6,520 | — | 36,701 | ||||||||||||
Goodwill impairment | — | — | 24,117 | — | 24,117 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total operating expenses | 23,788 | 70,122 | 48,497 | — | 142,407 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Operating (loss) profit | (23,634 | ) | 47,654 | (27,529 | ) | — | (3,509 | ) | |||||||||
Non-operating expenses (income): | |||||||||||||||||
Interest expense | 48,887 | — | — | — | 48,887 | ||||||||||||
Other (income) expense | 61 | (48 | ) | 432 | — | 445 | |||||||||||
| | | | | | | | | | | | | | | | | |
(Loss) earnings before income taxes | (72,582 | ) | 47,702 | (27,961 | ) | — | (52,841 | ) | |||||||||
(Benefit) provision for income taxes | (2,751 | ) | (5,312 | ) | 1,023 | — | (7,040 | ) | |||||||||
Equity earnings (loss) of subsidiaries, net of taxes | 24,030 | (28,984 | ) | — | 4,954 | — | |||||||||||
| | | | | | | | | | | | | | | | | |
Net (loss) earnings | $ | (45,801 | ) | $ | 24,030 | $ | (28,984 | ) | $ | 4,954 | $ | (45,801 | ) | ||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Other comprehensive (loss) income: | |||||||||||||||||
Foreign currency translation gain (loss) | 3,807 | 3,807 | 3,807 | (7,614 | ) | 3,807 | |||||||||||
| | | | | | | | | | | | | | | | | |
Comprehensive (loss) income | $ | (41,994 | ) | $ | 27,837 | $ | (25,117 | ) | $ | (2,660 | ) | $ | (41,994 | ) | |||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Comprehensive (Loss) Income | |||||||||||||||||
Year Ended December 31, 2011 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
Net sales | $ | — | $ | 233,176 | $ | 77,870 | $ | (29,729 | ) | $ | 281,317 | ||||||
Cost of products sold | — | 123,721 | 59,122 | (29,729 | ) | 153,114 | |||||||||||
Cost of products sold—acquisition related | — | 4,439 | — | — | 4,439 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Gross profit | — | 105,016 | 18,748 | — | 123,764 | ||||||||||||
Operating expenses: | |||||||||||||||||
Selling and administrative expenses | 17,475 | 11,766 | 10,999 | — | 40,240 | ||||||||||||
Advertising costs | — | 17,941 | 6,758 | — | 24,699 | ||||||||||||
Research and development costs | — | 2,307 | — | — | 2,307 | ||||||||||||
Amortization of acquired intangible assets | — | 30,181 | 6,520 | — | 36,701 | ||||||||||||
Acquisition related charges | 1,020 | — | — | — | 1,020 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Total operating expenses | 18,495 | 62,195 | 24,277 | — | 104,967 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Operating (loss) profit | (18,495 | ) | 42,821 | (5,529 | ) | — | 18,797 | ||||||||||
Non-operating expenses (income): | |||||||||||||||||
Interest expense | 48,090 | — | — | — | 48,090 | ||||||||||||
Other (income) expense | (64 | ) | (95 | ) | 239 | — | 80 | ||||||||||
| | | | | | | | | | | | | | | | | |
(Loss) earnings before income taxes | (66,521 | ) | 42,916 | (5,768 | ) | — | (29,373 | ) | |||||||||
(Benefit) provision for income taxes | (35,194 | ) | 24,099 | (610 | ) | — | (11,705 | ) | |||||||||
Equity earnings (loss) of subsidiaries, net of taxes | 13,659 | (5,158 | ) | — | (8,501 | ) | — | ||||||||||
| | | | | | | | | | | | | | | | | |
Net (loss) earnings | $ | (17,668 | ) | $ | 13,659 | $ | (5,158 | ) | $ | (8,501 | ) | $ | (17,668 | ) | |||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Other comprehensive (loss) income: | |||||||||||||||||
Foreign currency translation loss | (2,007 | ) | (2,007 | ) | (2,007 | ) | 4,014 | (2,007 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Comprehensive (loss) income | $ | (19,675 | ) | $ | 11,652 | $ | (7,165 | ) | $ | (4,487 | ) | $ | (19,675 | ) | |||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Schedule of Condensed Consolidating Statement of Cash Flows | ' | ||||||||||||||||
Condensed Consolidating Statement of Cash Flows | |||||||||||||||||
Year Ended December 31, 2013 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||
Net earnings (loss) | $ | (13,370 | ) | $ | 34,695 | $ | (3,784 | ) | $ | (30,911 | ) | $ | (13,370 | ) | |||
Adjustments: | |||||||||||||||||
Depreciation and amortization | 6,066 | 34,194 | 7,586 | — | 47,846 | ||||||||||||
Share based compensation | 290 | — | — | — | 290 | ||||||||||||
Deferred income taxes | 765 | (15,589 | ) | 41 | — | (14,783 | ) | ||||||||||
Equity (loss) earnings of subsidiaries, net of taxes | (34,695 | ) | 3,784 | — | 30,911 | — | |||||||||||
Other | — | 75 | (12 | ) | — | 63 | |||||||||||
Cash effect of changes, net of acquisition effects, in: | |||||||||||||||||
Receivables | 27 | 4,750 | 4,178 | — | 8,955 | ||||||||||||
Inventory | — | 7,165 | 2,111 | — | 9,276 | ||||||||||||
Due from Clorox | 69 | — | (115 | ) | — | (46 | ) | ||||||||||
Other current assets | (5,782 | ) | 6,709 | (146 | ) | — | 781 | ||||||||||
Prepaid taxes | 1,215 | — | — | — | 1,215 | ||||||||||||
Accounts payable and accrued liabilities | (3,052 | ) | (2,717 | ) | (4,853 | ) | — | (10,622 | ) | ||||||||
Intercompany | 66,019 | (70,338 | ) | 2,981 | — | (1,338 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Net cash provided by operating activities | 17,552 | 2,728 | 7,987 | — | 28,267 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Cash flows from investing activities: | |||||||||||||||||
Capital expenditures | (1,136 | ) | (2,728 | ) | (441 | ) | — | (4,305 | ) | ||||||||
Acquisition, net | — | — | (3,084 | ) | — | (3,084 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Net cash used in investing activities | (1,136 | ) | (2,728 | ) | (3,525 | ) | — | (7,389 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Cash flows from financing activities: | |||||||||||||||||
Borrowings under revolver | 23,000 | — | — | — | 23,000 | ||||||||||||
Payments on revolver | (23,000 | ) | — | — | — | (23,000 | ) | ||||||||||
Principal payments on notes payable and other | (3,000 | ) | — | (611 | ) | — | (3,611 | ) | |||||||||
Advance from Parent | (50 | ) | — | — | — | (50 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Net cash used in financing activities | (3,050 | ) | — | (611 | ) | — | (3,661 | ) | |||||||||
| | | | | | | | | | | | | | | | | |
Effect of exchange rate on cash | — | — | (170 | ) | — | (170 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Net increase in cash | 13,366 | — | 3,681 | — | 17,047 | ||||||||||||
Cash at beginning of period | 1,477 | — | 2,729 | — | 4,206 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Cash at end of period | $ | 14,843 | $ | — | $ | 6,410 | $ | — | $ | 21,253 | |||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Cash Flows | |||||||||||||||||
Year Ended December 31, 2012 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||
Net earnings (loss) | $ | (45,801 | ) | $ | 24,030 | $ | (28,984 | ) | $ | 4,954 | $ | (45,801 | ) | ||||
Adjustments: | |||||||||||||||||
Depreciation and amortization | 5,651 | 33,958 | 7,204 | — | 46,813 | ||||||||||||
Goodwill impairment | — | — | 24,117 | — | 24,117 | ||||||||||||
Share based compensation | 266 | — | — | — | 266 | ||||||||||||
Deferred income taxes | — | (11,360 | ) | 748 | — | (10,612 | ) | ||||||||||
Equity (loss) earnings of subsidiaries, net of taxes | (24,030 | ) | 28,984 | — | (4,954 | ) | — | ||||||||||
Other | — | 157 | — | — | 157 | ||||||||||||
Cash effect of changes, net of acquisition effects, in: | |||||||||||||||||
Receivables | 661 | (7,214 | ) | (8,749 | ) | — | (15,302 | ) | |||||||||
Inventory | — | (2,354 | ) | (2,840 | ) | — | (5,194 | ) | |||||||||
Due from Clorox | (244 | ) | 11,455 | 653 | — | 11,864 | |||||||||||
Other current assets | (40,890 | ) | 38,822 | 1,315 | — | (753 | ) | ||||||||||
Accounts payable and accrued liabilities | (2,885 | ) | 6,567 | 6,827 | — | 10,509 | |||||||||||
Book overdraft | (1,987 | ) | — | — | — | (1,987 | ) | ||||||||||
Income taxes payable | 31,173 | (35,531 | ) | (78 | ) | (4,436 | ) | ||||||||||
Intercompany | 83,755 | (81,930 | ) | (820 | ) | (402 | ) | 603 | |||||||||
| | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | 5,669 | 5,584 | (607 | ) | (402 | ) | 10,244 | ||||||||||
| | | | | | | | | | | | | | | | | |
Cash flows from investing activities: | |||||||||||||||||
Capital expenditures | (1,453 | ) | (4,976 | ) | (1,269 | ) | — | (7,698 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Net cash used in investing activities | (1,453 | ) | (4,976 | ) | (1,269 | ) | — | (7,698 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Cash flows from financing activities: | |||||||||||||||||
Borrowings under revolver | 64,001 | — | — | — | 64,001 | ||||||||||||
Payments on revolver | (64,001 | ) | — | — | — | (64,001 | ) | ||||||||||
Principal payments on notes payable | (3,000 | ) | — | — | — | (3,000 | ) | ||||||||||
Debt financing costs | (350 | ) | — | — | — | (350 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Net cash used in financing activities | (3,350 | ) | — | — | — | (3,350 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Effect of exchange rate on cash | 611 | (608 | ) | (330 | ) | 402 | 75 | ||||||||||
| | | | | | | | | | | | | | | | | |
Net (decrease) increase in cash | 1,477 | — | (2,206 | ) | — | (729 | ) | ||||||||||
Cash at beginning of period | — | — | 4,935 | — | 4,935 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Cash at end of period | $ | 1,477 | $ | — | $ | 2,729 | $ | — | $ | 4,206 | |||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Cash Flows | |||||||||||||||||
Year Ended December 31, 2011 | |||||||||||||||||
Issuer | Combined | Combined | Eliminations | Consolidated | |||||||||||||
Guarantor | Non- | Total | |||||||||||||||
Subsidiaries | Guarantor | ||||||||||||||||
Subsidiaries | |||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||
Net earnings (loss) | $ | (17,668 | ) | $ | 13,659 | $ | (5,158 | ) | $ | (8,501 | ) | $ | (17,668 | ) | |||
Adjustments: | |||||||||||||||||
Depreciation and amortization | 4,316 | 33,319 | 7,627 | — | 45,262 | ||||||||||||
Share based compensation | 266 | — | — | — | 266 | ||||||||||||
Deferred income taxes | (1,716 | ) | (12,410 | ) | — | — | (14,126 | ) | |||||||||
Equity (loss) earnings of subsidiaries, net of taxes | (13,659 | ) | 5,158 | — | 8,501 | — | |||||||||||
Other | — | 80 | 295 | 375 | |||||||||||||
Cash effect of changes, net of acquisition effects, in: | |||||||||||||||||
Receivables, net | (615 | ) | (15,881 | ) | (2,438 | ) | — | (18,934 | ) | ||||||||
Inventory | — | (932 | ) | 1,904 | — | 972 | |||||||||||
Due from Clorox | (820 | ) | (7,807 | ) | (1,426 | ) | — | (10,053 | ) | ||||||||
Other current assets | 1,040 | (541 | ) | (975 | ) | — | (476 | ) | |||||||||
Book overdraft | 1,987 | — | — | — | 1,987 | ||||||||||||
Accounts payable and accrued liabilities | 8,855 | (6,044 | ) | (512 | ) | — | 2,299 | ||||||||||
Intercompany receivable / payable | 34,712 | (40,710 | ) | 5,612 | 386 | — | |||||||||||
Income taxes payable | (35,142 | ) | 35,448 | — | — | 306 | |||||||||||
| | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | (18,444 | ) | 3,339 | 4,929 | 386 | (9,790 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Cash flows from investing activities: | |||||||||||||||||
Capital expenditures | (8,647 | ) | (3,339 | ) | (1,025 | ) | — | (13,011 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Net cash used in investing activities | (8,647 | ) | (3,339 | ) | (1,025 | ) | — | (13,011 | ) | ||||||||
| | | | | | | | | | | | | | | | | |
Cash flows from financing activities: | |||||||||||||||||
Borrowings under revolver | 29,500 | — | — | — | 29,500 | ||||||||||||
Payments on revolver | (29,500 | ) | — | — | — | (29,500 | ) | ||||||||||
Principal payments on notes payable | (3,000 | ) | — | — | — | (3,000 | ) | ||||||||||
Advance from Parent | 795 | — | — | — | 795 | ||||||||||||
Debt financing costs | (670 | ) | — | — | — | (670 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Net cash used in financing activities | (2,875 | ) | — | — | — | (2,875 | ) | ||||||||||
| | | | | | | | | | | | | | | | | |
Effect of exchange rate on cash | — | — | (704 | ) | (386 | ) | (1,090 | ) | |||||||||
| | | | | | | | | | | | | | | | | |
Net (decrease) increase in cash | (29,966 | ) | — | 3,200 | — | (26,766 | ) | ||||||||||
Cash at beginning of period | 29,966 | — | 1,735 | — | 31,701 | ||||||||||||
| | | | | | | | | | | | | | | | | |
Cash at end of period | $ | — | $ | — | $ | 4,935 | $ | — | $ | 4,935 | |||||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Quarterly_Financial_Informatio1
Quarterly Financial Information (Unaudited) (Tables) | 12 Months Ended | |||||||||||||
Dec. 31, 2013 | ||||||||||||||
Quarterly Financial Information (Unaudited) | ' | |||||||||||||
Schedule of unaudited financial information | ' | |||||||||||||
For these reasons, among others, the Company's results for any quarter are not necessarily indicative of future quarterly results and, accordingly, period-to-period comparisons should not be relied upon as an indication of future performance (in thousands). | ||||||||||||||
March 31, | June 30, | September 30, | December 31, | |||||||||||
2013 | 2013 | 2013 | 2013 | |||||||||||
Net sales | $ | 74,413 | $ | 80,075 | $ | 71,007 | $ | 64,461 | ||||||
Gross profit | 33,928 | 37,736 | 32,524 | 27,719 | ||||||||||
Income from operations | 10,939 | 4,093 | 6,102 | 3,030 | ||||||||||
Net loss | (506 | ) | (5,286 | ) | (2,275 | ) | (5,303 | ) | ||||||
March 31, | June 30, | September 30, | December 31, | |||||||||||
2012 | 2012 | 2012 | 2012 | |||||||||||
Net sales | $ | 86,396 | $ | 82,695 | $ | 68,348 | $ | 69,029 | ||||||
Gross profit | 43,306 | 38,565 | 28,620 | 28,407 | ||||||||||
Income (loss) from operations(1) | 15,206 | 3,683 | 27 | (22,425 | ) | |||||||||
Net earnings (loss) | 1,106 | (4,103 | ) | (9,773 | ) | (33,031 | ) | |||||||
-1 | ||||||||||||||
During the fourth quarter of 2012, the Company recorded a $24.1 million non-cash impairment charge on goodwill allocated to its Europe, Middle East and Africa reporting unit and its Australia and New Zealand reporting unit. See Notes 1 and 7. | ||||||||||||||
The_Company_and_Summary_of_Sig3
The Company and Summary of Significant Accounting Policies (Details) | 12 Months Ended |
Dec. 31, 2013 | |
item | |
The Company and Summary of Significant Accounting Policies | ' |
Number of most recognizable brands held | 2 |
Number of countries in which the entity has distributor relationships | 50 |
Land improvements | Minimum | ' |
Property, Plant and Equipment | ' |
Expected Useful Lives | '10 years |
Land improvements | Maximum | ' |
Property, Plant and Equipment | ' |
Expected Useful Lives | '30 years |
Buildings | Minimum | ' |
Property, Plant and Equipment | ' |
Expected Useful Lives | '7 years |
Buildings | Maximum | ' |
Property, Plant and Equipment | ' |
Expected Useful Lives | '40 years |
Machinery and equipment | Minimum | ' |
Property, Plant and Equipment | ' |
Expected Useful Lives | '2 years |
Machinery and equipment | Maximum | ' |
Property, Plant and Equipment | ' |
Expected Useful Lives | '15 years |
Computer software | Minimum | ' |
Property, Plant and Equipment | ' |
Expected Useful Lives | '3 years |
Computer software | Maximum | ' |
Property, Plant and Equipment | ' |
Expected Useful Lives | '7 years |
The_Company_and_Summary_of_Sig4
The Company and Summary of Significant Accounting Policies (Details 2) (USD $) | 12 Months Ended |
Dec. 31, 2013 | |
Employee Benefits | ' |
Employer matching contributions of participant income deferrals (as a percent) | 100.00% |
Maximum employer matching contributions of participant income deferrals | $1,000 |
Maximum percentage of employer contributions on participant's annual base salary | 10.00% |
Income Taxes | ' |
Goodwill expected to be deductible for tax purposes | $0 |
Customer relationships and licensing arrangements | Minimum | ' |
Intangible assets | ' |
Estimated useful life | '5 years |
Customer relationships and licensing arrangements | Maximum | ' |
Intangible assets | ' |
Estimated useful life | '10 years |
RelatedParty_Transactions_Deta
Related-Party Transactions (Details) (USD $) | 12 Months Ended | 12 Months Ended | 12 Months Ended | 2 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2010 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | 31-May-11 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2012 | Dec. 31, 2011 | |
Clorox | Clorox | Clorox | Clorox | Clorox | Avista and several employees | Avista and affiliates of Avista | Avista and affiliates of Avista | Avista and affiliates of Avista | Individuals prior to becoming Directors and Officers | Directors and Officers | Directors and Officers | Directors and Officers | Directors and Officers | Parent | Parent | Parent | Charles Mcllvaine | Charles Mcllvaine | ||||
Subsequent arrangement | Subsequent arrangement | |||||||||||||||||||||
Related-party transactions | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cost of products sold | ' | ' | ' | ' | $6,616,000 | ' | $1,326,000 | $1,154,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Selling and administrative expense | ' | ' | ' | 732,000 | 3,436,000 | ' | 712,000 | 333,000 | ' | 1,127,000 | 1,055,000 | 1,114,000 | ' | ' | ' | ' | ' | ' | ' | ' | 100,000 | 200,000 |
Research and development costs | 2,474,000 | 2,211,000 | 2,307,000 | ' | 621,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total TSA expenses | ' | ' | ' | 732,000 | 10,673,000 | ' | 2,038,000 | 1,487,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Pocket expenses | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Ownership percentage of Parent held by related party | ' | ' | ' | ' | ' | ' | ' | ' | 99.30% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Acquisition-related charges | ' | ' | 1,020,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt financing costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4,100,000 | ' | ' | ' | ' | 500,000 | ' | ' | ' | ' | ' | ' | ' |
Amortization expense related to deferred financing costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | 604,000 | 605,000 | 605,000 | ' | ' | 68,000 | 68,000 | 68,000 | ' | ' | ' | ' | ' |
Consulting expenses | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,800,000 | 1,300,000 | 400,000 | ' | ' | ' | ' | ' | ' | ' |
Consulting expenses reinvested through the purchase of common stock | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,400,000 | ' | ' | ' | ' | ' | ' | ' |
Proceeds received from sale of parent company stock to employees | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 795,000 | ' | ' | ' | ' |
Repurchased of stock from a employee as a result of termination | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50,000 | ' | ' | ' |
Amount due to related party | ' | ' | ' | $137,000 | ' | $91,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $745,000 | $795,000 | ' | ' |
Accounts_Receivable_net_Detail
Accounts Receivable, net (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Summary of allowance for obsolescence | ' | ' | ' |
Beginning Balance | $682 | $390 | $108 |
Provision for Doubtful Accounts | 174 | 370 | 282 |
Amounts Written-Off | -408 | -78 | ' |
Ending Balance | $448 | $682 | $390 |
Accounts receivable | Credit concentration risk | First | ' | ' | ' |
Credit Concentration Risk | ' | ' | ' |
Percentage of concentration risk | 24.00% | 22.00% | ' |
Accounts receivable | Credit concentration risk | Second | ' | ' | ' |
Credit Concentration Risk | ' | ' | ' |
Percentage of concentration risk | 7.00% | 9.00% | ' |
Net sales | Credit concentration risk | First | ' | ' | ' |
Credit Concentration Risk | ' | ' | ' |
Percentage of concentration risk | 22.00% | 22.00% | 20.00% |
Inventories_Details
Inventories (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Inventories | ' | ' | ' |
Finished goods | $28,400 | $33,386 | ' |
Raw materials and packaging | 7,896 | 11,087 | ' |
Allowances for obsolescence | -2,253 | -2,029 | -2,051 |
Inventory, net | 34,043 | 42,444 | ' |
Allowance for obsolescence | ' | ' | ' |
Beginning Balance | 2,029 | 2,051 | 20 |
Provision for obsolescence | 3,599 | 1,195 | 2,480 |
Amounts Written-Off | -3,375 | -1,217 | -449 |
Ending Balance | $2,253 | $2,029 | $2,051 |
Other_Current_Assets_Details
Other Current Assets (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Other Current Assets | ' | ' |
Current deferred taxes | $3,555 | $4,315 |
Deferred financing costs | 1,767 | 1,843 |
Prepaid income taxes | 2,453 | 3,963 |
Other | 2,015 | 2,770 |
Other current assets | $9,790 | $12,891 |
Property_Plant_and_Equipment_n2
Property, Plant and Equipment, net (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Property, Plant and Equipment, net | ' | ' | ' |
Property, plant and equipment, gross | $46,454 | $42,219 | ' |
Less : accumulated depreciation | -17,518 | -10,746 | ' |
Property, plant and equipment, net | 28,936 | 31,473 | ' |
Depreciation | 4,953 | 4,639 | 4,505 |
Amortization of capitalized software | 2,017 | 1,605 | 220 |
Depreciation and amortization of capitalized software | 6,970 | 6,244 | 4,725 |
Land and improvements | ' | ' | ' |
Property, Plant and Equipment, net | ' | ' | ' |
Property, plant and equipment, gross | 1,784 | 1,405 | ' |
Buildings | ' | ' | ' |
Property, Plant and Equipment, net | ' | ' | ' |
Property, plant and equipment, gross | 3,769 | 3,679 | ' |
Machinery and equipment | ' | ' | ' |
Property, Plant and Equipment, net | ' | ' | ' |
Property, plant and equipment, gross | 27,178 | 23,096 | ' |
Capitalized software | ' | ' | ' |
Property, Plant and Equipment, net | ' | ' | ' |
Property, plant and equipment, gross | 12,182 | 12,040 | ' |
Construction in progress | ' | ' | ' |
Property, Plant and Equipment, net | ' | ' | ' |
Property, plant and equipment, gross | $1,541 | $1,999 | ' |
Goodwill_and_Intangible_Assets2
Goodwill and Intangible Assets, net (Details) (USD $) | 3 Months Ended | 12 Months Ended |
In Thousands, unless otherwise specified | Dec. 31, 2012 | Dec. 31, 2012 |
Goodwill and Intangible Assets, net | ' | ' |
Non-cash goodwill impairment charge | $24,100 | $24,117 |
Goodwill_and_Intangible_Assets3
Goodwill and Intangible Assets, net (Details 2) (USD $) | 3 Months Ended | 12 Months Ended | |||
Sep. 30, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Goodwill | ' | ' | ' | ' | ' |
Balance at the beginning of the period | ' | ' | $362,216,000 | $384,793,000 | ' |
Impairment | ' | -24,100,000 | ' | -24,117,000 | ' |
Acquisition, net | 600,000 | ' | 580,000 | ' | ' |
Translation adjustments | ' | ' | -3,970,000 | 1,540,000 | ' |
Balance at the end of the period | ' | 362,216,000 | 358,826,000 | 362,216,000 | 384,793,000 |
Changes in the carrying amount of intangible assets subject to amortization | ' | ' | ' | ' | ' |
Amortization | ' | ' | -36,788,000 | -36,701,000 | -36,701,000 |
Balance at the end of the period | ' | ' | 218,761,000 | ' | ' |
Changes in the carrying amount of intangible assets | ' | ' | ' | ' | ' |
Balance at the beginning of the period | ' | ' | 352,905,000 | 388,175,000 | ' |
Amortization | ' | ' | -36,788,000 | -36,701,000 | -36,701,000 |
Acquisition, net | ' | ' | 1,823,000 | ' | ' |
Translation adjustments | ' | ' | -4,470,000 | 1,431,000 | ' |
Balance at the end of the period | ' | 352,905,000 | 313,470,000 | 352,905,000 | 388,175,000 |
Royalties | ' | ' | 2,300,000 | 3,000,000 | 3,300,000 |
Customer Relationships Subject to Amortization | ' | ' | ' | ' | ' |
Changes in the carrying amount of intangible assets subject to amortization | ' | ' | ' | ' | ' |
Balance at the beginning of the period | ' | ' | 249,610,000 | 284,001,000 | ' |
Amortization | ' | ' | -35,488,000 | -35,401,000 | ' |
Acquisition, net | 1,800,000 | ' | 1,823,000 | ' | ' |
Translation adjustments | ' | ' | -3,086,000 | 1,010,000 | ' |
Balance at the end of the period | ' | 249,610,000 | 212,859,000 | 249,610,000 | ' |
Changes in the carrying amount of intangible assets | ' | ' | ' | ' | ' |
Amortization | ' | ' | -35,488,000 | -35,401,000 | ' |
Accumulated amortization | ' | 79,300,000 | 114,700,000 | 79,300,000 | ' |
Weighted average remaining amortization period | '7 years | ' | '6 years | ' | ' |
Licensing Arrangements Subject to Amortization | ' | ' | ' | ' | ' |
Changes in the carrying amount of intangible assets subject to amortization | ' | ' | ' | ' | ' |
Balance at the beginning of the period | ' | ' | 3,698,000 | 4,998,000 | ' |
Amortization | ' | ' | -1,300,000 | -1,300,000 | ' |
Balance at the end of the period | ' | 3,698,000 | 2,398,000 | 3,698,000 | ' |
Changes in the carrying amount of intangible assets | ' | ' | ' | ' | ' |
Amortization | ' | ' | -1,300,000 | -1,300,000 | ' |
Accumulated amortization | ' | 79,300,000 | 114,700,000 | 79,300,000 | ' |
Weighted average remaining amortization period | ' | ' | '2 years | ' | ' |
Trademarks and Brands Not Subject to Amortization | ' | ' | ' | ' | ' |
Changes in the carrying amount of intangible assets not subject to amortization | ' | ' | ' | ' | ' |
Balance at the beginning of the period | ' | ' | 99,597,000 | 99,176,000 | ' |
Translation adjustments | ' | ' | -1,384,000 | 421,000 | ' |
Balance at the end of the period | ' | $99,597,000 | $98,213,000 | $99,597,000 | ' |
Goodwill_and_Intangible_Assets4
Goodwill and Intangible Assets, net (Details 3) (USD $) | Dec. 31, 2013 |
In Thousands, unless otherwise specified | |
Expected future amortization expense for intangible assets | ' |
2014 | $36,961 |
2015 | 36,759 |
2016 | 35,661 |
2017 | 34,173 |
2018 | 26,090 |
Thereafter | 49,117 |
Total | $218,761 |
Accrued_Expenses_and_Other_Cur2
Accrued Expenses and Other Current Liabilities (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Accrued Expenses and Other Current Liabilities | ' | ' |
Trade, sales promotion and advertising | $8,777 | $9,022 |
Accrued interest | 8,029 | 8,191 |
Accrued taxes | 50 | 3,421 |
Compensation and benefits | 2,156 | 2,928 |
Other | 4,443 | 5,009 |
Accrued expenses and other current liabilities | $23,455 | $28,571 |
Debt_Details
Debt (Details) (USD $) | 12 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Sep. 30, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Nov. 30, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Nov. 06, 2010 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Credit Facility | Revolver | Revolver | Revolver | Revolver | Term Loan | Term Loan | Term Loan | Senior Notes | Senior Notes | Senior Notes | Senior Notes | Senior Notes | Other | Other | Other | ||||
Debt | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Balance | $566,000,000 | $569,000,000 | ' | ' | $0 | ' | ' | ' | $291,000,000 | $294,000,000 | ' | ' | $275,000,000 | $275,000,000 | ' | ' | ' | ' | ' |
Less: discount | -12,418,000 | -15,140,000 | ' | ' | 0 | ' | ' | ' | -5,018,000 | -6,610,000 | ' | ' | -7,400,000 | -8,530,000 | ' | ' | ' | ' | ' |
Debt | 553,582,000 | 553,860,000 | ' | ' | 0 | ' | ' | ' | 285,982,000 | 287,390,000 | ' | ' | 267,600,000 | 266,470,000 | ' | ' | ' | ' | ' |
Less: current portion, net of discount | -71,000 | -279,000 | ' | ' | ' | ' | ' | ' | -1,324,000 | -1,414,000 | ' | ' | 1,253,000 | 1,135,000 | ' | ' | ' | ' | ' |
Long-term portion, net of discount | 553,511,000 | 553,581,000 | ' | ' | ' | ' | ' | ' | 284,658,000 | 285,976,000 | ' | ' | 268,853,000 | 267,605,000 | ' | ' | ' | ' | ' |
Variable reference rate, description | ' | ' | ' | 'LIBOR | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fixed reference rate (as a percent) | ' | ' | ' | 1.75% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Interest rate added to reference rate (as a percent) | ' | ' | ' | 4.25% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Maximum borrowing capacity under credit facility | ' | ' | ' | ' | 50,000,000 | ' | ' | 50,000,000 | 300,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Annual commitment fee (as a percent) | ' | ' | ' | ' | 0.75% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Quarterly principal payments on debt instrument | ' | ' | ' | ' | ' | ' | ' | ' | 800,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Interest rate (as a percent) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9.25% | ' | ' | ' | ' | ' | ' |
Principal amount of debt issued | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 275,000,000 | ' | ' | ' |
Additional interest accrued and paid | 43,878,000 | 45,314,000 | 40,866,000 | ' | ' | ' | ' | ' | ' | ' | ' | 300,000 | ' | ' | ' | ' | ' | ' | ' |
Interest expense | 48,024,000 | 48,887,000 | 48,090,000 | ' | 864,000 | 1,485,000 | 1,076,000 | ' | 19,954,000 | 20,110,000 | 20,096,000 | ' | 27,089,000 | 26,980,000 | 26,907,000 | ' | 117,000 | 312,000 | 11,000 |
Amount outstanding | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Costs associated with amendment | 9,979,000 | 9,979,000 | ' | ' | ' | ' | ' | 400,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Maturities | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
2014 | 3,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
2015 | 3,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
2016 | 285,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
2018 | 275,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total debt | 566,000,000 | 569,000,000 | ' | ' | 0 | ' | ' | ' | 291,000,000 | 294,000,000 | ' | ' | 275,000,000 | 275,000,000 | ' | ' | ' | ' | ' |
Deferred Financing Costs, net | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Balance | 9,979,000 | 9,979,000 | ' | ' | ' | ' | ' | 400,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Less: accumulated amortization | -4,814,000 | -3,228,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Deferred finance costs, current and non-current | 5,165,000 | 6,751,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Less: current portion, net of amortization | -1,767,000 | -1,843,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Long-term portion, net of amortization | $3,398,000 | $4,908,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair_Value_Measurement_of_Asse2
Fair Value Measurement of Assets and Liabilities (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Carrying Value | ' | ' |
Fair Value Measurement of Assets and Liabilities | ' | ' |
Term loan | $285,982 | $287,390 |
Senior notes | 267,600 | 266,470 |
Fair Value | ' | ' |
Fair Value Measurement of Assets and Liabilities | ' | ' |
Term loan | 291,000 | 281,138 |
Senior notes | $267,438 | $233,063 |
Commitments_and_Contingencies_1
Commitments and Contingencies (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Operating Leases | ' | ' | ' |
2014 | $1,573 | ' | ' |
2015 | 1,315 | ' | ' |
2016 | 1,165 | ' | ' |
2017 | 604 | ' | ' |
2018 | 515 | ' | ' |
Thereafter | 332 | ' | ' |
Operating leases, total | 5,504 | ' | ' |
Other operating lease information | ' | ' | ' |
Rent expense | 1,744 | 2,773 | 1,966 |
Procurement, Contract Manufacturing, Warehousing and Logistics Obligations | ' | ' | ' |
Future minimum payments required | ' | ' | ' |
2014 | 19,374 | ' | ' |
2015 | 3,386 | ' | ' |
2016 | 3,125 | ' | ' |
2017 | 1,976 | ' | ' |
Total | 27,861 | ' | ' |
Other operating lease information | ' | ' | ' |
Term for termination of contracts | '120 days | ' | ' |
Communication period based on orders and short-term projections | '3 months | ' | ' |
Software Maintenance, Systems Support and Hosting | ' | ' | ' |
Future minimum payments required | ' | ' | ' |
2014 | 1,065 | ' | ' |
2015 | 534 | ' | ' |
2016 | 143 | ' | ' |
Total | 1,742 | ' | ' |
Sponsorship and Media Agreements | ' | ' | ' |
Future minimum payments required | ' | ' | ' |
2014 | 8,801 | ' | ' |
2015 | 820 | ' | ' |
2016 | 845 | ' | ' |
Total | 10,466 | ' | ' |
Advisory Services and Monitoring | ' | ' | ' |
Future minimum payments required | ' | ' | ' |
2014 | 1,000 | ' | ' |
2015 | 1,000 | ' | ' |
2016 | 1,000 | ' | ' |
2017 | 1,000 | ' | ' |
2018 | 1,000 | ' | ' |
Thereafter | 1,000 | ' | ' |
Total | $6,000 | ' | ' |
Litigation_and_Other_Legal_Mat1
Litigation and Other Legal Matters (Details) (Potential contract claim, Clorox, USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Millions, unless otherwise specified | ||
Potential contract claim | Clorox | ' | ' |
Litigation and Other Legal Matters | ' | ' |
Percentage of first $5,000,000 in settlement costs agreed to be indemnified and reimbursed | 50.00% | ' |
Settlement costs as basis for determining settlement costs related to the contract claim to be indemnified and reimbursed | $5 | ' |
Accrued long-term liabilities related to loss contingency | $2.50 | $2.50 |
Common_Stock_Details
Common Stock (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, except Per Share data, unless otherwise specified | ||
Common Stock | ' | ' |
Common stock authorized (in shares) | 1 | 1 |
Common stock issued (in shares) | 1 | 1 |
Common stock outstanding (in shares) | 1 | 1 |
Common stock, par value (in dollars per share) | $0.01 | $0.01 |
Common stock owned by Avista (as a percent) | 99.30% | ' |
Common stock owned by certain members of management and the Board of Directors (as a percent) | 0.70% | ' |
Share_Based_Compensation_Plans2
Share Based Compensation Plans (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Share based compensation expense and related income tax benefits | ' | ' | ' |
Total share based compensation costs | $290 | $266 | $266 |
Cost of products sold | ' | ' | ' |
Share based compensation expense and related income tax benefits | ' | ' | ' |
Total share based compensation costs | 15 | 13 | 13 |
Selling and administrative expenses | ' | ' | ' |
Share based compensation expense and related income tax benefits | ' | ' | ' |
Total share based compensation costs | 260 | 243 | 243 |
Research and development costs | ' | ' | ' |
Share based compensation expense and related income tax benefits | ' | ' | ' |
Total share based compensation costs | $15 | $10 | $10 |
Share_Based_Compensation_Plans3
Share Based Compensation Plans (Details 2) (2010 AAG Option Plan, USD $) | Dec. 31, 2013 | Nov. 30, 2010 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 |
Time-based and performance based options | Time-based and performance based options | Time-based and performance based options | Time-based options | Time-based options | Time-based options | Performance based options | Performance based options | |||
Share Based Compensation Plans | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Authorized equity awards to be granted (in shares) | ' | 26,500,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Equity awards that remain available for grant (in shares) | 5,992,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted-average assumptions used for option grants | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Expected life | ' | ' | '6 years 6 months | '6 years 6 months | '6 years 6 months | ' | ' | ' | ' | ' |
Expected volatility (as a percent) | ' | ' | 34.00% | 35.00% | 50.00% | ' | ' | ' | ' | ' |
Risk-free interest rate, minimum (as a percent) | ' | ' | 1.23% | 0.91% | 1.45% | ' | ' | ' | ' | ' |
Risk-free interest rate, maximum (as a percent) | ' | ' | 2.03% | 1.36% | 3.05% | ' | ' | ' | ' | ' |
Dividend yield (as a percent) | ' | ' | 0.00% | 0.00% | 0.00% | ' | ' | ' | ' | ' |
Number of Shares | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested at the beginning of the period (in shares) | ' | ' | ' | ' | ' | 4,708,000 | 5,867,000 | ' | 12,862,000 | 12,848,000 |
Granted (in shares) | ' | ' | ' | ' | ' | 935,000 | 493,000 | ' | 1,869,000 | 985,000 |
Forfeited (in shares) | ' | ' | ' | ' | ' | -614,000 | -354,000 | ' | -926,000 | -971,000 |
Vested (in shares) | ' | ' | ' | ' | ' | -1,153,000 | -1,298,000 | ' | ' | ' |
Non-vested at the end of the period (in shares) | ' | ' | ' | ' | ' | 3,876,000 | 4,708,000 | 5,867,000 | 13,805,000 | 12,862,000 |
Vested and exercisable at the end of the period (in shares) | ' | ' | ' | ' | ' | 2,827,000 | ' | ' | ' | ' |
Outstanding at the end of the period (in shares) | ' | ' | ' | ' | ' | 6,703,000 | ' | ' | 13,805,000 | ' |
Weighted-Average Exercise Price | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested at the beginning of the period (in dollars per share) | ' | ' | ' | ' | ' | $1.02 | $1.01 | ' | $1.01 | $1.01 |
Granted (in dollars per share) | ' | ' | ' | ' | ' | $1 | $1 | ' | $1 | $1 |
Forfeited (in dollars per share) | ' | ' | ' | ' | ' | $1 | $1 | ' | $1 | $1 |
Vested (in dollars per share) | ' | ' | ' | ' | ' | $1.01 | $1.01 | ' | ' | ' |
Non-vested at the end of the period (in dollars per share) | ' | ' | ' | ' | ' | $1.02 | $1.02 | $1.01 | $1.01 | $1.01 |
Outstanding at the end of the period (in dollars per share) | ' | ' | ' | ' | ' | $1.01 | ' | ' | $1.01 | ' |
Vested and exercisable at the end of the period (in dollars per share) | ' | ' | ' | ' | ' | $1 | ' | ' | ' | ' |
Exercised (in shares) | ' | ' | ' | ' | ' | 0 | ' | ' | ' | ' |
Proceeds received from stock options exercised | ' | ' | ' | ' | ' | $0 | ' | ' | ' | ' |
Average Remaining Contractual Life | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding at the end of the period | ' | ' | ' | ' | ' | '7 years 9 months 18 days | ' | ' | ' | ' |
Vested and exercisable at the end of the period | ' | ' | ' | ' | ' | '7 years 1 month 6 days | ' | ' | ' | ' |
Aggregate Intrinsic Value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vested and exercisable at the end of the period (in dollars) | ' | ' | ' | ' | ' | 0 | ' | ' | ' | ' |
Fair value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted-average fair value of option granted (in dollars per share) | ' | ' | ' | ' | ' | $0.15 | $0.15 | $0.21 | ' | ' |
Weighted-average fair value of option granted to-date (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | $0.06 | ' |
Fair value of options vested (in dollars) | ' | ' | ' | ' | ' | 200,000 | 300,000 | 200,000 | ' | ' |
Other disclosures | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vesting period | ' | ' | ' | ' | ' | '5 years | ' | ' | ' | ' |
Expiration period | ' | ' | '10 years | ' | ' | ' | ' | ' | ' | ' |
Unrecognized compensation cost | ' | ' | ' | ' | ' | $600,000 | ' | ' | $800,000 | ' |
Weighted average vesting period to recognize unrecognized compensation cost | ' | ' | ' | ' | ' | ' | ' | ' | '7 years 6 months | ' |
Income_Taxes_Details
Income Taxes (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Current: | ' | ' | ' |
Federal | $3,006 | $1,425 | $1,323 |
State | 537 | 364 | 994 |
Foreign | 892 | 1,783 | 104 |
Total current | 4,435 | 3,572 | 2,421 |
Deferred: | ' | ' | ' |
Federal | -11,874 | -11,060 | -12,069 |
State | -2,818 | 1,206 | -1,343 |
Foreign | -518 | -758 | -714 |
Total deferred | -15,210 | -10,612 | -14,126 |
Total | -10,775 | -7,040 | -11,705 |
Components of loss before income taxes, by tax jurisdiction | ' | ' | ' |
United States | -19,478 | -24,880 | -20,823 |
Foreign | -4,667 | -27,961 | -8,550 |
Earnings (loss) before income taxes | ($24,145) | ($52,841) | ($29,373) |
Reconciliation of the statutory federal income tax rate to effective tax rate on loss | ' | ' | ' |
Statutory federal tax rate (as a percent) | 35.00% | 35.00% | 35.00% |
Non-deductible impairment of goodwill (as a percent) | ' | -12.30% | ' |
State taxes (net of federal tax benefits) (as a percent) | 6.80% | -1.90% | 0.80% |
Foreign rate differential (as a percent) | -1.30% | -3.00% | 2.90% |
Domestic production activities deduction (as a percent) | 0.80% | 0.60% | ' |
Acquisition-related (as a percent) | ' | 0.40% | -0.60% |
Change in Valuation Allowance (as a percent) | -2.30% | ' | ' |
UK interest deduction | 1.80% | ' | ' |
Other differences (as a percent) | 3.80% | -5.50% | 1.70% |
Effective tax rate (as a percent) | 44.60% | 13.30% | 39.80% |
Income_Taxes_Details_2
Income Taxes (Details 2) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Deferred tax assets: | ' | ' |
Accrual and reserves | $1,841 | $1,718 |
Inventory costs | 2,064 | 2,743 |
Acquisition-related | 2,225 | 2,438 |
Net operating losses | 1,806 | 1,190 |
Other | ' | 42 |
Total deferred tax assets | 7,936 | 8,131 |
Deferred tax liabilities: | ' | ' |
Fixed and intangible assets | -93,388 | -108,947 |
Total deferred tax liabilities | -93,388 | -108,947 |
Valuation Allowance | -603 | ' |
Net deferred tax liabilities | -86,055 | -100,816 |
Net deferred tax assets and liabilities | ' | ' |
Current deferred tax assets | 3,555 | 4,315 |
Non-current deferred tax liabilities | -89,610 | -105,131 |
Net deferred tax liabilities | ($86,055) | ($100,816) |
Income_Taxes_Details_3
Income Taxes (Details 3) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Operating loss carryforwards | ' | ' | ' |
Total balance of accrued interest and penalties related to uncertain tax positions | $100,000 | $200,000 | ' |
Reconciliation of gross unrecognized tax benefits | ' | ' | ' |
Unrecognized tax benefits - beginning of period | 379,000 | 417,000 | 586,000 |
Gross increases - tax positions in prior periods | 625,000 | ' | ' |
Gross increase - current period tax positions | ' | 75,000 | ' |
Statute of limitations lapse | -51,000 | ' | ' |
Settlements | -88,000 | -113,000 | -169,000 |
Unrecognized tax benefits - end of period | 865,000 | 379,000 | 417,000 |
Foreign | ' | ' | ' |
Operating loss carryforwards | ' | ' | ' |
Net operating loss carry-forwards | 10,000,000 | ' | ' |
Foreign | United Kingdom | ' | ' | ' |
Operating loss carryforwards | ' | ' | ' |
Net operating loss carry-forwards | 8,200,000 | ' | ' |
Foreign | China | ' | ' | ' |
Operating loss carryforwards | ' | ' | ' |
Net operating loss carry-forwards | 1,100,000 | ' | ' |
Operating loss carryforwards period | '5 years | ' | ' |
Foreign | Puerto Rico | ' | ' | ' |
Operating loss carryforwards | ' | ' | ' |
Net operating loss carry-forwards | 500,000 | ' | ' |
Operating loss carryforwards period | '10 years | ' | ' |
Foreign | Other foreign jurisdictions | ' | ' | ' |
Operating loss carryforwards | ' | ' | ' |
Net operating loss carry-forwards | $200,000 | ' | ' |
Income_Taxes_Details_4
Income Taxes (Details 4) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Unrecognized tax benefits | ' | ' |
Total amount of unrecognized tax benefits which affect the effective tax rate | $900,000 | $400,000 |
Uncertain tax position offset against net operating loss | 600,000 | ' |
Change in unrecognized tax benefits due to the lapse of statute of limitations | 51,000 | ' |
Provision for income taxes or foreign withholding taxes on cumulative unremitted earnings of foreign subsidiaries | 0 | ' |
Cumulative unremitted earnings of foreign subsidiaries | 700,000 | ' |
Expected | Clorox | ' | ' |
Unrecognized tax benefits | ' | ' |
Change in unrecognized tax benefits due to the lapse of statute of limitations | 100,000 | ' |
Predecessor | ' | ' |
Unrecognized tax benefits | ' | ' |
Total amount of unrecognized tax benefits which affect the effective tax rate | $200,000 | $300,000 |
Retirement_Income_and_Health_B2
Retirement Income and Health Benefit Plans (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
item | |||
Retirement Income and Health Benefit Plans | ' | ' | ' |
Number of components of the defined contribution plan | 2 | ' | ' |
Employer matching contribution per year | $1,000 | ' | ' |
Aggregate cost of defined contribution plans | $804,000 | $1,622,000 | $1,137,000 |
Segment_Data_Details
Segment Data (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
item | |||||||||||
Segment Data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of geographic segments | ' | ' | ' | ' | ' | ' | ' | ' | 2 | ' | ' |
Segment Data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | $64,461 | $71,007 | $80,075 | $74,413 | $69,029 | $68,348 | $82,695 | $86,396 | $289,956 | $306,468 | $281,317 |
Earnings (loss) before income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -24,145 | -52,841 | -29,373 |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | 4,305 | 7,698 | 13,011 |
Depreciation and amortization | ' | ' | ' | ' | ' | ' | ' | ' | 43,762 | 42,754 | 45,262 |
Share based compensation | ' | ' | ' | ' | ' | ' | ' | ' | 290 | 266 | 266 |
Non-cash goodwill impairment charge | ' | ' | ' | ' | 24,100 | ' | ' | ' | ' | 24,117 | ' |
North America | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 215,165 | 232,467 | 212,114 |
Operating segment | North America | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 215,165 | 232,467 | 212,114 |
Earnings (loss) before income taxes | ' | ' | ' | ' | ' | ' | ' | ' | 52,118 | 48,909 | 33,327 |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | 3,848 | 6,481 | 11,986 |
Depreciation and amortization | ' | ' | ' | ' | ' | ' | ' | ' | 6,133 | 5,622 | 7,454 |
Share based compensation | ' | ' | ' | ' | ' | ' | ' | ' | 266 | 256 | 256 |
Operating segment | International | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 74,791 | 74,001 | 69,203 |
Earnings (loss) before income taxes | ' | ' | ' | ' | ' | ' | ' | ' | 8,549 | -16,162 | 27,553 |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | 457 | 1,217 | 1,025 |
Depreciation and amortization | ' | ' | ' | ' | ' | ' | ' | ' | 841 | 431 | 1,107 |
Share based compensation | ' | ' | ' | ' | ' | ' | ' | ' | 24 | 10 | 10 |
Corporate | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Earnings (loss) before income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -84,812 | -85,588 | -90,253 |
Depreciation and amortization | ' | ' | ' | ' | ' | ' | ' | ' | $36,788 | $36,701 | $36,701 |
Segment_Data_Details_2
Segment Data (Details 2) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Segment data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total net sales | $64,461 | $71,007 | $80,075 | $74,413 | $69,029 | $68,348 | $82,695 | $86,396 | $289,956 | $306,468 | $281,317 |
North America | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total net sales | ' | ' | ' | ' | ' | ' | ' | ' | 215,165 | 232,467 | 212,114 |
Appearance products | North America | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total net sales | ' | ' | ' | ' | ' | ' | ' | ' | 160,180 | 171,592 | 152,035 |
Performance chemicals products | North America | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total net sales | ' | ' | ' | ' | ' | ' | ' | ' | $54,985 | $60,875 | $60,079 |
Segment_Data_Details_3
Segment Data (Details 3) (Net sales, Product Concentration) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
item | item | item | |
Segment data | ' | ' | ' |
Number of product lines accounting for more than 10% of total net sales | 3 | 3 | 3 |
Armor-All wipes | ' | ' | ' |
Segment data | ' | ' | ' |
Product line as a percentage of total combined net sales | 18.00% | 17.00% | 18.00% |
Armor-All protectant | ' | ' | ' |
Segment data | ' | ' | ' |
Product line as a percentage of total combined net sales | 21.00% | 22.00% | 26.00% |
STP fuel and oil additives | ' | ' | ' |
Segment data | ' | ' | ' |
Product line as a percentage of total combined net sales | 16.00% | 18.00% | 19.00% |
Segment_Data_Details_4
Segment Data (Details 4) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Segment data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total net sales | $64,461 | $71,007 | $80,075 | $74,413 | $69,029 | $68,348 | $82,695 | $86,396 | $289,956 | $306,468 | $281,317 |
U.S | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total net sales | ' | ' | ' | ' | ' | ' | ' | ' | 194,745 | 210,086 | 191,436 |
Canada | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total net sales | ' | ' | ' | ' | ' | ' | ' | ' | 20,420 | 22,381 | 20,678 |
Europe | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total net sales | ' | ' | ' | ' | ' | ' | ' | ' | 25,229 | 24,518 | 22,270 |
Australia and rest of world | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment data | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total net sales | ' | ' | ' | ' | ' | ' | ' | ' | $49,562 | $49,483 | $46,933 |
Segment_Data_Details_5
Segment Data (Details 5) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Segment data | ' | ' |
Total long-lived tangible assets | $28,936 | $31,473 |
U.S | ' | ' |
Segment data | ' | ' |
Total long-lived tangible assets | 26,095 | 28,079 |
Rest of world | ' | ' |
Segment data | ' | ' |
Total long-lived tangible assets | $2,841 | $3,394 |
Segment_Data_Details_6
Segment Data (Details 6) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Segment data | ' | ' |
Total assets | $832,247 | $880,757 |
North America | ' | ' |
Segment data | ' | ' |
Total assets | 123,964 | 128,461 |
International | ' | ' |
Segment data | ' | ' |
Total assets | 30,823 | 30,424 |
Corporate | ' | ' |
Segment data | ' | ' |
Total assets | $677,460 | $721,872 |
Financial_Information_for_the_2
Financial Information for the Company and Its Subsidiaries (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 |
In Thousands, unless otherwise specified | ||||
Current assets: | ' | ' | ' | ' |
Cash | $21,253 | $4,206 | $4,935 | $31,701 |
Accounts receivable | 62,210 | 69,602 | ' | ' |
Inventory | 34,043 | 42,444 | ' | ' |
Other current assets | 9,790 | 12,891 | ' | ' |
Total current assets | 127,296 | 129,143 | ' | ' |
Property, plant and equipment | 28,936 | 31,473 | ' | ' |
Goodwill | 358,826 | 362,216 | 384,793 | ' |
Intangible assets | 313,470 | 352,905 | 388,175 | ' |
Other assets | 3,719 | 5,020 | ' | ' |
Total assets | 832,247 | 880,757 | ' | ' |
Current liabilities: | ' | ' | ' | ' |
Accounts payable | 8,128 | 13,158 | ' | ' |
Accrued expenses and other current liabilities | 23,455 | 28,571 | ' | ' |
Notes payable, current portion | 71 | 279 | ' | ' |
Total current liabilities | 32,490 | 42,940 | ' | ' |
Notes payable, less current portion and discount | 553,511 | 553,581 | ' | ' |
Other liabilities | 2,500 | 2,500 | ' | ' |
Deferred income taxes | 89,610 | 105,131 | ' | ' |
Total liabilities | 678,111 | 704,152 | ' | ' |
Shareholder's equity | 154,136 | 176,605 | 218,333 | 237,742 |
Total liabilities and shareholder's equity | 832,247 | 880,757 | ' | ' |
Clorox | ' | ' | ' | ' |
Current liabilities: | ' | ' | ' | ' |
Due to Parent | 91 | 137 | ' | ' |
Parent | ' | ' | ' | ' |
Current liabilities: | ' | ' | ' | ' |
Due to Parent | 745 | 795 | ' | ' |
Reportable legal entities | Issuer | ' | ' | ' | ' |
Current assets: | ' | ' | ' | ' |
Cash | 14,843 | 1,477 | ' | 29,966 |
Accounts receivable | 78 | 105 | ' | ' |
Other current assets | 53,853 | 50,116 | ' | ' |
Total current assets | 68,774 | 51,698 | ' | ' |
Property, plant and equipment | 8,061 | 8,682 | ' | ' |
Investment in subsidiaries | 647,107 | 687,226 | ' | ' |
Other assets | 3,632 | 4,943 | ' | ' |
Total assets | 727,574 | 752,549 | ' | ' |
Current liabilities: | ' | ' | ' | ' |
Accounts payable | 169 | 888 | ' | ' |
Accrued expenses and other current liabilities | 10,063 | 12,397 | ' | ' |
Notes payable, current portion | 71 | 279 | ' | ' |
Total current liabilities | 11,117 | 14,359 | ' | ' |
Notes payable, less current portion and discount | 553,511 | 553,581 | ' | ' |
Other liabilities | 2,500 | 2,500 | ' | ' |
Deferred income taxes | 5,121 | 5,121 | ' | ' |
Total liabilities | 572,249 | 575,561 | ' | ' |
Shareholder's equity | 155,325 | 176,988 | ' | ' |
Total liabilities and shareholder's equity | 727,574 | 752,549 | ' | ' |
Reportable legal entities | Issuer | Clorox | ' | ' | ' | ' |
Current liabilities: | ' | ' | ' | ' |
Due to Parent | 69 | ' | ' | ' |
Reportable legal entities | Issuer | Parent | ' | ' | ' | ' |
Current liabilities: | ' | ' | ' | ' |
Due to Parent | 745 | 795 | ' | ' |
Reportable legal entities | Combined Guarantor Subsidiaries | ' | ' | ' | ' |
Current assets: | ' | ' | ' | ' |
Accounts receivable | 44,885 | 49,635 | ' | ' |
Inventory | 24,553 | 31,718 | ' | ' |
Other current assets | -45,072 | -38,357 | ' | ' |
Total current assets | 24,366 | 42,996 | ' | ' |
Property, plant and equipment | 18,037 | 19,397 | ' | ' |
Goodwill | 310,576 | 310,577 | ' | ' |
Intangible assets | 276,461 | 307,401 | ' | ' |
Investment in subsidiaries | 115,394 | 122,893 | ' | ' |
Other assets | 87 | 77 | ' | ' |
Total assets | 744,921 | 803,341 | ' | ' |
Current liabilities: | ' | ' | ' | ' |
Accounts payable | 5,103 | 8,868 | ' | ' |
Accrued expenses and other current liabilities | 8,263 | 7,215 | ' | ' |
Total current liabilities | 13,389 | 16,105 | ' | ' |
Deferred income taxes | 84,425 | 100,010 | ' | ' |
Total liabilities | 97,814 | 116,115 | ' | ' |
Shareholder's equity | 647,107 | 687,226 | ' | ' |
Total liabilities and shareholder's equity | 744,921 | 803,341 | ' | ' |
Reportable legal entities | Combined Guarantor Subsidiaries | Clorox | ' | ' | ' | ' |
Current liabilities: | ' | ' | ' | ' |
Due to Parent | 23 | 22 | ' | ' |
Reportable legal entities | Combined Non-Guarantor Subsidiaries | ' | ' | ' | ' |
Current assets: | ' | ' | ' | ' |
Cash | 6,410 | 2,729 | 4,935 | 1,735 |
Accounts receivable | 17,247 | 19,862 | ' | ' |
Inventory | 9,490 | 10,726 | ' | ' |
Other current assets | 1,009 | 1,132 | ' | ' |
Total current assets | 34,156 | 34,449 | ' | ' |
Property, plant and equipment | 2,838 | 3,394 | ' | ' |
Goodwill | 48,250 | 51,639 | ' | ' |
Intangible assets | 38,198 | 45,887 | ' | ' |
Total assets | 123,442 | 135,369 | ' | ' |
Current liabilities: | ' | ' | ' | ' |
Accounts payable | 2,856 | 3,402 | ' | ' |
Accrued expenses and other current liabilities | 5,129 | 8,959 | ' | ' |
Total current liabilities | 7,984 | 12,476 | ' | ' |
Deferred income taxes | 64 | ' | ' | ' |
Total liabilities | 8,048 | 12,476 | ' | ' |
Shareholder's equity | 115,394 | 122,893 | ' | ' |
Total liabilities and shareholder's equity | 123,442 | 135,369 | ' | ' |
Reportable legal entities | Combined Non-Guarantor Subsidiaries | Clorox | ' | ' | ' | ' |
Current liabilities: | ' | ' | ' | ' |
Due to Parent | -1 | 115 | ' | ' |
Eliminations | ' | ' | ' | ' |
Current assets: | ' | ' | ' | ' |
Intangible assets | -1,189 | -383 | ' | ' |
Investment in subsidiaries | -762,501 | -810,119 | ' | ' |
Total assets | -763,690 | -810,502 | ' | ' |
Current liabilities: | ' | ' | ' | ' |
Shareholder's equity | -763,690 | -810,502 | ' | ' |
Total liabilities and shareholder's equity | ($763,690) | ($810,502) | ' | ' |
Financial_Information_for_the_3
Financial Information for the Company and Its Subsidiaries (Details 2) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Condensed Consolidating Statement of Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | $64,461 | $71,007 | $80,075 | $74,413 | $69,029 | $68,348 | $82,695 | $86,396 | $289,956 | $306,468 | $281,317 |
Cost of products sold | ' | ' | ' | ' | ' | ' | ' | ' | 158,049 | 167,570 | 153,114 |
Cost of products sold-acquisition related | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4,439 |
Gross profit | 27,719 | 32,524 | 37,736 | 33,928 | 28,407 | 28,620 | 38,565 | 43,306 | 131,907 | 138,898 | 123,764 |
Operating expenses: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Selling and administrative expenses | ' | ' | ' | ' | ' | ' | ' | ' | 40,694 | 48,306 | 40,240 |
Advertising costs | ' | ' | ' | ' | ' | ' | ' | ' | 27,787 | 31,072 | 24,699 |
Research and development costs | ' | ' | ' | ' | ' | ' | ' | ' | 2,474 | 2,211 | 2,307 |
Amortization of acquired intangible assets | ' | ' | ' | ' | ' | ' | ' | ' | 36,788 | 36,701 | 36,701 |
Goodwill impairment | ' | ' | ' | ' | 24,100 | ' | ' | ' | ' | 24,117 | ' |
Acquisition related charges | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,020 |
Total operating expenses | ' | ' | ' | ' | ' | ' | ' | ' | 107,743 | 142,407 | 104,967 |
Operating (loss) profit | 3,030 | 6,102 | 4,093 | 10,939 | -22,425 | 27 | 3,683 | 15,206 | 24,164 | -3,509 | 18,797 |
Non-operating expenses (income) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Interest expense | ' | ' | ' | ' | ' | ' | ' | ' | 48,024 | 48,887 | 48,090 |
Other (income) expense | ' | ' | ' | ' | ' | ' | ' | ' | 285 | 445 | 80 |
Loss before income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -24,145 | -52,841 | -29,373 |
(Benefit) provision for income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -10,775 | -7,040 | -11,705 |
Net loss | -5,303 | -2,275 | -5,286 | -506 | -33,031 | -9,773 | -4,103 | 1,106 | -13,370 | -45,801 | -17,668 |
Other comprehensive (loss) income: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Foreign currency translation (loss) gain | ' | ' | ' | ' | ' | ' | ' | ' | -9,389 | 3,807 | -2,007 |
Comprehensive loss | ' | ' | ' | ' | ' | ' | ' | ' | -22,759 | -41,994 | -19,675 |
Reportable legal entities | Issuer | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statement of Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | ' | 154 | ' |
Gross profit | ' | ' | ' | ' | ' | ' | ' | ' | ' | 154 | ' |
Operating expenses: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Selling and administrative expenses | ' | ' | ' | ' | ' | ' | ' | ' | 19,316 | 23,788 | 17,475 |
Acquisition related charges | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,020 |
Total operating expenses | ' | ' | ' | ' | ' | ' | ' | ' | 19,316 | 23,788 | 18,495 |
Operating (loss) profit | ' | ' | ' | ' | ' | ' | ' | ' | -19,316 | -23,634 | -18,495 |
Non-operating expenses (income) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Interest expense | ' | ' | ' | ' | ' | ' | ' | ' | 48,015 | 48,887 | 48,090 |
Other (income) expense | ' | ' | ' | ' | ' | ' | ' | ' | -72 | 61 | -64 |
Loss before income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -67,259 | -72,582 | -66,521 |
(Benefit) provision for income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -19,194 | -2,751 | -35,194 |
Equity earnings (loss) of subsidiaries, net of taxes | ' | ' | ' | ' | ' | ' | ' | ' | 34,695 | 24,030 | 13,659 |
Net loss | ' | ' | ' | ' | ' | ' | ' | ' | -13,370 | -45,801 | -17,668 |
Other comprehensive (loss) income: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Foreign currency translation (loss) gain | ' | ' | ' | ' | ' | ' | ' | ' | -9,389 | 3,807 | -2,007 |
Comprehensive loss | ' | ' | ' | ' | ' | ' | ' | ' | -22,759 | -41,994 | -19,675 |
Reportable legal entities | Combined Guarantor Subsidiaries | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statement of Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 235,897 | 255,078 | 233,176 |
Cost of products sold | ' | ' | ' | ' | ' | ' | ' | ' | 124,194 | 137,302 | 123,721 |
Cost of products sold-acquisition related | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4,439 |
Gross profit | ' | ' | ' | ' | ' | ' | ' | ' | 111,703 | 117,776 | 105,016 |
Operating expenses: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Selling and administrative expenses | ' | ' | ' | ' | ' | ' | ' | ' | 10,903 | 13,434 | 11,766 |
Advertising costs | ' | ' | ' | ' | ' | ' | ' | ' | 21,549 | 24,296 | 17,941 |
Research and development costs | ' | ' | ' | ' | ' | ' | ' | ' | 2,463 | 2,211 | 2,307 |
Amortization of acquired intangible assets | ' | ' | ' | ' | ' | ' | ' | ' | 30,181 | 30,181 | 30,181 |
Total operating expenses | ' | ' | ' | ' | ' | ' | ' | ' | 65,096 | 70,122 | 62,195 |
Operating (loss) profit | ' | ' | ' | ' | ' | ' | ' | ' | 46,607 | 47,654 | 42,821 |
Non-operating expenses (income) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Interest expense | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | ' |
Other (income) expense | ' | ' | ' | ' | ' | ' | ' | ' | 82 | -48 | -95 |
Loss before income taxes | ' | ' | ' | ' | ' | ' | ' | ' | 46,524 | 47,702 | 42,916 |
(Benefit) provision for income taxes | ' | ' | ' | ' | ' | ' | ' | ' | 8,045 | -5,312 | 24,099 |
Equity earnings (loss) of subsidiaries, net of taxes | ' | ' | ' | ' | ' | ' | ' | ' | -3,784 | -28,984 | -5,158 |
Net loss | ' | ' | ' | ' | ' | ' | ' | ' | 34,695 | 24,030 | 13,659 |
Other comprehensive (loss) income: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Foreign currency translation (loss) gain | ' | ' | ' | ' | ' | ' | ' | ' | -9,389 | 3,807 | -2,007 |
Comprehensive loss | ' | ' | ' | ' | ' | ' | ' | ' | 25,306 | 27,837 | 11,652 |
Reportable legal entities | Combined Non-Guarantor Subsidiaries | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statement of Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 75,557 | 79,693 | 77,870 |
Cost of products sold | ' | ' | ' | ' | ' | ' | ' | ' | 55,353 | 58,725 | 59,122 |
Gross profit | ' | ' | ' | ' | ' | ' | ' | ' | 20,204 | 20,968 | 18,748 |
Operating expenses: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Selling and administrative expenses | ' | ' | ' | ' | ' | ' | ' | ' | 10,475 | 11,084 | 10,999 |
Advertising costs | ' | ' | ' | ' | ' | ' | ' | ' | 6,238 | 6,776 | 6,758 |
Research and development costs | ' | ' | ' | ' | ' | ' | ' | ' | 11 | ' | ' |
Amortization of acquired intangible assets | ' | ' | ' | ' | ' | ' | ' | ' | 6,607 | 6,520 | 6,520 |
Goodwill impairment | ' | ' | ' | ' | ' | ' | ' | ' | ' | 24,117 | ' |
Total operating expenses | ' | ' | ' | ' | ' | ' | ' | ' | 23,331 | 48,497 | 24,277 |
Operating (loss) profit | ' | ' | ' | ' | ' | ' | ' | ' | -3,127 | -27,529 | -5,529 |
Non-operating expenses (income) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Interest expense | ' | ' | ' | ' | ' | ' | ' | ' | 8 | ' | ' |
Other (income) expense | ' | ' | ' | ' | ' | ' | ' | ' | 275 | 432 | 239 |
Loss before income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -3,410 | -27,961 | -5,768 |
(Benefit) provision for income taxes | ' | ' | ' | ' | ' | ' | ' | ' | 374 | 1,023 | -610 |
Net loss | ' | ' | ' | ' | ' | ' | ' | ' | -3,784 | -28,984 | -5,158 |
Other comprehensive (loss) income: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Foreign currency translation (loss) gain | ' | ' | ' | ' | ' | ' | ' | ' | -9,389 | 3,807 | -2,007 |
Comprehensive loss | ' | ' | ' | ' | ' | ' | ' | ' | -13,173 | -25,117 | -7,165 |
Eliminations | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statement of Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | -21,498 | -28,457 | -29,729 |
Cost of products sold | ' | ' | ' | ' | ' | ' | ' | ' | -21,498 | -28,457 | -29,729 |
Non-operating expenses (income) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Equity earnings (loss) of subsidiaries, net of taxes | ' | ' | ' | ' | ' | ' | ' | ' | -30,911 | 4,954 | -8,501 |
Net loss | ' | ' | ' | ' | ' | ' | ' | ' | -30,911 | 4,954 | -8,501 |
Other comprehensive (loss) income: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Foreign currency translation (loss) gain | ' | ' | ' | ' | ' | ' | ' | ' | 18,778 | -7,614 | 4,014 |
Comprehensive loss | ' | ' | ' | ' | ' | ' | ' | ' | ($12,133) | ($2,660) | ($4,487) |
Financial_Information_for_the_4
Financial Information for the Company and Its Subsidiaries (Details 3) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Cash flows from operating activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net earnings (loss) | ($5,303) | ($2,275) | ($5,286) | ($506) | ($33,031) | ($9,773) | ($4,103) | $1,106 | ($13,370) | ($45,801) | ($17,668) |
Adjustments: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Depreciation and amortization | ' | ' | ' | ' | ' | ' | ' | ' | 47,846 | 46,813 | 45,262 |
Goodwill impairment | ' | ' | ' | ' | 24,100 | ' | ' | ' | ' | 24,117 | ' |
Share based compensation | ' | ' | ' | ' | ' | ' | ' | ' | 290 | 266 | 266 |
Deferred income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -14,783 | -10,612 | -14,126 |
Other | ' | ' | ' | ' | ' | ' | ' | ' | 63 | 157 | 375 |
Cash effect of changes, net of acquisition effects, in: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Receivables | ' | ' | ' | ' | ' | ' | ' | ' | 8,955 | -15,302 | -18,934 |
Inventory | ' | ' | ' | ' | ' | ' | ' | ' | 9,276 | -5,194 | 972 |
Due from Clorox | ' | ' | ' | ' | ' | ' | ' | ' | -46 | 11,864 | -10,053 |
Other current assets | ' | ' | ' | ' | ' | ' | ' | ' | 781 | -753 | -476 |
Prepaid taxes | ' | ' | ' | ' | ' | ' | ' | ' | 1,215 | ' | ' |
Accounts payable and accrued liabilities | ' | ' | ' | ' | ' | ' | ' | ' | -10,622 | 10,509 | 2,299 |
Book overdraft | ' | ' | ' | ' | ' | ' | ' | ' | ' | -1,987 | 1,987 |
Income taxes payable | ' | ' | ' | ' | ' | ' | ' | ' | 1,215 | -4,436 | 306 |
Intercompany | ' | ' | ' | ' | ' | ' | ' | ' | -1,338 | 603 | ' |
Net cash provided by (used in) operating activities | ' | ' | ' | ' | ' | ' | ' | ' | 28,267 | 10,244 | -9,790 |
Cash flows from investing activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | -4,305 | -7,698 | -13,011 |
Acquisition, net | ' | ' | ' | ' | ' | ' | ' | ' | -3,084 | ' | ' |
Net cash used in investing activities | ' | ' | ' | ' | ' | ' | ' | ' | -7,389 | -7,698 | -13,011 |
Cash flows from financing activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Borrowings under revolver | ' | ' | ' | ' | ' | ' | ' | ' | 23,000 | 64,001 | 29,500 |
Payments on revolver | ' | ' | ' | ' | ' | ' | ' | ' | -23,000 | -64,001 | -29,500 |
Principal payments on notes payable and other | ' | ' | ' | ' | ' | ' | ' | ' | -3,611 | -3,000 | -3,000 |
Advance from parent | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 795 |
Debt financing costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | -350 | -670 |
Payment on advance from Parent | ' | ' | ' | ' | ' | ' | ' | ' | -50 | ' | ' |
Net cash used in financing activities | ' | ' | ' | ' | ' | ' | ' | ' | -3,661 | -3,350 | -2,875 |
Effect of exchange rate changes on cash | ' | ' | ' | ' | ' | ' | ' | ' | -170 | 75 | -1,090 |
Net (decrease) increase in cash | ' | ' | ' | ' | ' | ' | ' | ' | 17,047 | -729 | -26,766 |
Cash at beginning of period | ' | ' | ' | 4,206 | ' | ' | ' | 4,935 | 4,206 | 4,935 | 31,701 |
Cash at end of period | 21,253 | ' | ' | ' | 4,206 | ' | ' | ' | 21,253 | 4,206 | 4,935 |
Reportable legal entities | Issuer | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash flows from operating activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net earnings (loss) | ' | ' | ' | ' | ' | ' | ' | ' | -13,370 | -45,801 | -17,668 |
Adjustments: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Depreciation and amortization | ' | ' | ' | ' | ' | ' | ' | ' | 6,066 | 5,651 | 4,316 |
Share based compensation | ' | ' | ' | ' | ' | ' | ' | ' | 290 | 266 | 266 |
Deferred income taxes | ' | ' | ' | ' | ' | ' | ' | ' | 765 | ' | -1,716 |
Equity (loss) earnings of subsidiaries, net of taxes | ' | ' | ' | ' | ' | ' | ' | ' | -34,695 | -24,030 | -13,659 |
Cash effect of changes, net of acquisition effects, in: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Receivables | ' | ' | ' | ' | ' | ' | ' | ' | 27 | 661 | -615 |
Due from Clorox | ' | ' | ' | ' | ' | ' | ' | ' | 69 | -244 | -820 |
Other current assets | ' | ' | ' | ' | ' | ' | ' | ' | -5,782 | -40,890 | 1,040 |
Prepaid taxes | ' | ' | ' | ' | ' | ' | ' | ' | 1,215 | ' | ' |
Accounts payable and accrued liabilities | ' | ' | ' | ' | ' | ' | ' | ' | -3,052 | -2,885 | 8,855 |
Book overdraft | ' | ' | ' | ' | ' | ' | ' | ' | ' | -1,987 | 1,987 |
Intercompany receivable / payable | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 34,712 |
Income taxes payable | ' | ' | ' | ' | ' | ' | ' | ' | ' | 31,173 | -35,142 |
Intercompany | ' | ' | ' | ' | ' | ' | ' | ' | 66,019 | 83,755 | ' |
Net cash provided by (used in) operating activities | ' | ' | ' | ' | ' | ' | ' | ' | 17,552 | 5,669 | -18,444 |
Cash flows from investing activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | -1,136 | -1,453 | -8,647 |
Net cash used in investing activities | ' | ' | ' | ' | ' | ' | ' | ' | -1,136 | -1,453 | -8,647 |
Cash flows from financing activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Borrowings under revolver | ' | ' | ' | ' | ' | ' | ' | ' | 23,000 | 64,001 | 29,500 |
Payments on revolver | ' | ' | ' | ' | ' | ' | ' | ' | -23,000 | -64,001 | -29,500 |
Principal payments on notes payable and other | ' | ' | ' | ' | ' | ' | ' | ' | -3,000 | -3,000 | -3,000 |
Advance from parent | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 795 |
Debt financing costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | -350 | -670 |
Payment on advance from Parent | ' | ' | ' | ' | ' | ' | ' | ' | -50 | ' | ' |
Net cash used in financing activities | ' | ' | ' | ' | ' | ' | ' | ' | -3,050 | -3,350 | -2,875 |
Effect of exchange rate changes on cash | ' | ' | ' | ' | ' | ' | ' | ' | ' | 611 | ' |
Net (decrease) increase in cash | ' | ' | ' | ' | ' | ' | ' | ' | 13,366 | 1,477 | -29,966 |
Cash at beginning of period | ' | ' | ' | 1,477 | ' | ' | ' | ' | 1,477 | ' | 29,966 |
Cash at end of period | 14,843 | ' | ' | ' | 1,477 | ' | ' | ' | 14,843 | 1,477 | ' |
Reportable legal entities | Combined Guarantor Subsidiaries | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash flows from operating activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net earnings (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 34,695 | 24,030 | 13,659 |
Adjustments: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Depreciation and amortization | ' | ' | ' | ' | ' | ' | ' | ' | 34,194 | 33,958 | 33,319 |
Deferred income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -15,589 | -11,360 | -12,410 |
Equity (loss) earnings of subsidiaries, net of taxes | ' | ' | ' | ' | ' | ' | ' | ' | 3,784 | 28,984 | 5,158 |
Other | ' | ' | ' | ' | ' | ' | ' | ' | 75 | 157 | 80 |
Cash effect of changes, net of acquisition effects, in: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Receivables | ' | ' | ' | ' | ' | ' | ' | ' | 4,750 | -7,214 | -15,881 |
Inventory | ' | ' | ' | ' | ' | ' | ' | ' | 7,165 | -2,354 | -932 |
Due from Clorox | ' | ' | ' | ' | ' | ' | ' | ' | ' | 11,455 | -7,807 |
Other current assets | ' | ' | ' | ' | ' | ' | ' | ' | 6,709 | 38,822 | -541 |
Accounts payable and accrued liabilities | ' | ' | ' | ' | ' | ' | ' | ' | -2,717 | 6,567 | -6,044 |
Intercompany receivable / payable | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -40,710 |
Income taxes payable | ' | ' | ' | ' | ' | ' | ' | ' | ' | -35,531 | 35,448 |
Intercompany | ' | ' | ' | ' | ' | ' | ' | ' | -70,338 | -81,930 | ' |
Net cash provided by (used in) operating activities | ' | ' | ' | ' | ' | ' | ' | ' | 2,728 | 5,584 | 3,339 |
Cash flows from investing activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | -2,728 | -4,976 | -3,339 |
Net cash used in investing activities | ' | ' | ' | ' | ' | ' | ' | ' | -2,728 | -4,976 | -3,339 |
Cash flows from financing activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Effect of exchange rate changes on cash | ' | ' | ' | ' | ' | ' | ' | ' | ' | -608 | ' |
Reportable legal entities | Combined Non-Guarantor Subsidiaries | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash flows from operating activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net earnings (loss) | ' | ' | ' | ' | ' | ' | ' | ' | -3,784 | -28,984 | -5,158 |
Adjustments: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Depreciation and amortization | ' | ' | ' | ' | ' | ' | ' | ' | 7,586 | 7,204 | 7,627 |
Goodwill impairment | ' | ' | ' | ' | ' | ' | ' | ' | ' | 24,117 | ' |
Deferred income taxes | ' | ' | ' | ' | ' | ' | ' | ' | 41 | 748 | ' |
Other | ' | ' | ' | ' | ' | ' | ' | ' | -12 | ' | 295 |
Cash effect of changes, net of acquisition effects, in: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Receivables | ' | ' | ' | ' | ' | ' | ' | ' | 4,178 | -8,749 | -2,438 |
Inventory | ' | ' | ' | ' | ' | ' | ' | ' | 2,111 | -2,840 | 1,904 |
Due from Clorox | ' | ' | ' | ' | ' | ' | ' | ' | -115 | 653 | -1,426 |
Other current assets | ' | ' | ' | ' | ' | ' | ' | ' | -146 | 1,315 | -975 |
Accounts payable and accrued liabilities | ' | ' | ' | ' | ' | ' | ' | ' | -4,853 | 6,827 | -512 |
Intercompany receivable / payable | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,612 |
Income taxes payable | ' | ' | ' | ' | ' | ' | ' | ' | ' | -78 | ' |
Intercompany | ' | ' | ' | ' | ' | ' | ' | ' | 2,981 | -820 | ' |
Net cash provided by (used in) operating activities | ' | ' | ' | ' | ' | ' | ' | ' | 7,987 | -607 | 4,929 |
Cash flows from investing activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | -441 | -1,269 | -1,025 |
Acquisition, net | ' | ' | ' | ' | ' | ' | ' | ' | -3,084 | ' | ' |
Net cash used in investing activities | ' | ' | ' | ' | ' | ' | ' | ' | -3,525 | -1,269 | -1,025 |
Cash flows from financing activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Principal payments on notes payable and other | ' | ' | ' | ' | ' | ' | ' | ' | -611 | ' | ' |
Net cash used in financing activities | ' | ' | ' | ' | ' | ' | ' | ' | -611 | ' | ' |
Effect of exchange rate changes on cash | ' | ' | ' | ' | ' | ' | ' | ' | -170 | -330 | -704 |
Net (decrease) increase in cash | ' | ' | ' | ' | ' | ' | ' | ' | 3,681 | -2,206 | 3,200 |
Cash at beginning of period | ' | ' | ' | 2,729 | ' | ' | ' | 4,935 | 2,729 | 4,935 | 1,735 |
Cash at end of period | 6,410 | ' | ' | ' | 2,729 | ' | ' | ' | 6,410 | 2,729 | 4,935 |
Eliminations | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash flows from operating activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net earnings (loss) | ' | ' | ' | ' | ' | ' | ' | ' | -30,911 | 4,954 | -8,501 |
Adjustments: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Equity (loss) earnings of subsidiaries, net of taxes | ' | ' | ' | ' | ' | ' | ' | ' | 30,911 | -4,954 | 8,501 |
Cash effect of changes, net of acquisition effects, in: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Intercompany receivable / payable | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 386 |
Intercompany | ' | ' | ' | ' | ' | ' | ' | ' | ' | -402 | ' |
Net cash provided by (used in) operating activities | ' | ' | ' | ' | ' | ' | ' | ' | ' | -402 | 386 |
Cash flows from financing activities: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Effect of exchange rate changes on cash | ' | ' | ' | ' | ' | ' | ' | ' | ' | $402 | ($386) |
Quarterly_Financial_Informatio2
Quarterly Financial Information (Unaudited) (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Quarterly Financial Information (Unaudited) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | $64,461 | $71,007 | $80,075 | $74,413 | $69,029 | $68,348 | $82,695 | $86,396 | $289,956 | $306,468 | $281,317 |
Gross profit | 27,719 | 32,524 | 37,736 | 33,928 | 28,407 | 28,620 | 38,565 | 43,306 | 131,907 | 138,898 | 123,764 |
Income from operations | 3,030 | 6,102 | 4,093 | 10,939 | -22,425 | 27 | 3,683 | 15,206 | 24,164 | -3,509 | 18,797 |
Net loss | -5,303 | -2,275 | -5,286 | -506 | -33,031 | -9,773 | -4,103 | 1,106 | -13,370 | -45,801 | -17,668 |
Non-cash goodwill impairment charge | ' | ' | ' | ' | $24,100 | ' | ' | ' | ' | $24,117 | ' |
Subsequent_Events_Details
Subsequent Events (Details) (Subsequent event, IDQ, USD $) | 0 Months Ended |
In Millions, unless otherwise specified | Mar. 17, 2014 |
Subsequent event | ' |
Amount of non-controlling equity interest acquired | $10 |
Transaction costs | 1.2 |
Board member | ' |
Subsequent event | ' |
Transaction costs | $0.30 |